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ABSTRACT
Few short-term psychosocial interventions have been devised for people in 
the acute stages of psychosis. The studies on psychoeducation for people 
with psychosis have focused on those in the chronic stages of illness. There 
is, however, increasing evidence to suggest that it is possible to intervene 
early in the course of a psychotic episode.
This study aims to assess the utility of a personalised psychoeducation 
package with a group of 16 inpatients diagnosed with acute psychosis. The 
scores of each participant were compared at three time points: prior to the 
intervention; post intervention and at six weeks follow-up. The five main 
areas assessed for change were: psychiatric symptomatology; insight; illness 
representations; compliance; and satisfaction.
There was evidence that this approach, together with routine care, may 
augment changes in psychiatric symptoms as measured by the Brief 
Psychiatric Rating Scale and the Brief Symptom Inventory. The findings of 
the study indicate that of those available for data collection, 46.15% 
significantly improved on Unusual Thought Content; 38.46% on Conceptual 
Disorganisation; and 38.46% on Paranoid Ideation. All change data was 
analysed using the Reliable Change Index.
In addition, the findings show that approximately 50% of the participants 
improved on at least one area of insight, as measured by the Scale to Assess 
Unawareness of Mental Disorder. The dimensions of insight measured
included awareness of having a mental disorder (53.85% of the participants 
available for data collection improved); awareness of the achieved effects of 
medication (46.15% improved); and awareness of the social consequences 
of having a mental disorder (53.85% improved). Approximately one third of 
participants improved and a further third deteriorated on one of the four 
illness representations measured using the Illness Perceptions 
Questionnaire-Revised. These included Consequences, Personal Control, 
Treatment Control and Illness Coherence. Only one participant improved on 
compliance with treatment, as operationalised for the purpose of this study. 
The majority of participants (78.57%) reported satisfaction with their care, as 
measured by the UKU-ConSat.
The useful elements of this psychoeducation package appear to be an 
individualised approach, a collaborative therapist-patient relationship and a 
brief number of sessions. These seem to allow participants to learn active 
means of controlling their illness.
This study is a useful preliminary investigation of a new personalised 
psychoeducation package for participants in the acute stages of psychosis. A 
larger scale randomised controlled trial, utilising a more robust design is 
advocated.
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1.0 INTRODUCTION
Psychosis is a confusing and frightening experience1. People with psychosis 
develop an alternative reality that can isolate them from society. Historically, 
medication has been the therapy of choice for treating psychosis. However, 
in recent times, more emphasis has been placed on interventions focusing on 
information provision.
“.. .man does have a need to know, and more than that, a need to 
understand” (Maslow, 1963, p. 111).
Maslow’s (1963) general view that people have a desire and also a right to 
understand their conditions has been an important foundation for several 
therapeutic approaches. People with psychosis may believe that they both 
know and understand their experiences, however, this is often clouded by 
complex delusional systems. Specific guidance is required to inform these 
people of their illness and allow them to develop means of coping. This study 
has considered methods of helping people with psychosis to reappraise their 
views of illness and reconsider their beliefs and choices that can lead to 
maladaptive behaviours.
Yalom (1975) suggested that useful explanations of behaviour and illness are 
those that seem credible to the patient. He argued in favour of a “believable 
story” for each patient and stressed that conceptualisations of the patient’s
1 The term “psychosis” will be used in the singular throughout this thesis. However, it refers 
to a range of psychotic disorders, including Schizophrenia, Brief Psychotic Disorder, 
Psychotic Disorder Not Otherwise Specified, amongst others. Please see DSM-IV (American 
Psychological Association, 1994) for further information.
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situation should be tailored for each individual. These are only useful if the 
patient can identify his or her own experiences within the ideas being 
suggested. Furthermore, Yalom stated that complicated interpretations are 
not useful if the patient cannot comprehend them or connect them with his or 
her own experiences and thoughts. This study aimed to incorporate some of 
Yalom’s ideas by taking into account the participants’ perspectives of their 
experiences before offering a “credible alternative”.
As has been highlighted above, it is not just the delivery of information that is 
important. There is a necessity to present a personalised account of the 
idiographic experiences of each patient. This study has created a brief 
intervention for patients with acute psychosis. It aimed to help them to not 
only know about psychosis, but to understand their own psychotic 
experiences. Furthermore, it attempted to provide them with ways in which 
they could control their illnesses and build for the future.
This Introduction is divided into five sections. The first will consider the 
biopsychosocial model of psychosis. The second will discuss the concept of 
“Patient as Partner”. The third section will review the research on 
psychoeducation, including a number of outcome variables and factors when
administering this type of treatment package. The fourth section will consider
\
the use of a model of Health Psychology to understand patients’ 
conceptualisations of having psychosis and the impact that this may have on 
treatment. Finally, the fifth section will relate the research discussed to a new 
personalised psychoeducation package that was designed for this study and
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outline the research questions. This Introduction will not provide an 
exhaustive review of all literature related to psychoeducation for people with 
psychosis, but will consider the research relevant to this study.
1.1 What is Psychosis? -  A Biopsychosocial Model
Schizophrenia, the most common psychotic disorder, is defined in DSM-IV 
(American Psychological Association, 1994) as two or more symptoms 
persisting for at least six months. Symptoms include: delusions, 
hallucinations, disorganised behaviour, catatonic behaviour and/or negative 
symptoms (e.g. anhedonia and apathy). In addition, DSM-IV stipulates that 
symptoms must affect the individual’s functioning in areas of work, social 
contact and self-care.
It is interesting to note that the DSM-IV criteria do not only include the 
medical view of the symptoms required to meet a diagnosis, but also 
consider the psychosocial functioning of the individual. This view is known as 
the ‘Biopsychosocial Model’ and was originally introduced by Engel (1977):
“Boundaries between well and sick are not clear and never will be 
clear, for they are diffused by cultural, social and psychological 
considerations” (p. 129).
The Biopsychosocial Model takes an idiographic perspective of the 
individual’s experience of the illness. It is defined as the impact of the 
biological changes on the person’s psychological and social functioning. In
3
the case of psychosis, an individual may have a genetic predisposition to 
develop the illness. When activated, there are significant changes in the 
person’s belief systems and interaction with others. The biopsychosocial 
model therefore takes a holistic perspective of the effects of an illness on all 
areas of a person’s functioning.
It could be argued that this model is useful not only to gather a full 
assessment, but also in targeting interventions. However, within the field of 
psychosis, psychosocial interventions have been somewhat neglected and 
patients are treated primarily with medication (Goldberg & Huxley, 1992). 
Although drug therapy is imperative in managing the symptoms of psychosis, 
there has been limited and inconclusive research on psychosocial 
interventions (as will be described in detail below). This study aimed to 
develop a useful psychoeducation package that may be used as an adjunct 
to medication.
1.2 Patient as Partner
The National Institute of Clinical Excellence (NICE), a government body, has 
outlined guidelines of care for various conditions. In 2002, a document 
regarding the care of people with Schizophrenia was published. It 
emphasised the importance of providing individuals with “clear and intelligible 
information” about Schizophrenia and its possible causes (guideline 1.1.4.2). 
It also stated,
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“The provision of infomiation is essential to routine treatment and 
management of Schizophrenia” (Guideline 1.1.6.1).
The timing of the provision of information was suggested to be “towards the 
end of the acute episode of Schizophrenia”. This had the intention of allowing 
patients to recover from the most severe symptoms in order that they would 
be more able to attend to the information delivered than when they were 
acutely ill. It also had the purpose of intervening sufficiently early to minimise 
the development of hopelessness regarding the future. The guidelines were 
devised with the aims of lessening the disability caused by Schizophrenia by 
instilling hope for the future and helping patients to reintegrate back into 
society; reducing risk of relapse by increasing insight into illness; and 
improving quality of life. In particular, the guidelines stated that local 
resources and services should be identified and the individual should be 
offered advice about drug treatments (guideline 1.3.3).
The process by which this information should be disseminated to individuals 
with Schizophrenia remains unclear. As is noted in the review below, much of 
the research on psychoeducation for people with psychosis has indicated 
that although knowledge increases, insight and treatment compliance have 
not been shown to consistently improve.
1.3 Psychoeducation
Psychoeducation for people with severe mental illness is a broad, ill-defined 
term. It has been used to refer to a number of different approaches, including
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education packages for families, behavioural management programmes and 
social skills training. This has made comparisons between different studies 
difficult (Gibbons, Hogan & McGauran, 1999). Glick, Burti, Okonogi and 
Sacks (1994) stated,
“Psychoeducation as a technique in clinical practice can be defined as 
the systemic administration by the physician of information about 
symptoms, aetiology, treatment and course, with the goals of 
increasing understanding and changing behaviour” (p. 104).
Often, psychoeducation has been referred to as an educational package 
aimed at providing information with regards to the aetiology of Schizophrenia, 
neuroleptic medication and relapse prevention (e.g. Smith, Birchwood & 
Haddrell, 1992; Atkinson, Coia, Gilmour & Harper, 1996). Studies of 
psychoeducation expect increases in the participants’ knowledge of 
psychosis, compliance with medication, insight, social functioning, quality of 
life and satisfaction. Decreases in outcome measures of psychiatric 
symptomatology and relapse rates are expected, although the mechanisms 
involved in this decrease are not yet understood. If psychoeducation were 
found to be effective for people with psychosis, it would be a useful and 
inexpensive addition to medication treatment.
Merinder (2000) conducted a review of studies of psychoeducation for people 
with psychosis. There were three categories of studies: randomised 
controlled trials (RCTs) involving people with Schizophrenia only; naturalistic
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(i.e. non-RCTs) of people with Schizophrenia; and RCTs of patients from 
mixed psychotic populations. The review excluded studies involving complex 
interventions of social skills training; interventions aimed at families alone; 
naturalistic studies of mixed psychotic samples; and those studies that used 
ill-defined outcome measures. This is a useful review of patient education 
programmes and will be referred to on several occasions throughout this 
Introduction.
Merinder (2000) noted that most studies demonstrated that knowledge could 
be improved by educational intervention. However, it was not possible to 
conduct a meta-analysis because there was a low number of 
methodologically sound studies; many studies did not provide sufficient 
details of the psychoeducation package used; and a wide range of outcome 
measures were used. In an earlier study, Merinder et al. (1999) stated that 
the few psychoeducation studies that have been published used a variety of 
interventions, outcome measures and follow-up periods. Furthermore, flaws 
in the research designs compromised the validity and generalisability of 
these studies. These included a lack of randomisation and the use of non­
validated assessment instruments (Merinder et al., 1999).
In Merinder’s (2000) review, of the 19 studies included, 14 were based on 
group interventions and the remaining 5 were based on individualised 
programmes. The sessions used a range of outcome variables, including 
knowledge, medication compliance, insight, satisfaction and level of 
symptomatology.
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In summary, different researchers have used varying definitions of 
psychoeducation and have delivered education to patients in a range of 
ways. However, the outcome measure that has been consistently found to 
improve following psychoeducation is knowledge (e.g. Smith et al., 1992). 
These authors reported that knowledge gains following a psychoeducation 
programme allowed participants to normalise their experiences. Furthermore, 
participants were able to gain knowledge of coping strategies. Smith et al. 
concluded that despite an increase in knowledge, it was not clear whether 
participants were able to apply this information to their own personal 
circumstances. The clinical relevance of an increase in knowledge is 
therefore debatable. Below is a review of a number of other outcome 
measures following psychoeducation programmes.
1.3.1 Psvchoeducation and symptomatology
The links between symptom change and psychoeducation are unclear. In a 
review, Merinder (2000) mentioned five studies (written in English) that have 
measured symptom changes following psychoeducation. Of the five studies, 
two found a change in symptomatology (Goldman & Quinn, 1988; Kelly & 
Scott, 1990) and three found no change following a psychoeducation 
programme (Atkinson et al., 1996; Merinder et al., 1999; Browne et al.,
1996). Each of these studies is detailed below.
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1.3.1.1 Studies finding change in symptomatology following
psvchoeducation
Goldman and Quinn (1988) conducted the first randomised controlled trial to 
study the effect of psychoeducation on variables other than knowledge. All 
participants had a diagnosis of Schizophrenia. They measured positive and 
negative symptoms in a sample of inpatients before and after an intensive 
three-week group programme. They found that the intervention group had 
significantly fewer negative symptoms following the programme than the 
controls, although positive symptom levels remained unchanged.
The authors hypothesised that psychoeducation served to improve 
participants’ self-esteem and reduced the fear caused by symptoms. 
Furthermore, they suggested that the provision of practical ideas regarding 
resources increased hope for the future. These aspects of psychoeducation 
may have led to a decrease of negative symptoms.
However, the authors highlighted a number of limitations, which prevented 
generalisability of the findings. These included significant differences 
between the intervention and control groups in terms of gender and 
knowledge about Schizophrenia at baseline. Moreover, they did not measure 
long-term effects of the programme. As changes were found in negative 
symptoms and not positive symptoms, the authors concluded that different 
psychopathological processes are involved in the development of each 
symptom group.
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The other study mentioned by Merinder (2000) that found change in 
symptoms following psychoeducation was that of Kelly and Scott (1990). 
They conducted a four-year trial that involved 418 outpatients with varying 
diagnoses of psychosis. Each participant underwent a six-month course of 
psychoeducation. This study aimed to develop “individualised compliance 
plans” in order to overcome the idiosyncratic problems of treatment 
compliance as identified by the individual’s family members and the 
researcher. Participants were either seen at home, at the clinic or both at 
home and the clinic and results were compared with that of a control group 
who received treatment as usual. Measures of psychiatric symptomatology 
were taken pre-intervention and at six months follow-up. This study found 
significantly lower scores for depression, paranoid ideation, psychoticism and 
Schizophrenia in all intervention groups when compared to the control group.
Kelly and Scott (1990) noted that the study was limited by a large drop-out 
rate of 35% of the sample at follow-up. Many of the participants who did not 
complete the programme had co-morbid diagnoses of alcohol and substance 
misuse. Kelly and Scott stated that the results of the study must therefore be 
restricted to patients without these co-diagnoses. Perhaps these results are 
indicative of a need to treat alcohol and substance misuse prior to providing 
information regarding psychosis.
In summary, both Goldman and Quinn (1988) and Kelly and Scott (1990) 
found decreases in levels of psychiatric symptomatology following a course 
of psychoeducation. However, the samples were different: Goldman and
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Quinn used psychiatric inpatients suffering from Schizophrenia and Kelly and 
Scott used outpatients with a range of psychotic disorders. Furthermore, the 
content of the packages was different: Goldman and Quinn focused on 
knowledge about the illness and Kelly and Scott individualised their 
programmes with the aim of improving treatment compliance. The designs of 
the studies were also different as Kelly and Scott (1990) had a six-month 
follow-up phase, whereas Goldman and Quinn (1988) had no follow-up 
period.
In terms of positive and negative symptoms, Goldman and Quinn (1988) 
found changes in negative symptoms only, whereas Kelly and Scott (1990) 
found changes in both positive and negative symptoms. However, Kelly and 
Scott used briefer measures of symptomatology (Brief Symptom Inventory, 
Derogatis & Spencer, 1982 and the Schizophrenia Symptom Severity Scale, 
which has not been published. The latter is a self-report 14-item scale). 
Goldman and Quinn used more comprehensive scales (Experiential World 
Inventory - EWI, El-Meligi & Osmond, 1970; Scale for the Assessment of 
Negative Symptoms - SANS, Andreasen, 1983). The EWI is a 400-item self- 
report measure used to assess distress, but Goldman and Quinn (1988) 
reported that it mainly measured positive symptomatology. The SANS is a 
well-researched and widely used tool to assess negative symptoms.
As can be seen, due to the differences in samples, measures, designs and 
interventions, it is not possible to conclude that psychoeducation packages 
for people with psychosis reduce psychiatric symptomatology.
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1.3.1.2 Studies finding no change in symptomatology following
psvchoeducation 
Atkinson et al. (1996) studied a sample of 146 outpatients with 
Schizophrenia. They randomly allocated the participants to either a 
psychoeducation group or a control group, which ran a placebo intervention. 
The intervention lasted for 20 weeks. Sessions alternated between providing 
information about Schizophrenia and problem solving. Participants’ 
symptomatology was measured using the Brief Psychiatric Rating Scale - 
BPRS (Overall & Gorham, 1962). Measures were repeated pre-test, post-test 
and at nine months follow-up. The authors found no significant differences 
between groups at any of the time points.
Browne et al. (1996) conducted a study of 19 patients in a rehabilitation 
programme. They all met criteria for Schizophrenia and volunteered to 
participate in the study. The programme was of 16 weeks duration and 
involved education about Schizophrenia with particular emphasis placed on 
medication compliance and the prodromal signs of relapse. Psychiatric 
symptomatology was measured using the SANS and the Scale for the 
Assessment of Positive Symptoms -  SAPS (Andreasen, 1984). Pre and post­
test measures were used and there was no follow-up assessment. The 
authors found no significant differences in scores on SANS or SAPS. The 
limitations of the study were that there was a small sample size and the 
groups differed significantly in age and duration of illness. All participants had 
volunteered to participate in the study. The authors suggested that the results 
might have therefore been biased towards those with a good prognosis. They
12
offered no suggestion regarding the lack of change in levels of 
symptomatology. It may have been that the period of assessment (i.e. 16 
weeks) was too short to have found a change in symptomatology. Perhaps a 
follow-up assessment would have found different results.
The final study not to have found symptom change mentioned in the review 
by Merinder (2000) is that of Merinder et al. (1999). This was a randomised 
controlled trial of an eight-session psychoeducation programme for 23 
inpatients with Schizophrenia. Psychiatric symptoms were measured using 
the BPRS. Measures were repeated pre-test, post-test and at one year 
follow-up. Although these authors found one significant result, (a decrease in 
the Schizophrenia subscale of the BPRS), they concluded that the 
intervention did not affect symptomatology. This study was limited due to the 
small sample size. Merinder et al. noted that the mechanisms for the 
decrease in symptoms found by Goldman and Quinn (1988) and by Kelly and 
Scott (1990) are complex and have not been fully explained in those papers. 
Merinder et al. concluded that the main aim for any psychoeducation 
programme should be to improve knowledge.
In summary, the three studies that did not show symptom change following 
psychoeducation vary considerably in sample size and intervention.
However, two of the studies (Atkinson et al., 1996 and Merinder et al., 1999) 
were consistent in using the BPRS. As can be seen from this section, the 
literature is inconclusive with regards to whether or not psychoeducation 
programmes can reduce psychiatric symptomatology.
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1.3.2 Psvchoeducation and satisfaction
Amongst those reviewed by Merinder (2000), only two studies measured 
participants’ satisfaction with the intervention (i.e. Kelly & Scott, 1990; 
Merinder et al., 1999). Both studies used different measures of satisfaction: 
Merinder et al. (1999) used the Verona Service Satisfaction Scale (Ruggeri & 
Dall’Agnola, 1993). This measure included seven scales, one of which 
considered the participants’ satisfaction with their relatives’ involvement in 
the intervention. The intervention used by Merinder et al. (1999) involved 
both participants and relatives. The authors found a change in satisfaction in 
the scale for relative involvement only. This scale therefore may only be 
suitable for interventions that involve family members. Kelly and Scott (1990) 
used the Slater Satisfaction with Mental Health Care scale (Ellsworth, 1975). 
However, they found no change in satisfaction following the administration of 
their intervention.
To understand the reasons for the lack of improvement in satisfaction in the 
above studies, literature from Health Psychology may be useful. Ley (1988) 
found that patients with physical health problems who felt dissatisfied with 
medical communications were less likely to comply with treatment 
recommendations. Areas of dissatisfaction included a lack of empathy and 
interest from the health professional to the patient’s concerns. Furthermore, 
patients were dissatisfied when the clinician did not involve them in the 
decision-making process regarding their care.
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In terms of the literature on psychosis, patient dissatisfaction with 
consultations by health professionals may explain why compliance is often 
not improved by psychoeducation (e.g. Macpherson, Jerrom & Hughes,
1996; Atkinson et al., 1996; Merinder et al., 1999). It is suggested that when 
psychoeducation is delivered as a blanket treatment, not personalised to 
each individual case and not negotiated with the patient, dissatisfaction and 
failure to adhere to treatment regimens may arise. In cases of physical health 
problems, Weinman and Petrie (2000) noted that patient dissatisfaction was 
often associated with insufficient information, poor understanding of medical 
advice and subsequent reluctance to follow recommended treatment 
guidelines. These issues are pertinent for people with psychosis, particularly 
as they may have difficulty receiving information due to the existence of 
positive symptoms. It is useful to consider the literature from Health 
Psychology regarding the components of patient satisfaction and to include 
these in clinical practice.
Isen, Rosenzweig and Young (1991) suggested that doctors’ use of positive 
verbal and non-verbal behaviour and “partnership building” improved patient 
satisfaction. Weinman and Petrie (2000) described “partnership building” as 
the doctor’s use of open questions and appropriate responses to signs of 
distress in the patient. When relating this literature to individuals with 
psychosis, it could be hypothesised that their satisfaction with care may 
improve following a psychoeducation intervention in which the clinician 
focuses on “partnership building”. However, the studies of psychoeducation 
and psychosis to date have shown little evidence of participant satisfaction.
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This may be associated with a didactic style of teaching, as used by Merinder 
et al. (1999). It would be interesting to determine whether or not a more 
collaborative approach in which the participant felt like a valued partner in 
understanding his or her symptoms may be more effective in increasing 
satisfaction. Furthermore, appropriate responding by the clinician to the 
patient’s emotional needs may also improve satisfaction.
In summary, patient satisfaction following psychoeducation is rarely 
measured. The literature from patients with physical illnesses has indicated 
that the main implication of patient dissatisfaction is treatment non- 
compliance. Furthermore, previous research has indicated that strong 
“partnership building” is a contributing factor to satisfaction in physical health 
patients. In terms of patients with psychosis who receive psychoeducation, 
there has been little evidence of partnership building. The findings of 
psychoeducation studies point to a move away from didactic delivery of 
information to more involvement of the patient. This may increase patient 
satisfaction of psychoeducation programmes. One area that may contribute 
to partnership building is personalisation of information delivered to patients. 
This literature will be reviewed below.
1.3.3 Personalising Psvchoeducation
In an extensive critique of psychoeducation for patients suffering from first- 
episode psychosis, McGorry (1995) suggested that the patient, as a 
consumer of mental health services, has a basic right to receive information 
about his/her diagnosis. McGorry further stated that psychoeducation has a
16
number of objectives. These include promoting a speedy recovery; aiding the 
person to accept future treatment; facilitating appropriate coping strategies; 
and finally, reducing the risk of early relapse. McGorry (1995) further stated 
that in order for psychoeducation to be effective, the information has to be 
provided “flexibly and sensitively” to each individual. This approach is in 
contrast to the methodology of many of the studies described in the review by 
Merinder (2000) in which group approaches employing didactic lecturing 
were frequently utilised.
Kilkku, Munnukka and Lehtinen (2003) conducted a qualitative analysis of the 
meaning of information provision to people experiencing their first episode of 
psychosis. Although the authors are vague about the type of 
psychoeducation delivered, it seems that it was factually based with little 
personalising of the information. They found that the individuals’ own 
experiences of psychosis affected the way in which information was 
interpreted. Information was received with feelings of worthlessness, relief or 
confusion. The study concluded that it is important to take into account the 
experiences of the individual and tailor the information accordingly, rather 
than to use a blanket approach for all participants.
Tarrier and Barrowclough (1986), in a study designed for families, described 
psychoeducation as an interactive process between the patients, their 
families and health professionals. They commented on the “interaction 
model”, which takes into account the personalised lay models of illness held 
by the patient and family. It stated that information received from the health
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professional by the patient and family is “assimilated, organised and possibly 
rejected” on the basis of whether or not it contradicts the patient’s and 
relatives’ internalised illness models. The authors suggested that information 
should be carefully tailored to each person’s symptoms and experiences, 
rather than focusing on psychopathology in general. Tarrier and 
Barrowclough (1986) suggested that patients and relatives should be 
questioned extensively regarding their beliefs about the patient’s illness prior 
to the delivery of information. They stated,
“...information is not given in a vacuum” (p. 462).
Similarly, McGorry (1995) suggested that individuals are more likely to recall 
information regarding their own symptoms and experiences than more 
general facts about psychosis.
In summary, although researchers have indicated that information regarding 
diagnoses should be personalised and delivered flexibly, this has not been 
the case in the psychoeducation literature. It is suggested that an individually 
tailored psychoeducation package may be a useful intervention for a group of 
psychotic patients. The review will now consider whether or not the 
effectiveness of a treatment of this nature is altered by the stage of the 
illness.
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1.3.4 Duration of Illness and Psvchoeducation
1.3.4.1 Psychoeducation and early intervention
Studies of psychoeducation treatment protocols for people with severe 
mental health problems have generally focused on patients with chronic, 
treatment-resistant Schizophrenia. There has been little research on patients 
with recent-onset or acute symptoms (Haddock et al., 1999). McGorry (1995) 
stated that psychoeducation should be offered as early as possible to be 
most effective.
Birchwood, McGorry and Jackson (1997) stated that the time between the 
onset of psychotic symptoms and the individual’s presentation to services is 
approximately one year. These authors emphasised the importance of 
intervening with both medication and psychological therapy as soon as the 
person is diagnosed with a psychotic disorder. This defines “early 
intervention” and implies that treatment is offered whilst the individual is 
suffering from florid psychotic symptoms (i.e. during the acute stage of 
psychosis).
Birchwood et al. (1997) speculated that the early phase of psychosis is 
influential in terms of the biological, psychological and social development of 
the individual. Furthermore, they suggested that long-term outcome is 
predicted in the early course of the illness. However, they did not assess this 
directly and based their opinions on some previous evidence together with 
their clinical opinions. They emphasised that it is critical to intervene at the
19
early phases of psychosis in order to minimise further deterioration. One key 
area of intervention that they proposed was psychoeducation.
Tarrier and Barrowclough (1986) suggested that the longer the duration of a 
psychotic episode, the more time the individual has to form personalised lay 
models of the symptomatology (i.e. believing that their positive symptoms are 
reality and not part of an illness). These authors therefore advocated 
providing psychoeducation at an early stage of psychosis. They defined the 
optimal time for intervention as being soon after an episode has begun.
Some literature on psychoeducation for people with psychosis has concluded 
that it is important to intervene during the early phases of a psychotic 
episode. Further studies have been conducted using Cognitive-Behavioural 
Therapy and have addressed the question of whether or not to intervene 
during the acute phases of psychosis. As some of the components of 
psychoeducation and CBT are similar (including the development of a 
collaborative therapeutic relationship), CBT studies of the acute phases of 
illness are informative when considering a psychoeducation approach. Some 
of these will be explored below.
1.3.4.2 CBT and early intervention
Haddock et al. (1999) conducted a pilot study of 20 patients (11 in the CBT 
group and 9 in the supportive counselling / psychoeducation group - SC) over 
a one-year period. Participants received between 3 and 18 sessions. The 
sample used in this study was defined as having had first treatment for
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psychosis less than 5 years previously. Furthermore, they were all inpatients 
on an acute psychiatric ward at the time of the study. Suitable, potential 
participants were approached within 10 days of admission to hospital by a 
Psychiatrist to obtain consent.
Haddock et al. (1999) found that the number of relapses and the time until 
recurrence of psychosis was lower in the CBT group than the SC group.
They also found that both groups reduced significantly on levels of 
symptomatology, according to scores on the BPRS. A key limitation of this 
study was the small sample size. It was not possible to calculate the optimal 
number of sessions of CBT that should be offered. The authors also noted 
that the lack of a no-treatment control group limited the conclusions that 
could be drawn regarding the suitability of CBT for acutely ill patients.
Despite these difficulties, Haddock et al. (1999) concluded that it is possible 
to intervene with people in the acute stage of psychosis.
This study was later followed-up by a large randomised controlled trial (Lewis 
et al., 2002). They randomly assigned a group of 309 inpatients with 
Schizophrenia-related diagnoses to CBT or supportive counselling. Potential 
participants were screened within 14 days of admission and written consent 
was obtained soon after. The CBT group received a mean of 16.1 sessions 
over a 10-week treatment period. They found that those treated with CBT 
showed a trend towards faster weekly improvement over the treatment period 
than the control group. The authors concluded that it is possible and effective 
to deliver psychological treatments to people with acute psychosis.
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Loebel et al. (1992) also commented on treating patients in the acute stages 
of psychosis. They suggested that long periods of untreated illness are 
associated with increased risk of relapse and treatment resistance. In 
another randomised controlled trial of CBT for acute psychosis, Drury, 
Birchwood, Cochrane and MacMillan (1996a, b) stated that delusions 
originating in this stage of illness are likely to recur or persist over the next 2 
to 8 years. They indicated that it is appropriate to consider the acute phase 
as the source of symptoms that remain over the long-term and are difficult to 
shift. They therefore advocated early intervention to attempt to modify 
delusional beliefs and minimise their presence over time.
In summary, there is a growing body of research (mainly CBT) indicating that 
interventions should take place when patients are in the acute phase of 
psychosis. However, most studies of psychoeducation have been conducted 
with chronically ill participants (i.e. those who have had recurrent episodes).
It has been suggested that early intervention allows patients to form realistic, 
rather than personalised lay models of illness. Furthermore, it has been 
hypothesised that the acute phase of psychosis predicts future outcomes in 
terms of residual symptoms and psychological, biological and social 
changes. Early interventions may allow patients to cope with difficult 
symptoms and to make sense of the experience.
The CBT interventions mentioned above have been lengthy. This is not 
always appropriate for patients residing in inpatient settings. Perhaps a 
treatment that intervenes when the participant is acutely ill, but is short in
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duration may be helpful. Moreover, the utility of psychoeducation in the early 
stages of illness has rarely been researched.
1.3.5 Insight
This review will briefly consider the literature on insight in psychosis. As was 
mentioned above, one of the outcome measures of psychoeducation has 
been insight. This section will consider the means by which insight has been 
defined; the problems this entails; and finally, the literature regarding 
psychoeducation and insight.
1.3.5.1 Problems with the definition of insight
The definition of “insight” is complex and controversial. It has been most 
commonly used with patients who have psychosis as a means of describing 
their mental state. However it is an ill-understood concept with varying 
definitions and measures. In a comprehensive review, Markova and Berrios 
(1995) suggested that the lack of a consistent definition of insight and the use 
of different measures has resulted in contradicting and confusing results.
This therefore causes difficulty in drawing valid conclusions and appropriate 
comparisons between studies.
Amador and Kronengold (1998) suggested that there is a spectrum of 
perspectives in defining insight. It has frequently been defined in terms of its 
absence. Amador and Kronengold reported that some authors believe that 
lack of insight is a psychological defence to cope with the frightening 
experiences of psychosis. Others considered lack of insight as a cognitive
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deficit caused by the psychosis. Aside from theoretical differences, Amador 
and Kronengold (1998) suggested that the definition of absence of insight 
that transcends all perspectives is:
“An individual’s perception of him or herself that is grossly at odds with 
that of his or her community and culture” (p. 16).
This is the definition that will be adopted in this study.
The concept of insight has evolved over time from having been studied as a 
categorical, unitary idea (i.e. it is either present or absent) to being 
considered as a continuous, multidimensional phenomenon (Markova & 
Berrios, 1995).
1.3.5.2 Categorical perspectives of insight 
Categorical studies suggested that patients’ insight into their conditions is 
either present or absent. For example, Lin, Spiga and Fortsch (1979) defined 
insight as:
"... recognition of existence of problems and the need for medical 
intervention” (p. 430).
This and other categorical definitions of insight have been critiqued in a 
number of studies (e.g. Amador & Seckinger, 1997). These authors 
suggested that categorical definitions do not take into account those patients
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who recognise that they have some difficulties or unusual experiences, but 
do not attribute these to illness. Furthermore, there are patients who accept 
medical intervention but who deny that they have a condition that needs to be 
treated. These problems with categorical definitions led to the consideration 
of insight as a continuous scale.
1.3.5.3 Continuous perspectives of insight
It has been widely accepted in recent years that insight is a multidimensional 
concept (e.g. Markova & Berrios 1995; David, 1998; Amador & Kronengold, 
1998). However, the specific components of insight continue to be debated. 
David (1990) stated that insight has three related parts: recognition of having 
a mental illness; treatment compliance; and the ability to label unusual 
symptoms as being part of an illness.
Amador et al. (1993) suggested that insight is a multidimensional concept 
consisting of awareness of having a mental disorder, awareness of the 
achieved effects of medication and awareness of the social consequences of 
having a mental disorder. They suggested that both current and retrospective 
views should be assessed in terms of insight.
It may be argued that the most appropriate measure of insight to use 
depends on the individual’s status at the time of testing, specifically in 
relation to compliance with medication. In cases where patients are 
hospitalised and have been sectioned under the Mental Health Act (1983), 
they have no choice about whether or not they take medication. This would
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render a measure of treatment compliance (e.g. David, 1990) inaccurate. In 
this case, it is suggested that the conceptualisation of Amador et al. (1993) 
would be more useful as this examines the individual’s perception of the 
effects of medication, rather than compliance.
In terms of the other components of insight, as operationalised by Amador et 
al. (1993), (awareness of having a mental disorder and the social 
consequences this entails), it is argued that these are appropriate when 
assessing insight in patients detained in hospital. Both of these components 
are emphasised to inpatients by the fact that they have been hospitalised and 
removed from their communities. A poor level of insight is indicated in 
patients whose awareness does not improve during hospitalisation.
Amador and Seckinger (1997) indicated that multidimensional definitions 
allow for interventions to be focused on one particular area of insight. These 
authors concluded that all types of insight together comprise an important 
domain of psychopathology that has been neglected in the research and 
treatment of psychotic patients. The debate about the exact definition and 
means of measuring the concept is ongoing.
In summary, the literature on insight into psychosis is vast and this review 
has briefly outlined the main points in relation to the present study. A major 
difficulty with comparing studies of insight has been that a variety of 
definitions have been used. The modern perspective on insight is that it is a 
multidimensional and not a categorical scale. This allows interventions to be
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tailored according to specific areas of insight. This study has adopted the 
definition of Amador and Kronengold (1998) mentioned above and has 
operationalised insight according to Amador et al. (1993). As was explained 
above, this definition and conceptualisation were chosen because they 
account for the involuntary detention of patients in hospital under the Mental 
Health Act (1983). A review of the literature on psychoeducation for patients 
with psychosis and whether or not this has been found to increase levels of 
insight is considered below.
1.3.5.4 Psychoeducation and insight
Few studies have been conducted into the effect of psychoeducation on an 
individual’s level of insight. Macpherson et al. (1996) used an individualised 
package, which was tailored to the particular symptoms of each participant. 
The study used a chronic sample with a mean age of 45.2 years and mean 
years since first admission of 23.4 years. Participants were randomly 
assigned to a control group, or to one or three sessions of psychoeducation. 
Insight was measured using the Schedule for Assessment of Insight (David, 
1990). This is a multidimensional scale, which considers subscales of 
treatment compliance, awareness of illness and ability to label psychotic 
symptoms as being part of a mental illness.
Macpherson et al. (1996) reported global scores of insight. They found that 
insight increased significantly at one-month follow-up for the group that had 
received three sessions of psychoeducation, but not for those who had 
received one session. These authors concluded that a structured,
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individualised, interactive education programme of three sessions was useful 
in promoting insight. It is suggested that this format is particularly useful with 
inpatients who are unlikely to reside in hospital for sufficient time to conduct a 
long-term intervention.
Merinder et al. (1999) did not find insight to improve following an eight- 
session group intervention involving patients who had lengthy illness histories 
and their relatives. They used the Insight Scale, (Birchwood et al., 1994) 
which rates insight according to three factors: awareness of illness; need for 
treatment; and attribution of symptoms. However, they did not comment on 
the individual scores of each of the subscales. Merinder et al. (1999) studied 
a chronic sample (mean age of 35.9 years; mean duration of illness of 8.2 
years). They concluded that the baseline measure of insight was high, 
allowing little chance of measuring improvement over time. They also stated 
that the brevity of the programme might have made changes in insight 
difficult to achieve. However, they provided five more sessions than 
Macpherson et al. (1996) who found an improvement in insight. It is 
suggested that the key difference between the above studies was that 
Macpherson et al. (1996) used an individualised approach and Merinder et 
al. (1999) used a group approach. The personalisation of information in the 
individualised packages (Macpherson et al., 1996) possibly led to a better 
outcome.
In summary, there is a lack of studies that have considered the effects of 
psychoeducation on the insight of patients with psychosis. Furthermore,
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although these studies have used multidimensional tools to measure insight, 
the subscale scores were rarely reported and insight was conceptualised as 
one global construct. As was highlighted in the above section, it may be 
misleading to formulate insight in this way, as there is no unifying definition of 
this construct. The literature on psychoeducation and insight is sparse and 
the results remain inconclusive. This would suggest that a study to consider 
the effects of psychoeducation on each individual component of insight would 
be useful.
1.3.5.5 Risks of Insight
Although studies have aimed to increase insight, certain risks of heightened 
awareness of psychosis must be highlighted. Amador et al. (1996) stated that 
increased insight leads to higher rates of depression and elevated risks of 
suicide. This occurs when the individual realises that they have a long-term, 
potentially recurring condition with numerous psychosocial consequences 
(including on relationships and jobs). Similarly, Iqbal, Birchwood, Chadwick 
and Trower (2000), in a study examining Post-Psychotic Depression (PPD), 
found that those with greater insight into their illness were more likely to 
develop PPD than those with less insight. They concluded that PPD is 
dependent on the appraisals that the individual makes about psychosis and 
it’s implications on his / her sense of self, feelings of loss, entrapment and 
humiliation.
Despite these risks, it could be argued that the benefits of increased insight, 
including treatment compliance, outweigh the costs.
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1.3.6 Medication Compliance
This section will review some of the literature of psychoeducation and 
medication compliance and will introduce ‘Compliance Therapy’, which 
utilises components of psychoeducation in trying to improve medication 
compliance. A critique of this model is offered at the end of this section.
A contributing factor to the readmission of many patients is non-compliance 
with medication (Bebbington, 1995). It has been found that psychoeducation 
(delivered didactically) had limited effectiveness in increasing medication 
compliance (e.g. Smith et al., 1992). In a review by Merinder (2000), it was 
found that most studies measured compliance. Of these studies, one found 
an improvement in compliance (Boczkowski, Zeichnar & Desanto, 1985) and 
three found a reduction in compliance (Macpherson et al., 1996; Atkinson et 
al., 1996; Merinder et al., 1999). However, compliance has been a difficult 
construct to measure.
Kemp, Kirov, Everitt, Hayward and David (1998) stated that the 
measurement of compliance poses a methodological issue for research.
They noted that pill counts have been used in past studies, but these are 
time-consuming and labour intensive. Furthermore, they stated that pill 
counts are not suitable for inpatient studies where medication is administered 
by staff, nor for studies involving participants who are on depot medication. 
Kemp et al. (1998) stated that urine tests could also be used to measure 
compliance, but that these have a tendency to overestimate compliance as 
anti-psychotics have a long half-life.
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In the studies reviewed by Merinder (2000), there was no consistent means 
of measuring compliance. Boczkowski et al. (1985) measured compliance 
using a self-report scale for participants and their relatives. Furthermore, this 
sample self-administered medication and pill counts were undertaken. This 
method of measuring compliance is clearly relevant only for outpatient 
populations. Macpherson et al. (1996) and Merinder et al. (1999) measured 
compliance within insight measures and did not have a separate compliance 
measure. Atkinson et al. (1996) measured compliance at the nine-month 
follow-up only for patients who were on depot medication. They calculated 
the percentage of injections received and elicited this information from the 
medical notes.
As is highlighted above, the construct of compliance is difficult to measure, 
particularly in the case of inpatients and, specifically, for those detained 
under the Mental Health Act (1983). This study has considered these 
difficulties and has operationalised the construct of compliance accordingly. 
This operationalisation consists of insight into the achieved effects of 
medication and attitudinal changes of the extent to which medication can 
cure an illness and the degree of personal control that can be exerted over 
the illness.
1.3.6.1 Compliance Therapy
In light of the evidence that psychoeducation delivered didactically has 
limited effectiveness, Kemp and colleagues designed a brief intervention, 
entitled, ‘Compliance Therapy’ (Kemp, Hayward, Applewhaite, Everitt &
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David, 1996a; Kemp & David, 1996b; Kemp et al., 1998). This approach 
included components of motivational interviewing (Miller & Rollnick, 1991) 
and emphasised a collaborative relationship between therapist and patient. It 
was conducted over the course of 4 to 6 sessions in three phases. On 
average, participants spent three hours with the researcher. The first phase 
involved the therapist ascertaining the patient’s stance towards treatment. 
Then, the patient’s ambivalence towards treatment was explored in the 
second phase. Finally, the third phase considered maintenance of treatment 
regimes. Kemp and David (1996b) noted that in the third phase, patients 
frequently asked about the meaning of their diagnostic labels, psychotic 
symptoms and physiological brain changes during psychosis. The authors 
emphasised the importance of making the information directly relevant to the 
individual rather than discussing these issues abstractly.
Kemp et al. (1996a) assessed patients within one week of admission and 
randomly assigned them to the intervention group or the control group 
(supportive counselling). There were 25 and 22 participants in each group 
respectively. Nurses rated compliance blind to the intervention group using a 
seven-point scale. This assessment was conducted at initial assessment, 
following the intervention, at discharge, after three months and after six 
months. At three-month and six-month follow-ups, the scale was 
corroborated with as many sources as possible, including relatives, the 
Psychiatrist, the Community Psychiatric Nurse and the GP.
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Kemp et al. (1996a) found that Compliance Therapy improved insight, 
attitudes to medication interventions and compliance. These changes 
remained largely intact at 6-month follow-up. Kemp et al. also found that 
increased insight did not lead to higher rates of depression and elevated 
suicide risk (as was indicated by Amador et al., 1996). Kemp and David 
(1996b) reflected that the lack of increase in depression (and associated 
suicide risk) following increased insight was an important and unique finding. 
The authors hypothesised that the focus on improving self-esteem in the 
treatment package had prevented depression from increasing. This is a 
concept that has been incorporated into the psychoeducation package 
utilised in this study. The authors also reported that participants appreciated 
being asked their opinion of their illness and that this was an unusual 
occurrence in routine care. They emphasised the importance of allowing 
patients this opportunity.
The results of Kemp et al. (1996a) and Kemp and David (1996b) were 
encouraging and the study was repeated using a more robust design 
(randomised controlled trial) to ascertain whether or not the findings were 
upheld over an 18-month follow-up period. Kemp et al. (1998) recruited a 
total of 74 participants: 39 in the treatment group and 35 in the control group. 
This was an extended sample and included those in the Kemp et al. (1996a) 
study. They found that the improvements in compliance, insight and attitudes 
to medication in the intervention group were indicated at the post-test stage 
and these gains were maintained over the follow-up period. It is suggested 
that a brief, individualised approach is a useful means of increasing insight
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and compliance. These principles have been incorporated into the design of 
the current study.
In summary, Compliance Therapy, a brief intervention aimed at improving 
medication compliance, has been shown to be effective for psychiatric 
inpatients. Although this study found positive outcomes, it emphasised the 
control of psychosis through medication, but did not provide the patient with 
any other ideas of how to deal with his or her illness (e.g. through occupation, 
socialising, exercising). It is argued that this defines psychosis as an illness 
in which the patient is passive in terms of taking medication and cannot take 
an active role in managing his or her difficulties. However, the research into 
Compliance Therapy has provided important indicators about ways to 
develop psychoeducation programmes. These include personalising 
information; allowing patients the chance to discuss their experiences in a 
non-threatening environment; a collaborative patient and therapist approach; 
and a brief number of sessions. These elements have been utilised in the 
current study.
1.3.7 Collaborative Therapist-Patient Relationship 
The concept of a collaborative therapist-patient relationship has been 
discussed in the literature of CBT for psychosis as an important factor in 
motivating people to participate in therapy. It has also been discussed in the 
area of information provision to people with severe mental illness. A 
collaborative therapist-patient relationship may be utilised in the delivery of 
psychoeducation. Some of the research in this area will be outlined below.
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Kuipers (1996) noted the importance of a “partnership or treatment alliance” 
in which a collaborative, rather than didactic, approach should be considered. 
Similarly, Kingdon (1998), in a review of engagement of patients with 
psychosis, found that a collaborative relationship is imperative when working 
with people who have psychosis. He outlined that there are two major 
components to achieving this level of engagement: firstly, understanding why 
the patient holds his or her beliefs and secondly, providing credible 
alternatives.
Prior to literature on CBT for psychosis, Greene (1984) reflected that 
clinicians have been reluctant to inform patients with Schizophrenia of their 
diagnoses because they believe that the diagnosis implies ongoing 
deterioration of both positive and negative symptoms. However, Greene 
commented that some patients can recover from Schizophrenia and the 
outlook is not necessarily bleak. He therefore encouraged open 
communication between therapists and patients in order that the patient may 
be motivated to manage the illness effectively. Furthermore, he speculated 
that open communication would allow the patient to feel comfortable to talk 
about his or her fears regarding psychiatric symptomatology. Greene 
speculated that this openness could be the beginning of a functional 
therapeutic relationship.
In summary, a brief educational package for patients with psychosis in which 
a collaborative approach is utilised may be a useful adjunct to routine care in
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inpatient psychiatric settings. This study has devised a programme with these 
issues in mind.
1.3.8 Importance of goals for the future
Often people who have had a psychosis have difficulties reintegrating into 
society. Research has suggested that following a psychotic episode, the 
individual may have low self-esteem and may mourn the loss of the previous 
self (e.g. Birchwood, Iqbal, Chadwick & Trower, 2000). Furthermore, people 
who have recovered from psychosis can feel as though they have no means 
of preventing a future episode, other than by taking medication. This 
perspective can be disempowering and does not take into account the 
biopsychosocial view of psychosis. The NICE guidelines (2002) recognised 
this issue and recommended that clinicians should direct people who have 
had a psychosis to local resources and services following discharge from 
hospital.
In personalising information, McGorry (1995) firmly stressed that it is 
important to provide the individual with hope for the future. He suggested that 
patients should be provided with strategies that can help to resolve the 
current psychotic episode and reduce the rate of relapse. McGorry stated 
that a useful model to empower the individual is the “Stress / Vulnerability 
Model” (Zubin & Spring, 1977). This is widely acclaimed and suggests that 
people who experience Schizophrenia have an underlying vulnerability to the 
illness. Although it has its critics (e.g. Morrison, Renton, Dunn, Williams &
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Bentall, 2004), it provides a useful platform for helping patients to understand 
and cope with their experience of illness.
The Stress / Vulnerability model suggests that the risk of a psychotic episode 
emerging is mediated by the amount of stress experienced by the individual 
and his / her means of coping. Zubin and Spring (1977) suggested that this 
framework underpins all other theories of Schizophrenia, including genetic, 
developmental and psychosocial. The importance of the Stress / Vulnerability 
model is that it empowers people with Schizophrenia to take an active role in 
controlling relapse by maintaining low stress levels. This contrasts with the 
medical model, which encourages the individual to take a passive role of 
consuming medication to control symptoms and relapse.
Birchwood et al. (1997) commented that many people suffering from first- 
episode psychosis are young and value independence, employment and the 
youth culture. They stated that psychosis can exclude these individuals from 
their peer group and can prevent them from fulfilling their aspirations. 
Birchwood et al. (1997) stated that it is important for clinicians to be aware of 
these losses and to take a positive approach to reintegrating the individual 
back into society. They advised that a vocational outcome should be a 
central aim of the recovery process.
Following the acute phase of psychosis, there is a risk that increased insight 
will lead to Post-Psychotic Depression. Iqbal et al. (2000) found that those 
who developed PPD believed that their future roles would be of lower status
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than if they had not had a psychosis. These authors noted that work is a 
highly valued social role and recommended that services focus on helping 
people who have had a psychosis to reintegrate into the workforce at a 
suitable level. They hypothesised that this may be a useful way of reducing 
the individual’s feelings of low self-worth, loss, entrapment and humiliation 
following a psychotic episode and may prevent the onset of depression.
In summary, it is important to instil goals for the future into people with 
psychosis. This is a means of empowering these individuals to control the 
emergence of future episodes of illness by taking medication, by being 
occupied (through work or education) and by socially reintegrating back into 
society. It is suggested that by having goals and instilling hope for the future, 
the individual can protect against Post-Psychotic Depression. The 
intervention described in this study has attempted to incorporate 
recommendations for the future in terms of a biopsychosocial perspective of 
psychosis.
1.4 Illness Representations
When developing a new psychoeducation package, it is important to consider 
factors that aid in patients’ ability to cope with their illnesses. However, the 
literature considering mental health patients’ coping responses is sparse. In 
an extensive review of models of illness in severe mental health, Lobban, 
Barrowclough and Jones (2003) noted that research into individuals’ 
responses to physical health problems are useful in understanding coping 
styles of those with mental health difficulties. Specifically, they believed that
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the Self-Regulation Model (Leventhal, Nerenz & Steele, 1984) could be 
usefully applied to those with mental health problems2.
2 Please see Figure 1.1.
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Figure 1.1 Self-Regulation Model, Leventhal et al. (1984)
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1.4.1 Self-Regulation Model
This model assumes that people actively problem-solve and use health- 
related behaviours to try to shift from their present health status to a desired 
future goal. They use coping strategies to reach their future goals, which are 
based on their interpretation and evaluation of their illness. The outcome of 
these strategies is fed back into the model and used to further amend coping 
techniques.
Leventhal et al. (1984) suggested that cognitive representations guide an 
individual’s responses. These consist of five specific components: the 
individual’s perceptions of the identity, consequences, causes, timeline and 
cure /control of the illness. Moss-Morris et al. (2002) have further examined 
these components. Amongst other changes, an additional component of 
illness coherence has been suggested. This is the extent to which the 
individual believes that s/he understands the illness. Additionally, the cure /  
control component has been sub-divided into personal control (i.e. the extent 
to which the individual believes that s/he can exert control over the illness) 
and treatment control (i.e. the degree to which the individual believes that 
treatment, medication or otherwise, can cure the illness).
In addition to the cognitive representations of illness, Leventhal et al. (1984) 
suggested that emotional representations (i.e. the feelings that the individual 
attributes to having the illness) also lead to the development and appraisal of 
coping strategies.
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1.4.2 Self-Regulation Model and Severe Mental Illness 
Although the Self-Regulation Model has been used to conceptualise severe 
mental illness, there have been few validation studies. Lobban et al. (2003) 
provided a detailed overview of research that supported each of the five 
components of cognitive representations. They concluded that the Self- 
Regulation model is a potentially useful model for understanding mental 
illness. Furthermore, they stated that it is crucial to examine each individual’s 
appraisal of his or her mental illness in order to ascertain goals for 
intervention. On a clinical level, the Self-Regulation Model seems 
appropriately used to understand the beliefs of people with psychosis. Their 
cognitive and emotional representations may lead to inaccurate assumptions 
about their environments. It may be possible for these beliefs to be 
manipulated through the use of appropriate interventions. A personalised 
psychoeducation package may serve this purpose.
1.5 The Present Study
This pilot study is centred on the development of an approach that blends 
together those elements thought most likely to increase the chances of a 
positive outcome. These include a personalised approach using a 
collaborative therapist-patient relationship; intervention during the acute 
phase of illness; and information about local resources to help reintegration 
to society.
Similar to Compliance Therapy, a three-session intervention has been 
designed for this study. The literature described above indicated that there is
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no pattern to the number of sessions offered to participants who have 
psychosis. Factors such as the type of setting; the usual duration of 
admission; and the number of staff members involved in administering the 
treatment affect the number of sessions that can be offered. These are 
issues that will be particularly pertinent to the current study. The participants 
will be acutely ill inpatients residing in a Psychiatric Intensive Care Unit. The 
duration of stay is variable, but mainly patients are discharged to open wards 
within six weeks of admission. The main researcher will be the only staff 
member to administer the intervention. A three-session intervention was 
therefore deemed attainable.
The sample of this study will be similar to that of Haddock et al. (1999) who 
recruited 21 participants from four admission wards over a one-year period. 
These authors concluded that their study did not have sufficient power to 
withstand “methodological rigour” and they found no significant differences 
between the intervention and control groups. The current study has the 
potential of recruiting proportionally similar numbers to Haddock et al. over 
an 8-month period. It was decided that when taking into account the small 
numbers, it would be most helpful to use an open trial without a control 
group, with each participant serving as his own control. This will allow for 
detailed examination of the effects of the intervention, together with routine 
care, on a number of outcome variables.
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1.5.1 Outcome Variables
The review above has highlighted four outcome variables that have remained 
inconclusive in the psychoeducation literature. These are psychiatric 
symptomatology, insight, compliance and patient satisfaction. The only 
outcome measure to have been found to consistently improve following 
psychoeducation is knowledge. As this is a robust finding, it will not be 
measured in the present study.
1.5.1.1 Psychiatric Symptomatology
Previous research has been inconclusive regarding changes in psychiatric 
symptomatology following psychoeducation. This study aims to examine 
positive and negative symptoms together with general ratings of psychiatric 
symptomatology. This involves a thorough examination of the key symptoms 
of psychosis and whether or not these symptoms alter following a brief 
course of psychoeducation. In particular, it is hoped that there will be 
reductions in anxiety, depression, suspiciousness and hostility as these 
symptoms are related to confusion caused by psychosis regarding the 
environment and other people. A reduction may also be found in a range of 
positive symptoms after participants have been provided with an explanation 
of their experiences.
1.5.1.2 Insight
The research on psychoeducation and insight is sparse and inconclusive. A 
major problem with measuring insight in general is that there is no common 
definition across studies. It is now widely accepted that insight is a
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multidimensional phenomenon, but this has not been utilised in previous 
studies of psychoeducation and insight. This study aims to consider different 
facets of insight, including awareness of having a mental disorder, 
awareness of the achieved effects of medication and awareness of the social 
consequences of having a mental disorder. In addition, the study will 
consider participants’ self reports of their levels of insight. Improvements in 
all areas of insight are anticipated.
1.5.1.3 Compliance
Some studies have found that personalised psychoeducation (in the form of 
Compliance Therapy) leads to improved compliance. This study will utilise 
many of the components of Compliance Therapy, including a brief number of 
sessions, personalising of information and a collaborative approach.
Although Compliance Therapy has been useful in improving medication 
compliance, it is suggested that it educates participants about passive means 
of managing their illnesses (i.e. by taking medication), rather than active 
ways that they might prevent or delay a future episode (e.g. social and 
occupational activities). This study aims to extend the brief of Compliance 
Therapy to include active roles that patients could utilise in order to control 
their psychosis.
However, there has been no standard measure of compliance, other than 
invasive and inaccurate tests (e.g. urine tests). Compliance is a difficult 
construct to measure when patients are detained involuntarily and they have 
no choice about taking medication. This study will consider compliance in
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terms of insight into the achieved effects of medication and cognitive 
representations of personal control and treatment control of illness, as 
indicated in the Self-Regulation Model. This operationalisation will consider 
attitudinal changes towards compliance.
1.5.1.4 Patient Satisfaction
Patient satisfaction has rarely been measured in studies of people with 
severe mental health problems. However, the physical health studies have 
shown that patient dissatisfaction often leads to treatment non-compliance. 
This is an important consideration when working with patients who have 
psychosis. The research into physical health has also indicated that 
satisfaction increases when information is personalised and the therapist 
attempts to build rapport with the patient. Furthermore, research into CBT for 
psychosis has indicated that collaborative approaches improve engagement.
In the present study, the concept of “partnership building” will be central to 
the intervention. Participants will be asked their opinions of their experiences 
and these will be incorporated into the intervention. The literature on 
Compliance Therapy also suggests that patients value the rare opportunities 
they have to tell clinicians about their experiences. This is one of the main 
goals of the present study. It is hoped that this will improve patient 
satisfaction.
This study incorporated the guidelines of the National Institute of Clinical 
Excellence (2002), which stated that patients should be provided with
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information regarding their illnesses. Furthermore, they should be directed 
towards local resources and services. It is hoped that this approach to 
psychoeducation in people with psychosis will be beneficial in terms of 
decreasing symptomatology and improving satisfaction, aspects of insight 
and compliance. The specific research questions of this study are outlined 
below.
As this study will investigate the utility of a new intervention, it is deemed 
appropriate to carry out a pilot study. The results will be considered as 
hypotheses for future work.
1.5.2 Research Questions
This section will highlight research questions and not hypotheses. As this 
study is an exploratory investigation of a new treatment package and does 
not have a comparison group, it is appropriate to state research questions. 
Hypotheses for future research will be borne out of this study.
This study aims to answer the following questions:
1. Does a personalised psychoeducation approach alter psychiatric 
symptomatology in people with psychosis?
Psychiatric symptomatology will be measured using observer-rated and self- 
report tools. Specifically, anxiety, depression, hostility, suspiciousness and a 
range of positive symptoms will be examined for change.
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2. Having received this intervention, do participants change in particular 
areas of insight, namely, awareness of having a mental disorder, 
awareness of the achieved effects of medication and awareness of the 
social consequences of having a mental disorder?
This study will consider the construct of insight in terms of its facets and not 
as a global phenomenon. It is the aim of the study to understand the effect of 
the intervention on the dimensions of insight.
3. Does a personalised psychoeducation approach alter participants’ 
perspectives on the cognitive representations of their illnesses?
This study aims to consider specific cognitive representations of illness and 
whether the intervention will alter these representations. The study will 
consider participants’ beliefs regarding the consequences of illness; the 
extent to which they believe they have personal control over the illness; the 
degree of control that they believe their treatment has over their psychosis; 
and whether they feel that they have developed a coherent understanding of 
their illness.
4. Following receipt of this psychoeducation intervention, do participants 
change in areas of treatment compliance, namely, awareness of the 
achieved effects of medication; feelings of personal control over 
psychosis; and the attitude that treatment will improve their illness?
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This study has operationalised the construct of compliance in terms of insight 
and cognitive representations of illness and therefore overlaps with research 
questions 2 and 3. It aims to examine whether or not compliance will change 
following this treatment package.
5. What are participants’ feelings regarding their satisfaction with 
treatment following receipt of a personalised psychoeducation 
package?
This study will be unable to provide a quantitative analysis of changes in 
satisfaction following the administration of this psychoeducation programme. 
However, hypotheses of the most helpful aspects of the intervention will be 
drawn from some of the comments made by participants during a semi­
structured interview regarding satisfaction with care.
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2.0 METHOD
This section will provide details of the participants of the study, the measures 
used, the design of the research and information regarding ethical approval.
2.1 Participants
Participants1 recruited were inpatients at a low secure psychiatric intensive 
care unit2. The base unit is rurally located and serves two counties. It 
consists of two wards, each with 16 beds. Patients are referred from one of 
two sources: court and prison diversions in which the individual is sent to the 
base unit for assessment and treatment of a deteriorating mental state; or 
from local Mental Health Units for patients whose illnesses are too acute to 
be managed on an open unit (due to absconding or threats of violence). The 
base unit is a controlled environment where most patients are restricted and 
under a section of the Mental Health Act (1983). All participants of this study 
were acutely psychotic at the time of recruitment and all were detained 
involuntarily under a section.
Over the course of data collection (eight months), 84 people were admitted to 
the ward. Of these, 16 participants were recruited. Figure 2.1 illustrates the 
recruitment of the study. Table 2.1 below outlines the demographic details 
and information regarding illness for the sample.
1 Please note that when referring to participants, the pronoun, “he” will be used for ease of 
reading, as the vast majority of participants were male.
2 This will be referred to as the “base unit” for the remainder of this thesis.
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Figure 2.1
Flow Chart of Recruitment to Study
4 people 
did not 
consent to 
participate
23 people 
fulfilled 
inclusion 
criteria
16 people 
recruited to 
the study
16 people 
completed Pre- 
Intervention 
data
Total number of 
patients admitted over 
recruitment period: 84
14 people completed 
Pre-Intervention and 
Post-Intervention 
data
7 people completed data 
at Pre-Intervention, Post- 
Intervention and Follow-
3 people consented, but were 
later deemed unsuitable because 
they fulfilled the exclusion criteria 
of Personality Disorder (1) and 
medically unstable (2)
61 people fulfilled exclusion criteria:
Not staying at base unit 
for long enough and 
being transferred out 
of region
Personality Disorder: 
Medically unstable:
Did not speak English: 
Dementia:
Deaf:
Learning Disabilities:
Table 2.1 Demographics and Illness Details
Gender
Diagnosis
Age
Ethnicity
Marital Status
Duration of Illness
Number of Previous Episodes of
Illness
Number taking anti-psychotic 
medication
15 Male; 1 Female
15 Schizophrenia; 1 Unspecified 
Psychosis
20-42 years (Mean: 27.94; sd: 6.18) 
10 White; 3 Black or Black British; 2 
Asian or Asian British; 1 Mixed 
14 Single; 2 Married 
0-14 years (Mean: 5.32; sd: 4.51)
0-15 (Mean: 3.33; sd: 3.96)
16
There were two participants who dropped out of the study after Pre- 
Intervention and a further five who dropped out after Post-Intervention3. The 
table below highlights information regarding demographics and illness of the 
group of participants who dropped out throughout the study.
3 There were three time points in this study -  they will be termed Pre-Intervention, Post- 
Intervention and Follow-Up throughout this thesis.
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Table 2.2 Demographics and Illness Details of Participants who Dropped Out
Gender
Diagnosis
Age
Ethnicity
Marital Status
Duration of Illness
Number of Previous Episodes of
Illness
Number taking anti-psychotic 
medication
6 Male; 1 Female
7 Schizophrenia
20-35 years (Mean: 27.43; sd: 5.44) 
4 White; 2 Black or Black British; 1 
Asian or Asian British
6 Single; 1 Married
0.67-13 years (Mean: 5.38; sd: 4.22)
1-3 (Mean: 1.75; sd: 0.96)
7
2.1.1 Inclusion and Exclusion Criteria 
Inclusion criteria for this study were:
• Ability to give informed consent, as rated by a Psychiatrist 
independent of the study.
• Admission for acute psychosis (irrespective of diagnosis).
• A high probability (as decided by the Multi-disciplinary team) 
that the participant would remain on the unit for a period of at 
least 6 weeks (i.e. sufficient time to complete the intervention).
• The participant to be transferred to a local unit where it would 
be possible to collect follow-up data (i.e. not an out of region 
referral).
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The Independent Psychiatrist made the decision regarding capacity to 
consent following a detailed interview. The potential participant was deemed 
capable of giving consent on the basis of four criteria as mentioned by 
Berghmans (2001). These are:
” (i) the capacity to make and express a choice; (ii) the capacity to 
understand relevant information; (iii) the capacity to evaluate the 
character of the situation and possible consequences; and (iv) the 
capacity to handle information rationally’ (Berghmans, 2001, p.4).
Exclusion criteria of this study were:
• Personality Disorder as the primary diagnosis
• Dementia as the primary diagnosis
• Insufficient ability in the English language
• Learning disability
• Hearing Impairment
• Medically unstable
2.1.2 Obstacles to Recruitment
Admission figures for the previous three months were considered prior to the 
start of the study. It was identified that there were, on average, two 
admissions per week, which would have fulfilled the inclusion criteria for this 
study. On this basis, it was estimated that in the time available (i.e. six to 
seven months of data collection), two groups of 26 people (control versus
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intervention) would be recruited. This sample size was in line with the power 
analysis.
However, over the course of the first ten weeks of data collection, a total of 
five participants had completed the intervention (and not 20, as had originally 
been predicted). Only two patients per month (who fulfilled inclusion criteria) 
were being admitted. It would therefore have taken approximately 26 months 
to collect the appropriate amount of data for an experimental design. This 
was beyond the scope of the time restraints of this study. The difference in 
admissions in comparison to the previous three months seemed to be that 
there were far more admissions of people with Personality Disorder over the 
recruitment phase of this study than there had been previously. These 
patients were unsuitable for this study.
Due to the recruitment problems mentioned above, the design was changed 
to an open trial without a control group, with each participant serving as his 
own control. Chairman’s Action was obtained from the Local Ethics 
Committee to pursue this amended version of the research. The duration of 
data collection was extended to eight months and it was calculated that 16 
participants would be obtainable, on the basis of two suitable admissions per 
month.
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2.2 Measures
This section will outline details of all the measures used in this study.
2.2.1 Brief Psychiatric Rating Scale -  BPRS (Overall & Gorham. 1962)4 
This tool was designed to measure levels of general psychopathology. The 
authors suggested that trained clinicians should rate the BPRS. In this study, 
either the Psychiatrist or Consultant Clinical Psychologist fulfilled this role. 
Symptom severity is rated following a standard clinical interview, which can 
take between 10 and 40 minutes depending on the interviewer’s familiarity 
with the participant (Lukoff, Liberman & Nuechterlein, 1986).
The BPRS is the most established scale for a rapid assessment of 
psychopathology (Hafkenscheid, 1991). It consists of 18 items rated on a 
seven-point severity scales (from zero, “Absent” to six, “Extremely Severe”). 
Items include Conceptual Disorganisation, Unusual Thought Content and 
Depression.
Van Riezen and Segal (1988), cited in Morlan and Tan (1998), evaluated the 
BPRS together with other general psychopathology rating scales. They found 
the BPRS to be superior in terms of resolution, sensitivity and simplicity. In 
addition, they recommended that the BPRS be used in all studies of people 
with Schizophrenia. A meta-analysis of studies involving the BPRS noted that 
10 out of 13 studies reported reliability coefficients of .80 or greater for total 
pathology score, indicating high reliability (Hedlund & Vieweg, 1980).
4 Please see Appendix 1 for a copy of the BPRS.
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Flemenbaum and Zimmerman (1973) published test-retest reliability figures 
for every item on the BPRS. These ranged from -.05 (Excitement) to .91 
(Grandiosity).
In terms of validity, a meta-analysis found that BPRS scores over time have 
consistently reflected treatment changes that are corroborated and supported 
by other clinical ratings (Hedlund & Vieweg, 1980). The analysis used 
required information regarding Standard Deviations. These were obtained 
from Morlan and Tan (1998) and ranged from 0.92 (Conceptual 
Disorganisation) to 1.50 (Anxiety).
2.2.2 Brief Symptom Inventory - BSI (Deroqatis. 1993)
The BSI is a self-report inventory and was developed to measure nine 
primary symptom dimensions: somatisation, obsessive-compulsiveness, 
interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, 
paranoid ideation and psychoticism. In addition, it provides a global score. It 
is scored from zero (‘not at all’) to four (‘completely’).
The BSI is a clinically accepted instrument (Morlan & Tan, 1998). Francis, 
Rajan and Turner (1990) reported that it is easy to administer, takes little time 
to complete and has had extensive validation. Furthermore, Piersma,
Reaume and Boes (1994) noted that it is relatively non-intrusive.
In terms of reliability, the BSI has been extensively investigated and shows 
good internal consistency and test-retest reliability. Coefficients range from
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.68 for somatisation to .91 for phobic anxiety (Derogatis, 1993). The global 
rating shows excellent test-retest reliability at .90 (Derogatis, 1993). The 
analysis used required information regarding Standard Deviations. These 
were obtained from Morlan and Tan (1998) and ranged from 9.50 
(Depression) to 12.46 (Paranoid Ideation).
In order to help participants to use this measure, the Assistant Psychologist 
read out the items and provided them with a card of the various responses. 
This was particularly useful with participants who had trouble concentrating 
due to their psychotic symptoms.
2.2.3 Scale to Assess Unawareness in Mental Disorder -  SUMP (Amador, 
et al.. 1993)5
This measure conceptualises insight as a multidimensional rather than 
categorical construct. It includes items of awareness of having a mental 
disorder; insight into the achieved effects of medication; awareness of the 
social consequences of having a mental disorder; and awareness of having a 
number of psychiatric symptoms. These include hallucinations, delusions and 
poor social judgment. Items are rated for current and past insight and on a 
scale from one (‘aware’) to five (‘unaware’). A score of zero is given to 
patients who cannot be assessed or if the item is not relevant.
This study utilised the first three items only (i.e. awareness of having a 
mental disorder, the achieved effects of medication and the social
5 Please see Appendix 2 for a copy of the SUMD.
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consequences of having a mental disorder). Furthermore, only current (not 
past) awareness was assessed as it was deemed problematic to assess 
insight in the past without corroborator information. As participants had a 
number of different symptoms, the individual symptom ratings were not 
included in the study. This allowed for ease of comparison between 
participants.
The measure was scored following a clinical interview conducted by a trained 
clinician (the Consultant Clinical Psychologist or Psychiatrist). Amador et al. 
(1993) reported inter-rater reliability correlations of .89, .75 and .68 for each 
of the three items (respectively). There have been no studies of test-retest 
reliability.
2.2.4 The Insight Scale (Markova & Berrios. 1992)6 
This is a self-report scale of insight designed for psychiatric inpatients. It 
incorporates both quantitative and qualitative features. The scale includes 
patients’ perceptions of changes within themselves and within their 
environments, their recognition of being ill and their acknowledgement of 
needing help. The scale has 32 items. Thirty-one of the items are rated “yes”, 
“no” or “don’t know”. The remaining item is a series of reasons for having to 
come into hospital and the participant is required to circle the ones that best 
describe his situation. The items are divided into “Positive insight”, (i.e. if 
answered positively would indicate greater insight) and “Negative insight” (i.e. 
if answered positively would indicate less insight).
6 Please see Appendix 3 for a copy of the Insight Scale.
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Markova and Berrios (1992) found the test-retest reliability coefficient to be 
.71 and stated that this was adequate. They also found that scores on the 
scale were inversely correlated with the severity of the patients’ disorders. 
The analysis used required information regarding Standard Deviations. 
Markova and Berrios (1992) reported a standard deviation of 3.50 for Positive 
insight and a standard deviation of 1.80 for Negative insight.
2.2.5 Illness Perception Questionnaire -  Revised. IPQ-R (Moss-Morris et 
al.. 2002)7
The IPQ-R is a measure of cognitive and emotional representations of illness 
as described in Leventhal’s Self-Regulatory model (Leventhal et al., 1984). 
The components of illness representations that it considers are identity, 
timeline (acute / chronic), timeline (cyclical), consequences, personal control, 
treatment control, illness coherence and emotional representations. The IPQ- 
R is a 56 item self-report measure. Each item is rated on a five-point scale 
from “strongly disagree” to “strongly agree”. Similar to the BSI, the Assistant 
Psychologist read the items to the participant as he held a card with all of the 
possible responses.
Test-retest reliability has been used from patients on renal dialysis (Moss- 
Morris et al., 2002). The dimensions of the IPQ-R showed good stability over 
time with correlations ranging from .46 to .88. Evidence was also provided for 
internal reliability: the Cronbach alphas ranged from .79 (timeline cyclical) to 
.89 (timeline acute / chronic). The analysis required information regarding
7 Please see Appendix 4 for a copy of the IPQ-R.
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Standard Deviations. The authors reported standard deviations for a chronic 
pain sample. These were utilised in this study and ranged from 3.36 
(Treatment Control) to 4.78 (Illness Coherence).
In this study, it was deemed that the most relevant illness representations to 
assess for change over time were Consequences, Personal Control, 
Treatment Control and Illness Coherence. It was felt that these four sub­
scales best characterised the illness representations that were expected to 
change following the receipt of a psychoeducation programme.
2.2.6 Udvalq for Kliniske Undersoaelser (Committee for Clinical Trials) 
Consumer Satisfaction - UKU-ConSat (Ahlfors et al.. 2001 )8 
This scale was used to assess participants’ overall satisfaction with care in 
the base unit, with later specific questions regarding their satisfaction with the 
psychoeducation package. The UKU-ConSat consists of six items related to 
the structure and process of treatment / care and two items related to 
outcome and well-being. The scale is administered as a brief semi-structured 
interview. The authors suggested that a person who is not directly involved in 
the treatment / care of the patient should conduct the interview. In this study, 
the Assistant Psychologist fulfilled this role. Whilst carrying out the interview, 
the Assistant Psychologist noted comments made by each participant 
regarding the psychoeducation package.
8 Please see Appendix 5 for a copy of the UKU-ConSat.
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A total score of between -24 and +24 is obtained for this measure. The 
authors stated that any score below zero represents a degree of 
dissatisfaction and any score above zero is indicative of satisfaction. There 
have been no studies of test-retest reliability for this measure.
2.3 Procedure
This section will outline the procedures adopted for informing each participant 
of the study, obtaining consent and collecting data.
2.3.1 Selection for the study
Patients’ suitability for this study was discussed at the weekly Multi­
disciplinary team meeting. Each potential participant was then approached by 
an Assistant Psychologist who explained the study and provided a Patient 
Information Sheet. After reading this, the patient was asked to sign the 
Consent Form if he agreed to participate9.
2.3.2 Collection of data
Data was collected at three time points: Pre-Intervention, Post-Intervention 
(following the intervention) and Follow-Up (six weeks after the completion of 
the intervention).
The figure below illustrates the process of data collection adopted by the 
study.
9 Please see Appendix 6 for the Patient Information Sheet and the Consent Form.
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Figure 2.2 Flow Chart of data collection process for patients who consented
to participate in the study.
Within 2 weeks
Within 5 days
Within 5 days
i r
Within 5 days
Within 5 days
After 6 weeks
Admission
Follow-Up data collected
Pre-Intervention data collected.
Post-Intervention data collected
Capacity for consent assessed by 
Psychiatrist independent of study.
3-session intervention administered. Each 
session conducted 2 weeks apart.
Participant approached by Assistant Psychologist. Patient 
information sheet provided. If agreed to participate, consent 
sheet signed.
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After obtaining consent, the Assistant Psychologist returned within the next 
five days to collect baseline data. This consisted of the BSI; the IPQ-R; and 
The Insight Scale.
The Psychiatrist also visited the participant within five days of consent. A 
psychiatric interview was conducted and ratings were completed on the 
following measures: the BPRS and the SUMD. Following the collection of all 
relevant baseline data, the researcher administered the intervention at 
approximately 2, 4 and 6 weeks post admission.
Within five days of the final session of the intervention, the Assistant 
Psychologist and Psychiatrist again administered the same measures as Pre- 
Intervention (referred to as the Post-Intervention stage). In addition, the 
Assistant Psychologist also administered the UKU-Consat. Six weeks after 
the final intervention session, the Assistant Psychologist and Psychiatrist 
again administered the same measures that were used at Post-Intervention 
in the Follow-Up stage.
The Assistant Psychologist administered all psychological measures (i.e.
BSI, IPQ-R, The Insight Scale and the UKU-ConSat). This maintained 
consistency for all participants. The Psychiatry measures (i.e. BPRS and 
SUMD) were completed by one of two people: a Psychiatrist or the 
Consultant Clinical Psychologist. It was ensured that the same clinician 
completed all three-time points with each participant in order to maintain 
consistency of rater.
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Data was generally collected at the base unit in order to maintain consistency 
of setting. However, some participants were transferred during the course of 
the intervention and data was collected from the units in which they were 
residing. After completing Post-Intervention data, all participants who had 
been discharged from the base unit were sent a letter to offer an appointment 
time for collection of Follow-Up data. As this study was clinically based, it 
was not possible to maintain all participants within the same setting for the 
duration of data collection.
2.4 Design
The design of this study was an open trial without a control group. When 
developing a new intervention, Barker, Pistrang and Elliot (2002) 
recommended the use of a simple design. They stated that,
“In clinical research it is often a good first step to use a simple design 
such as a one-group pretest-posttest to demonstrate that a gross 
effect exists at air (p. 149).
The gross effect is the effect that can be attributed to the intervention i.e. the 
overall effect minus the confounding variables (Rossi, Freeman & Lipsey, 
1999). Barker et al. (2002) suggested that if no effect has been found from a 
simple design, then there would be no purpose in carrying out a randomised 
controlled trial. They therefore stated that a simple design is an important 
initial study when evaluating a new intervention. Halpern, Karlawish and
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Berlin (2002) similarly reported that one of the few types of study in which a 
small sample is acceptable is in early-phase trials of a new drug or device.
2.4.1 Power
In terms of power, the original experimental design needed 26 participants in 
each group at a=.80 (assuming a large effect size similar to those expected 
for therapy and waiting list controls). As the study has changed in order to 
pursue a simple design, power is not relevant. Findings can therefore be 
described as hypotheses and not as firm conclusions due to the lack of 
power in this study.
2.5 Ethical Approval
Permission to carry out the study was obtained from the Local Research 
Ethics Committee. After 10 weeks of data collection, Chairman’s Action was 
granted to alter the design to an open trial without a control group10.
10 Please see Appendix 7 for confirmation of Ethical Approval and a copy of the Chairman’s 
Action letter.
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3.0 INTERVENTION
The intervention is designed based on three facets: theory; general clinical 
knowledge of those working in this field; and information that is readily 
available to patients in the base unit. It has been developed in line with NICE 
(2002) guidelines for delivering information regarding diagnosis to patients 
with Schizophrenia whilst they are in the acute stages of illness. By 
intervening early, this treatment attempts to allow participants to alter their 
trajectories regarding the long-term influences of their psychotic symptoms 
and help them to develop coping strategies (as suggested by Birchwood et 
al., 1997). The paragraphs below outline literature that contributed to the 
development and design of the intervention.
The recommendations of Kemp and David (1996b) were influential in the 
development of the intervention. These authors specified the importance of 
personalising information (in accordance with McGorry, 1995); the need to 
allow participants to discuss their experiences in a non-threatening 
environment; the collaborative therapy relationship (as is suggested by 
Kingdon, 1998); and a brief number of sessions. As is indicated in detail 
below, the intervention involves a process of eliciting participants’ beliefs 
regarding their psychosis; empowering them to share these experiences 
through the lack of challenging in the initial assessment; and negotiating the 
details outlined in the manual1. These principles are an attempt to fulfil the 
first three of the recommendations mentioned by Kemp and David above.
1 Each participant received a manual regarding their experiences. This is detailed in the 
sections below.
67
The final criterion of a brief number of sessions was implemented and three 
were offered to each participant.
A key contributing factor in the design of the intervention is the objectives for 
delivering psychoeducation as indicated by McGorry (1995). Firstly, a 
“speedy recovery” is promoted through information regarding symptoms and 
ways of dealing with psychosis (medication and otherwise). Secondly, the 
psychoeducation package aims to present psychosis as a long-term, but 
manageable illness with the use of treatment. This fulfils McGorry’s aim of 
aiding the person to accept future therapy. Thirdly, as directed by McGorry, 
appropriate coping strategies are discussed in the intervention, with an 
emphasis on avoidance of illicit substances and encouragement to partake in 
healthy activities (e.g. exercise and socialising). Finally, as McGorry 
recommended, the risk of early relapse is addressed through discussion of 
the key symptoms that would be likely to re-emerge in the prodromal stages 
of psychosis. Furthermore, the healthcare professionals and family members 
whom the participant may contact are highlighted.
This chapter will provide details about the ways in which this 
psychoeducation package was delivered. The sections below will include 
information regarding the initial assessment and the format of the 
intervention. Subsequently, the procedure of delivery of the intervention is 
specified.
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3.1 Initial Assessment
In an attempt to take into account the experiences of each participant (as 
directed by Kilkku et al., 2003) and subsequently personalise each 
psychoeducation package, a detailed assessment was undertaken. The aim 
of the initial assessment is to obtain each participant’s views of his 
circumstances without challenging by the main researcher. This is in line with 
the suggestions of Yalom (1975), who stipulated that patients’ views must be 
considered before “credible alternatives” are offered.
The design of the initial assessment is also influenced by the literature on 
patient satisfaction. Weinman and Petrie (2000) highlighted that “partnership 
building”, involving open questioning and appropriate responses to signs of 
distress increased satisfaction. The initial assessment was designed 
accordingly.
A semi-structured interview was devised which attempts to elicit the beliefs of 
each participant regarding: detention in the base unit; symptoms 
experienced; history of drug and alcohol misuse; and plans for the future2. 
The interview incorporates components from biological, psychological and 
social aspects of each individual. The assessment and intervention were 
designed within a biopsychosocial framework.
2 Please see Appendix 8 for Initial Assessment.
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3.2 Format of Intervention
The intervention centres on the development and provision of a shared, 
personalised view of the key factors of each participant’s illness. Participants 
are more likely to retain information that is personalised to their condition and 
not delivered as abstract concepts (e.g. McGorry, 1995). In order to achieve 
this standard, limited jargon and professional shorthand are used throughout 
the manual. Information is delivered where possible in the participant’s own 
words (as was suggested by Tarrier & Barrowclough, 1986)3. The 
paragraphs below outline the content of each page of the manual.
3.2.1 Views of participant -  Page 1
The first part of the manual reiterates the information collected in the semi- 
structured interview conducted in the first session. This includes beliefs 
regarding admission; precipitating events to admission; and the views of 
doctors and family or friends.
3.2.2 Introduction of the term ‘psychosis’ -  Page 2
Towards the end of the first section of the manual, the term “psychosis” is 
introduced and the definition is provided. The definition was obtained from 
the Collins English Dictionary (1998). This stated
“A psychosis is a condition in which the person’s contact with reality is 
lost or highly distorted”.
3 Please see Appendix 9 for the template of the manual and Appendix 21 for a sample 
manual. In Appendix 21, details have been changed to protect confidentiality.
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It is important to begin this section with a definition that is easily accessible to 
all readers. This section then tries to normalise the experience of having a 
psychosis by stating,
“Many people who have a psychosis don’t believe they are suffering 
from an illness in the early stages”.
The text aims to relate the experiences of the participant to the symptom and 
to personalise the information, e.g.
“You mentioned that you hear voices telling you to kill yourself. This 
symptom is called a hallucination and often seems to occur out of 
nowhere. Hearing voices that other people can’t hear is the most 
common type of hallucination.”
3.2.3 Summary of participant’s beliefs and alternative explanations -  Page 3 
As pages 1 and 2 of the manual are often lengthy, the aim of page 3 is to 
include a summary table of the beliefs that the participant was experiencing 
together with associated symptoms. Please see the table below for an 
example:
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Your Belief Alternative Explanations
• Your water was poisoned • This belief seems to be true to 
you, but can make you feel 
alone because other people 
don’t believe you.
• Although you believe this very 
strongly, we think these 
feelings are due to a symptom 
called a delusion.
• Delusions are a common 
symptom of psychosis.
3.2.4 Causes of Psychosis -  Page 4
This section begins with biological, developmental or genetic reasons for the 
development of psychosis. It introduces the participant to the concept of 
organic causes of psychosis. In cases where the participant reports a difficult 
birth or pregnancy, this is linked as being a possible cause of psychosis. For 
those patients who have a family history of mental illness, the genetic 
characteristics of psychosis are highlighted as a possible cause.
The Stress-Vulnerability model is then introduced (Zubin & Spring, 1977). 
Information from the initial interview is used to ascertain the stressful 
experience that the participant had been experiencing prior to the onset of 
illness. This is then directly related to the model. In this section, a diagram is 
used to help to condense the information and better explain the model.
This page then informs the participant of the problems that can be 
encountered when taking drugs (for those participants who admitted to taking 
drugs). It is extremely common for people with psychosis to take drugs, 
usually cannabis (Negrete & Gill, 1999). These authors stated that cannabis
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is the third most commonly used substance by people with psychosis, 
following tobacco and alcohol. They reported that the use of cannabis has 
the effect of unblocking dopamine pathways, heightening the risk of a further 
psychotic episode and possible hospital readmission.
This section aims to introduce to the participant that a degree of control over 
psychosis is attainable and by refraining from illicit substances, the likelihood 
of hospital readmission is lessened (Negrete &Gill, 1999). This section is the 
first of several designed to empower the participant to take an active role in 
controlling his psychosis.
3.2.5 Theories to understand symptoms -  Page 5
This page aims to outline relevant theories in a simplistic way whilst relating 
them directly to the experiences of the individual. In cases where the 
participant is struggling with delusions, theories by Garety and colleagues are 
used (e.g. Garety, Hemsley & Wessley, 1991). These authors suggested that 
people who have delusions are likely to switch their judgments rapidly and 
draw on less firm conclusions. The manual firstly re-states the delusion that 
was mentioned by the participant in the first session, then provides 
information regarding the theory.
The next section is headed “How this relates to you” in which alternative 
explanations of reasons for experiencing the specific delusion are provided, 
including,
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“You believe that people who are close to you do not care about your 
welfare, when, in fact, there may be many other explanations, like 
there is a chemical imbalance in your brain that causes you to think 
this way. You may not have much evidence for believing your family 
doesn’t care for you. Instead, your psychosis causes you to think this 
way.”
In order to include a balanced perspective, Bentall’s theory is also provided 
(e.g. Bentall, 1990). This suggested that delusions, particularly persecutory in 
nature, serve the function of defending self-esteem and minimising negative 
affect. Similar to the above format, the information is presented as a brief, 
accessible outline of the theory. This is followed by a section entitled, “How 
this may relate to you”, in which the particular delusion of the participant is 
referred to and an alternative explanation is offered, e.g.
“Your experiences of attacking others may be examples of blaming 
other people for your symptoms. In your case, you become paranoid 
and then engage in violent behaviour, e.g. you stabbed a man in 1982, 
you threatened to hit a member of staff and you attacked another 
patient. These people may not have been trying to upset you, your 
psychosis may have been making you misinterpret your environment 
and feel this way. So, you blamed others for your behaviour, instead of 
feeling sad about being unwell. ”
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In cases where auditory hallucinations are the main symptom, various 
theories to explain the experience to the participant were utilised. The format 
is the same as that described above for delusions, i.e. each section stated 
the theory and then related it to the individual.
Baddeley’s (1986) theory of “disturbances of inner speech” is included which 
suggests that the articulatory loop (the short-term verbal store component of 
working memory) operates without adequate monitoring of the source of the 
stimulus, i.e. the person experiences thoughts as occurring from outside his 
head. An example of the section of “How this may relate to you” is,
“The difficult thoughts that you have about killing yourself are 
generated from your own anxieties about the world. They are your 
own thoughts that are interpreted as coming from outside your head.”
The ‘Input Theory’ (Bentall & Slade, 1986) is also included. This theory 
suggests that an external stimulus might be misperceived, thereby giving a 
false perception. These authors suggested that disturbances are likely to 
occur due to a combination of poor signal discrimination and biases of 
perception. An example of the way in which this theory is related to a 
participant is highlighted below:
“You sometimes become confused about noises from outside your 
head and misinterpret these as voices and telepathic messages. ”
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Finally, Frith’s (1992) theory of ‘Disturbances of Self Monitoring’ is utilised. 
This suggests that auditory hallucinations are caused by the failure to monitor 
the intention to produce inner speech, i.e. the source of the thought. In this 
case, an example of the section entitled “How this may relate to you” is,
“The thoughts originate from inside your head, but because of a 
disturbance of self monitoring, you do not realise that you had 
intended to think them, so you perceive them as voices coming from 
outside your head. ”
The main symptoms described in the first session interview by all participants 
were either delusions or auditory hallucinations. It is for this reason that 
theories of these symptoms have been documented only.
3.2.6 Metaphor to understand symptoms -  Page 6 
A metaphor from Acceptance and Commitment Therapy (ACT) is 
incorporated to allow the participant to begin to externalise psychosis (Hayes, 
Strosahl & Wilson, 1999). ACT is based on the premise that maladaptive 
behaviours are produced by attempts to suppress thoughts, feelings and 
symptoms. Bach and Hayes (2002) found ACT to be particularly helpful in 
reducing hospital readmission of psychotic patients. The first aim of ACT is to 
identify and abandon internally oriented control strategies. It uses metaphors 
to remove the focus directly from the patient and to help him to begin to think 
more laterally about problem solving strategies he employs that may be 
failing to help.
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The metaphor used in the present intervention is called “Tug of war with a 
Monster”4. Following reading this metaphor, each participant is asked how he 
feels it relates to his own life circumstances. For those who find it a difficult 
idea to conceptualise, the “monster” is identified as psychosis and the rope 
(for the “tug of war”) is likened to all the strategies that the participant has 
used to deal with the “monster”, including taking drugs, having little structure 
in the day and stopping medication. It is suggested to the participant that the 
metaphor states that he should “drop the rope”, i.e. stop using these 
strategies, because the “monster” or psychosis is becoming worse, or 
“winning”, as the metaphor suggested. The researcher and participant then 
engage in a discussion about the metaphor and the personal relevance of the 
image to the participant.
3.2.7 Ideas to improve symptoms -  Page 7
This section informs the participants of the biopsychosocial factors involved 
in psychosis and attempts to provide them with relevant information 
regarding control over symptoms. In terms of biology, it provides the 
participant with a rationale to continue to take medication, i.e. that it acts on 
the dopamine in the brain and can help to reduce many of the symptoms of 
psychosis. This section aims to improve the participants’ insight into the 
achieved effects of medication.
Further to the biological control of psychosis, this section emphasises the 
importance of avoiding illicit substances. It reinforces the connection between
4 Please see Appendix 21 (sample manual), page 6.
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increased dopamine caused by illegal drug taking and the onset of psychosis 
as a result (Negrete & Gill, 1999).
In terms of the psychosocial aspects of psychosis, the importance of 
reducing stress and creating a daily routine are highlighted. This is in 
accordance with the Stress-Vulnerability model (Zubin & Spring, 1977). 
Finally, for those participants whose social network increases the likelihood 
of returning to illicit drug taking, alcohol misuse and of remaining 
unemployed, they are encouraged to think about the dangers of socialising 
with these people and the consequences for their future mental health. 
Several researchers have stated that it is important for patients with 
psychosis to have structure to their lives in order to reduce the frequency of 
relapse (e.g. Iqbal et al., 2000).
3.2.8 Relapse prevention -  Pages 8 and 9
This section begins by reminding the participant of the aspirations that they 
stated in the initial assessment. Attempts are made to instil hope in the 
participants in order that they might be able to pursue those avenues in the 
future. This is in accordance with Birchwood et al. (2000), who stated that a 
vocational approach is appropriate when attempting to reintegrate patients 
with psychosis into society.
This section then emphasises the importance of remaining well in terms of a 
biopsychosocial perspective, including continuing to take medication, eating 
healthily, exercising and socialising. With regards to medication, this section
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informs the participant that if he were to stop taking medication, the 
symptoms would be likely to re-emerge. It then mentions the symptoms that 
the participant may be likely to re-experience in the prodromal stages of 
psychosis. These symptoms are discussed with the participant in the second 
intervention session and are incorporated into the final draft of the manual. 
This is another example of personalising information to each participant by 
increasing awareness of personal relapse patterns. This approach is in line 
with literature on CBT for relapse prevention (e.g. Morrison et al., 2004).
Although the above issues were covered in an earlier part of the manual, it 
was deemed important to reiterate information that could empower the 
participant. Furthermore, it is known that people with psychosis may have 
difficulties in concentrating and that it is useful to repeat information (e.g. 
Lindsay & Powell, 1994).
The participant is then reminded of the importance of contacting his GP, 
Psychiatrist, CPN or Social Worker if he begins to notice his symptoms re- 
emerging. In session 2, the participant is asked the names of these 
individuals and these are included in the final draft. This helps to further 
personalise the manual.
Finally, this section informs the participant of the likelihood of further 
prescriptions of medication if symptoms re-emerge. It also reiterates the 
number of professionals available to help the participant should the need
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arise. The aim of this section is to heighten the participant’s awareness of the 
risk of relapse.
3.2.9 Plans for the future -  Page 10
On the basis of the hopes of participants as elicited in the initial assessment, 
information is given regarding possible contacts in a number of areas, 
including help with substance misuse, social and leisure activities, education, 
voluntary work and employment. Although the delivery of this information 
may seem premature whilst the participant remains acutely psychotic, it is in 
line with both NICE (2002) guidelines (regarding provision of contact details 
for local resources and services) and literature by Birchwood et al. (2000) 
and Iqbal et al. (2000).
3.3 Procedure of Intervention
This section will describe the various stages of developing the intervention 
and will then outline the procedure used for administering the package.
3.3.1 Piloting of intervention
The intervention was prepared as an anonymous letter and manual. Both 
versions were presented to 10 members of a Clinical Psychology department 
(five Clinical Psychologists, four Assistant Psychologists and one 
Psychotherapist) for review and comment. A pilot was conducted with three 
patients prior to the start of data collection for assessment of comprehension 
and face validity. In the final session, each was presented with the 
information as a letter and in a manual form. A brief questionnaire was
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designed to assess the preference of formats5. The results indicated that all 
individuals preferred the manual format. This format was therefore used for 
the study.
3.3.2 Readability of the Manual
Each manual was checked for ease of reading using Flesch scores. This 
analysis is from 0 to 100 and states that the higher the score, the easier the 
document is to read and understand. Standard documents should obtain 
scores between 60 and 70. All manuals had scores of this range. On 
occasion, there were some participants who had some difficulties in reading. 
In these circumstances, both the manual and an audio taped version were 
presented to the participants. This occurred on two occasions.
3.3.3 First session / Initial Assessment
The emphasis in the first session was on building the therapeutic alliance. It 
was important for the participants to feel safe enough to reveal their beliefs 
without feeling judged. The researcher created this atmosphere by explaining 
to the participant that he would be questioned about his beliefs, but that the 
researcher would not be imposing her views.
At the end of the first session, each participant was informed that he would 
be meeting the researcher again in two weeks time. It was also explained 
that, at that time, he would be given a manual. It was indicated that this 
would incorporate both his views and those of the researcher (and the Multi-
5 Please see Appendix 10 for a sample letter and Appendix 11 for the questionnaire used in 
pilot study.
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disciplinary team) about the symptoms he was experiencing. This session 
usually lasted between 45 minutes and 1 hour.
3.3.4 Second Session
In this session, each participant was presented with a manual. As can be 
seen in Appendix 21, the manual was held together without staples. This 
avoided the risk of self-harming behaviour with the use of staples.
The session was introduced to the participant as his opportunity to discuss 
the manual and to amend the parts with which he strongly disagreed. 
Specifically, the researcher would amend errors in the documentation of the 
participant’s beliefs surrounding the events leading up to admission to the 
base unit. The researcher was not able to amend parts of the manual that 
related to theories explaining psychotic symptoms. This session usually 
lasted between 30 and 45 minutes.
Although the researcher focused closely on the text, time was spent 
discussing the various parts of the manual with each participant. At the end 
of this session, each participant was reminded that the researcher would be 
returning in two weeks for the final session and at that time, the participant 
would be presented with the amended version of the manual.
At the end of sessions 2 and 3, the participant was given his own colour copy 
of the manual. As it contained a large amount of information, it was deemed
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important for the participant to have the opportunity to look through the 
information again whilst alone in order to aid comprehension.
3.3.5 Final Session
The amended version of the manual was presented to the participant and 
was read through by the researcher. At various points, the researcher 
encouraged the participant to engage in discussion regarding his views. This 
session usually lasted approximately 20 to 30 minutes.
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4.0 RESULTS
This study employed an open trial without a control group. A total of 16 
people were considered suitable for the study. Of these 16, two participants 
dropped out after the Pre-Intervention stage due to the destabilisation of their 
mental states. Following the intervention, a further five people dropped out 
prior to the Follow-Up as they had been discharged from hospital and chose 
to withdraw.
4.0.1 Data Analysis
This study utilised the Reliable Change Index (developed by Jacobson, 
Follette & Revenstorf, 1984; amended by Christensen & Mendoza, 1986; 
cited in Jacobson & Truax, 1991), an analysis that defines whether or not a 
single case has statistically changed across two time points. This analysis 
considers the difference between each participant’s pre-test and post-test 
scores1 and compares this against the standard error of the measurement, 
as calculated using test-retest reliability figures.
Jacobson and Truax (1991) stated that in cases where the RCI is greater 
than 1.96, the post-test score is statistically significantly greater than the pre­
test score, that is, “real change” is indicated. This assumes a probability of a 
5% chance that the observed change is due to the unreliability of the 
measurement.
1 1n the case of this study, Pre-Test is referred to as Pre-Intervention and Post-Test as Post- 
Intervention.
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The Reliable Change Index will be used to analyse research question 1 
(Psychiatric Symptomatology), question 3 (Illness Representations) and 
question 4 (Compliance). Question 2 (Insight) will compare results by 
subtracting Post-Intervention and Follow-Up scores from Pre-Intervention 
scores. Question 5 (Satisfaction) will report total scores and quote 
participants’ comments regarding the psychoeducation package. Appendix 
12 indicates the Standard Error and Standard Error of Difference between 
two test scores for each measure that was analysed using the Reliable 
Change Index.
4.0.2 Analysis of data across 3 time points
Data was analysed by comparing Pre-Intervention to Post-Intervention and 
Pre-Intervention to Follow-Up scores, i.e. the analysis considered whether 
any improvement at Post-Intervention was upheld at Follow-Up. It was 
therefore deemed superfluous to requirements to analyse Post-Intervention 
to Follow-Up.
A total of 14 out of 16 participants (87.50%) completed the intervention (i.e. 
Pre-Intervention and Post-Intervention) and 7 out of 16 participants (43.75%) 
completed a full data set (i.e. Pre-Intervention, Post-Intervention and Follow- 
Up). Appendix 13 outlines each participant’s recruitment over the three time 
points and states when missing values were used. Appendix 14 provides raw 
data for each participant on all of the variables analysed for this study.
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4.1 Psychiatric Symptomatology
This study aimed to answer the following question:
Does a personalised psychoeducation approach alter psychiatric 
symptomatology in people with psychosis?
The study considered both positive and negative symptoms. The specific 
symptoms of interest were: anxiety, depression, hostility, suspiciousness, 
unusual thought content, conceptual disorganisation, psychoticism and 
paranoid ideation.
Appendices 15 and 16 show the Reliable Change Indices for each participant 
from Pre-Intervention to Post-Intervention and from Pre-Intervention to 
Follow-Up for the BPRS and BSI respectively (labelled A to P for purposes of 
confidentiality). Table 4.1 below indicates the number of participants whose 
scores, according to the Reliable Change Indices, were found to significantly 
improve, significantly deteriorate and those who showed no change across 
the time points. The table is divided into two halves: the first highlights Pre- 
Intervention to Post-Intervention data (i.e. any changes occurring during the 
active stage of intervention); the second indicates Pre-Intervention to Follow- 
Up (i.e. changes sustained over six weeks following the intervention). The 
table shows individual figures for BPRS and BSI ratings. Each cell includes 
the number of participants who had changed significantly. The time points 
Pre-Intervention and Post-Intervention have been abbreviated to Pre- and 
Post- in Table 4.1. It is noted that of the 16 participants, at Post-Intervention,
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13 were available for assessment using the BPRS and 14 were assessed 
using the BSI. At Follow-Up, 8 were available for assessment of the BPRS 
and 9 for the BSI. Those available for assessment will be referred to as 
“responders”.
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Table  4.1 Num ber of Participants with Significant Changes across Tim e  
on Psychiatric Sym ptom atology
Pre- to Post- Pre- to Follow-
Up
Deteriorate No
Change
Improved Deteriorate No
Change
Improved
BPRS
Anxiety 0 13 0 0 8 0
Depression 0 12 1 0 7 1
C D * 0 8 5 0 5
3
U T C * 0 10 6 0 4 4
Hostility 0 12 1 0 8 0
Suspiciousness
BSI
0 10 3 0 5 3
Anxiety 0 12 2 0 7 2
Depression 0 10 4 0 7 2
Paranoid
Ideation
2 7 5 1 5 4
Psychoticism 0 10 4 0 6 3
Hostility 1 11 2 0 7 2
* C D  = Conceptual Disorganisation
* U TC  = Unusual Thought Content
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The shaded areas in Table 4.1 above indicate the three symptoms that were 
found to have the highest proportion of significant changes over the three 
time points.
During the active phase of the intervention (i.e. Pre-Intervention to Post- 
Intervention), the variables found to have the highest number of significant 
improvements were Unusual Thought Content (six participants, i.e. 46.15% 
of responders), Conceptual Disorganisation (five participants, i.e. 38.46% of 
responders) and Paranoid Ideation (five participants, i.e. 38.46% of 
responders). A number of other variables showed smaller numbers of 
participants who had significant differences in the active intervention stage. 
These included Psychoticism (four participants, i.e. 28.57% of responders); 
Depression -  as rated in the BSI (four participants, i.e. 28.57% of 
responders); and Suspiciousness (three participants, i.e. 23.08% of 
responders). However, some variables that were measured showed few 
significant differences in the active treatment stage. These included Anxiety 
(no participants, i.e. 0% in BPRS and two participants, i.e. 14.29% in BSI) 
and Hostility (one participant, i.e. 7.69% in BPRS and two participants, i.e. 
14.29% in BSI).
At Follow-Up, of the 8 participants available using the BPRS, four showed 
gains on Unusual Thought Content and three had gains on Conceptual 
Disorganisation from Post-Intervention. In terms of the 9 participants 
available for Follow-Up on the BSI, four had gains on Paranoid Ideation.
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The box plots below (Figure 4.1) illustrate the changes found in these 
symptoms over the three time points. The graphs show that the median of 
the variables decreased over the three time points for Conceptual 
Disorganisation and Paranoid Ideation. In the cases of Conceptual 
Disorganisation and Unusual Thought Content, the median at Post- 
Intervention reached 0 and this was maintained at Follow-Up.
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Figure 4.1 Box Plots of Psychiatric Sym ptom atology with M ost Significant 
Changes
Conceptual Disorganisation (BPRS)
5
4
3
2
1
0
-1
N •  16 13 a
Pre-Intervention Post-Intervention Follow-Up
7
6
5
4
3
2
1
0 
-1
a - a a a
Pre-Intervention Post-Intervention Follow-Up
Unusual Thought Content (BPRS)
91
Paranoid Ideation (BSI)
2 •
16
Pre-Intervention
u
Post-Intervention
9
Follow-Up
92
In summary, this study found that three positive symptoms (Unusual Thought 
Content, Conceptual Disorganisation and Paranoid Ideation) showed the 
highest number of participants who had significant changes during the active 
phase of treatment. These changes were maintained at Follow-Up in many of 
the responders. However, changes in Anxiety and Hostility were not found. 
Only moderate changes were found in the remaining symptoms that were 
measured. These included Depression, Psychoticism and Suspiciousness.
4.2 Insight
The second research question posed by this study was:
Having received this personalised psychoeducation package, do participants 
change in particular areas of insight, namely, awareness of having a mental 
disorder, awareness of the achieved effects of medication and awareness of 
the social consequences of having a mental disorder?
The results will be described below according to the two measures (SUMD 
and Insight Scale) respectively.
4.2.1 Scale to Assess Unawareness in Mental Disorder 
The SUMD was analysed by subtracting Post-Intervention scores from Pre- 
Intervention scores and Follow-Up scores from Pre-Intervention scores. The 
study recognised that any decrease from a high score to a lower score 
represented some improvement in insight.
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Appendix 17 outlines the change in scores from Pre-Intervention to Post- 
Intervention and from Pre-Intervention to Follow-Up in each of the 16 
participants. Table 4.2 below indicates the number of participants found to 
decrease in scores over time for each of the three items. The table is divided 
into two halves: the first indicates changes from Pre-Intervention to Post- 
Intervention; the second denotes changes from Pre-Intervention to Follow- 
Up. The headings for each of the items have been condensed from 
“awareness of having a mental disorder” to “Mental Disorder”; “awareness of 
the achieved effects of medication” to “Medication”; and “awareness of the 
social consequences of having a mental disorder” to “Social Consequences”. 
It is noted that 13 participants were available for data collection at Post- 
Intervention and 8 were available at Follow-Up. These participants will be 
referred to as “responders”.
Table 4.2 Number of Participants to have improved in insight on SUMD
Pre-Intervention to 
Post-Intervention
Pre-Intervention to 
Follow-Up
Mental Disorder 7 5
Medication 6 5
Social Consequence 7 4
Table 4.2 above indicates that, during the active phase of treatment, 53.85% 
of participants (7 out of 13 responders) improved on awareness of having a 
mental disorder (i.e. from Pre-Intervention to Post-Intervention). At Follow- 
Up, of the eight available participants, five were found to have improved. It is
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noted that all participants had a degree of unawareness of having a mental 
disorder at Pre-Intervention.
In terms of awareness of the achieved effects of medication, 46.15% of 
participants (6 out of 13 responders) improved from Pre-Intervention to Post- 
Intervention. At Follow-Up, this gain was found in five of the eight 
responders. Participant O sustained full awareness of the achieved effects of 
medication across the three time points.
Finally, with regards to awareness of the social consequences of having a 
mental disorder, 53.85% of participants (7 out of 13 responders) improved 
from Pre-Intervention to Post-Intervention. This was upheld in four of the 
eight participants available at Follow-Up.
The bar graphs in Figure 4.2 below illustrate the change of scores over the 
three time points. They show the mean scores of all responders for each of 
the three time points. As can be seen, in the cases of awareness of having a 
mental disorder and awareness of the achieved effects of medication, the 
mean score consistently decreased over time. However, in the case of 
awareness of the social consequences of having a mental disorder, the mean 
at Follow-Up was slightly higher than at Post-Intervention, although the 
amount of change is negligible (i.e. 0.02 points on the scale).
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It has been illustrated above that approximately 50% of participants improved 
on insight in at least one area following the psychoeducation intervention.
4.2.2 The Insight Scale
This questionnaire was analysed using the Reliable Change Index. The 
differences between scores from Pre-Intervention to Post-Intervention and 
from Pre-Intervention to Follow-Up were considered. Appendix 18 states 
each participant’s Reliable Change Index for both Positive and Negative 
Insight. The significant findings are illustrated in Table 4.3 below.
Table 4.3 Number of Participants with Significant Changes on the Insight 
Scale
Pre-Intervention to Pre-Intervention to
Post-I nterve ntion Follow-Up
Positive Insight 2 2
Negative Insight 1 0
The results show that two participants (A and C) had significant gains in 
Positive Insight from Pre-Intervention to Post-Intervention (RCI = 2.62 and 
RCI = 5.24 respectively). This was upheld on the Pre-Intervention to Follow- 
Up comparison for Participant C (RCI = 3.00). In addition, Participant F was 
found to have significant improvements on Positive Insight at Follow-Up (RCI 
= 3.00). Participant A’s data was recorded as missing at Follow-Up due to his 
deteriorating mental state.
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In terms of Negative Insight, Participant G’s scores were found to significantly 
increase when comparing Pre-Intervention and Post-Intervention (RCI =
3.51). Participant G dropped out after Post-Intervention and missing data was 
recorded. As can be seen in Appendix 18, Participant J’s scores were found 
to significantly decrease on Negative Insight from Pre-Intervention to Follow- 
Up (RCI = -2.34).
In response to the research question of whether insight changes following the 
administration of a personalised psychoeducation package, the results 
indicate that in the three facets of insight, as assessed by the SUMD 
(awareness of having a mental disorder, awareness of the achieved effects 
of medication and awareness of the social consequences of having a mental 
disorder) all significantly improved for approximately 50% of the participants 
over time. The results of the Insight Scale confirm, but add little to this 
finding.
4.3 Illness Representations
This study aimed to answer the following question:
Does a personalised psychoeducation approach alter participants’ 
perspectives on the cognitive representations of their illnesses?
The specific cognitive representations of illness that were examined in this 
study were Consequences, Personal Control, Treatment Control and Illness 
Coherence. The direction of results that signified a positive change for all of
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the above sub-scales was Post-Intervention scores higher than Pre- 
Intervention scores, or Follow-Up scores higher than Pre-Intervention scores. 
Appendix 19 details the Reliable Change Indices for each of the 16 
participants on the IPQ-R.
Table 4.4 below highlights the number of participants who were found to 
have improved significantly from Pre-Intervention to Post-Intervention and 
from Pre-Intervention to Follow-Up. Furthermore, the table identifies each 
significant participant. As is illustrated, very few participants were shown to 
have any significant change. There were 13 participants available for data 
collection at Post-Intervention and 8 at Follow-Up. They will be referred to as 
“responders”.
Table 4.4 Number of Participants found to have Significant Findings in 
IPQ-R
Pre-Intervention to 
Post-Intervention
Pre-Intervention to 
Follow-Up
Consequences 1 (D) 0
Personal Control 2 (F, H) 1(F)
Treatment Control 1(F) 1(F)
Illness Coherence 2 (D, E) 1(B)
Table 4.4 above indicates that a total of five out of 13 participants (38.46% of 
responders) showed significant changes on at least one sub-scale of the 
IPQ-R. Participant F had significant changes on more sub-scales than any
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other participant (Personal Control and Treatment Control). These findings 
were maintained at Follow-Up. Of note is the finding of Illness Coherence as 
this does not seem to relate to increased insight. Neither Participant D nor E 
was found to increase on any area of insight as measured by the SUMD.
Appendix 19 also indicates participants who showed significant deterioration 
(i.e. RCI < -1.96) on the four subscales. These results are presented in Table
4.5 below.
Table 4.5 Number of Participants who Significantly Decreased on Sub- 
Scales of the IPQ-R
Pre-Intervention to 
Post-Intervention
Pre-Intervention to 
Follow-Up
Consequences 4 (A, B, L, 0 ) 1 (0 )
Personal Control 0 0
T reatment Control 1 (0 ) 0
Illness Coherence 1(F) 0
A total of five out of the 13 responders (38.46%) significantly decreased on at 
least one sub-scale of the IPQ-R. Two of these Participants (B and F) 
significantly increased in some of the sub-scales. However, the sub-scales 
are measuring different cognitive representations and do not correlate (Moss- 
Morris et al., 2002).
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In response to the research question of whether this psychoeducation 
programme altered participants’ perspectives of the cognitive representations 
of their illnesses, the results of this study have been inconclusive. Five 
participants (i.e. 38.46% of responders) showed significant increases in their 
scores on at least one cognitive representation. However, the same number 
significantly deteriorated on at least one cognitive representation.
4.4 Compliance
This study aimed to answer the following research question:
Following receipt of this psychoeducation intervention, do participants 
change in areas of treatment compliance, namely, awareness of the 
achieved effects of medication; feelings of personal control over psychosis; 
and the attitude that treatment will improve their illness?
The concept of “Compliance to Treatment” was operationalised for the 
purpose of this study. It included the item entitled, “current awareness of the 
achieved effects of medication” from the SUMD; and two items from the 
Illness Perception Questionnaire -  Revised (IPQ-R): “Treatment Control” and 
“Personal Control”. Appendices 17 and 19 detail each participant’s scores on 
these items. In terms of the research question mentioned above, participants 
had to show significant improvements in all three items to be considered 
compliant with treatment.
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Only one participant, F, showed significant improvements in all of the above 
variables. These findings were maintained at Follow-Up. Table 4.6 below 
details the results of Participant F.
Table 4.6 Overview of Participant F’s results for Compliance
Pre-Intervention to 
Post-Intervention
Pre-Intervention to 
Follow-Up
Achieved Effects of 2* (shift from unaware 4* (shift from unaware
Medication to somewhat aware) to aware)
Treatment Control RCI = 2.78** RCI = 2.42**
Personal Control RCI = 2.42** RCI = 2.43**
* improvement in insight 
** significant finding (i.e. RCI >1.96)
As can be seen, Participant F fulfilled the criteria for improvement in 
compliance. It is suggested that the administration of the psychoeducation 
package contributed to this improvement.
One other participant, H, fulfilled two out of three criteria to meet compliance 
(current awareness of the achieved effects of medication and Personal 
Control). Significant changes were found between Pre-Intervention and Post- 
Intervention. However, Participant H dropped out after Post-Intervention. The 
table below outlines the results for Participant H. It is suggested that 
Participant H partially fulfilled criteria for improved compliance, as 
operationalised for this study.
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Table 4.7 Overview of Participant H’s results for Compliance
Pre-Intervention to 
Post-Intervention
Pre-Intervention to 
Follow-Up
Achieved Effects of 4* (shift from unaware -
Medication to aware)
Treatment Control RCI = 0.35 -
Personal Control RCI = 2.42** -
* improvement in insight 
** significant finding (i.e. RCI >1.96) 
- missing data
In response to the research question regarding whether participants change 
on compliance following the administration of this personalised 
psychoeducation package, the results have shown that only one participant 
in the sample of 16 improved on compliance over the course of treatment. 
One further participant partially improved on compliance. The study has 
therefore found that the majority of participants do not improve on 
compliance following the receipt of psychoeducation.
4.5 Satisfaction
The final question posed by this study was:
What are participants’ feelings regarding their satisfaction with treatment 
following the receipt of a psychoeducation programme?
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The design of this study did not allow for comparisons of satisfaction Pre- 
Intervention to Post-Intervention as satisfaction was not measured at Pre- 
Intervention. The total scores of the measure used will be reported (regarding 
overall satisfaction of care in the unit), together with quotes from participants 
regarding their experiences of the psychoeducation package.
Appendix 20 indicates the scores of each participant on the UKU-ConSat. At 
Post-Intervention, the mean total score was 2.29 (sd = 7.00). At Follow-Up, 
the mean of the total score was 2.00 (sd = 7.26). The means of scores at 
both Post-Intervention and Follow-Up were positive, indicating some 
satisfaction with overall care at the base unit.
Table 4.8 below indicates the participants who were dissatisfied with the 
treatment they received whilst residing at the base unit.
Table 4.8 UKU-ConSat Scores for Participants who were Dissatisfied with 
Care
Post-Intervention Follow-Up
D -10 -10
G -12 -
P -4 -
J 3 -2
- missing data
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There were 14 participants in the sample assessed for satisfaction at Post- 
Intervention as two had dropped out after Pre-Intervention. A total of nine 
participants were available for assessment at Follow-Up. These participants 
will be referred to as “responders”.
The results indicate that, immediately following the active phase of treatment, 
11 of the 14 responders (78.57%) were satisfied with their overall care whilst 
at the base unit and only 3 participants (21.43% of responders) were 
dissatisfied. At Follow-Up, 7 of the 9 responders expressed a degree of 
satisfaction with their care and only two were dissatisfied.
As can be seen in Table 4.9 (Case Summary), there was no common area of 
improvement amongst the four participants who were dissatisfied with their 
care. However, three of the four participants (D, G and P) did not improve on 
any aspect of insight as measured by the SUMD.
Whilst administering the UKU-ConSat, information was recorded regarding 
participants’ satisfaction of the psychoeducation package (separate from 
routine care). These have been grouped into two broad themes of “Positive 
Feedback” and “Negative Feedback”. Themes have been elicited from each 
of these broad categories and are highlighted below in the form of quotations. 
Examples of participants’ comments in each theme are cited below.
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4.5.1 Positive Feedback regarding Psvchoeducation Package
■ This approach should be accessible to all patients
“I think everyone should get it. It clarifies to people where they are, where 
they’ve come from and where they’re going in terms of their illness and 
treatment”. (Participant F)
“It should be given to everyone. It’s better to talk to name of researcher than 
just to patients -  you give better advice”. (Participant L)
■ Information regarding local resources and services was useful
“It was very useful. Especially the telephone numbers like the Citizens Advice 
Bureau”. (Participant L)
“The practical advice was the most helpful. Especially the contact details for 
the Personal Advisor Service. It’s good to know where to get help with getting 
a job”. (Participant J)
■ The benefits of being able to express views to a member of staff 
“They actually tell you what is wrong with you. Name of researcher ex plains 
the reasons why you feel like you do. She tells you stuff the doctors don’t tell 
you.” (Participant P)
“The best thing about it was to be understood by a member of staff, although 
it was difficult and uncomfortable at times”. (Participant J)
4.5.2 Negative Feedback regarding Psvchoeducation Package
■ Problems in feeling understood
“It was frustrating at first, trying to get my message across”. (Participant J)
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“Some of the information in the booklet was a bit muddled. For example, she 
wrote the wrong information about what happened in name of previous 
inpatient unit - 1 know it happened”. (Participant D)
■ Problems in retaining the information in the booklet
“I can’t remember much of what she talked about. I haven’t read the booklet
since”. (Participant I).
“Its early days. I don’t know if it will be useful”. (Participant I)
Of note in the above quotes is the comment by Participant P regarding the 
benefits of being able to express himself to a member of staff. Participant P’s 
total scores for the UKU-ConSat described a degree of dissatisfaction in his 
overall care at the base unit (as is noted in Table 4.8). However, he was 
enthusiastic about his experiences of receiving the psychoeducation package 
and had clearly processed this as a separate entity to his overall care.
In response to the research question concerning participants’ feelings 
regarding their satisfaction of treatment following receipt of this 
psychoeducation package, the results suggest that the majority of 
responders (78.57%) showed a degree of satisfaction with their care at the 
base unit in general. Satisfaction with overall care was also found in the 
majority of responders at Follow-Up. When considering the comments of 
participants regarding the psychoeducation package specifically, results were 
mixed. There were both positive and negative comments.
108
4.6 Case Summaries
Although it is not possible to draw general conclusions of the utility of this 
psychoeducation programme due to the small sample size and lack of control 
group, it is useful to consider the outcomes for each individual participant. 
This section will be divided into two parts: firstly it will provide a summary 
table detailing gains by each participant in the five outcome areas. Secondly, 
it will provide two brief case illustrations: one of Participant F who arguably 
obtained the best outcomes in comparison to the rest of the sample; and 
Participant D who responded the least well of those who completed data at 
all three time points.
4.6.1 Gains in the Five Outcome Areas
Table 4.9 below provides a summary of each individual participant and 
highlights whether or not significant changes or positive results (i.e. in the 
case of satisfaction) were found in at least one sub-scale of the five main 
areas assessed. In the case of Compliance, positive results have been 
indicated if the participant fulfilled all three criteria. For those who obtained 
positive results in one or two of the three criteria of compliance, their gains 
are indicated as Illness Representations or Insight. The table is organised in 
ascending order of those who obtained the most improvement to those who 
did not improve. It is noted that Participants K and N dropped out after Pre- 
Intervention and therefore no gains have been found.
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The first column of the table states the confidential label of each participant. 
The second column indicates each participant’s gender. The column labelled, 
“Illness Reps” is an abbreviation of “Illness Representations”.
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Table 4.9 Case Summary
Ethnicity Psychiatric
Symptoms
Insight Compliance Illness
Reps
Satisfaction
F Male White * * * * *
A Male Black * * - * *
B Male White * * - * *
H Male White * * - * *
L Male White * * - * *
0  Male Mixed * * - * *
C Male Asian * * - - *
M Male Black * * - - *
E Male Black - - - * *
I Male White - * - - *
J Male White * * - - -
D Male White - - - * -
G Male White * - - - -
P Male Asian * - - - -
K Fern White - - - - -
ale
N Male White - - - - -
* denotes significant change on at least one sub-scale.
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Table 4.9 above indicates that 6 participants (37.50% of the sample) were 
found to significantly improve or show positive results on at least one sub­
scale of all four areas; two improved in three areas (12.50% of the sample); 
three improved in two areas (18.75% of the sample); three improved in one 
area (18.75% of the sample); and two (12.50%) did not improve in any area. 
In summary, 87.50% of the sample improved in at least one sub-scale of one 
area of outcome, although it is noted that change in only one sub-scale may 
be viewed as having occurred by chance alone.
4.6.2 Brief Case Illustrations
This section will provide brief case illustrations of Participants F and D for the 
purposes of understanding both their improvement and lack of improvement 
in greater detail. Demographic and personal details have been altered in 
order to protect confidentiality.
4.6.2.1 Participant F
Participant F is a White, single man in his early 40s. He has had a diagnosis 
of Paranoid Schizophrenia for 14 years. He was admitted to hospital due to 
non-compliance with medication and physical attacks on another patient in a 
Community Centre. At the initial assessment, Participant F stated that prior to 
his admission, he was having difficulty in sleeping, he was neglecting his self- 
care and he was unable to look after his home. He reported that he felt that 
at this time, he was either going through a “Psychological Evolution”, in which 
his thinking became clearer and faster, or he had a mental illness.
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Participant F had a history of violent behaviour and had stabbed a man 
approximately 20 years prior to his present admission. He believed that this 
man was trying to extort money from Participant F.
In terms of his future goals, Participant F was keen to work. He believed that 
he should begin to earn his own money and to stop relying on benefits.
When asked about his diagnosis at the initial assessment, Participant F said 
that he had been told that he had Paranoid Schizophrenia, but that he 
disagreed with this and felt that his problems were “a lack of discipline, lack 
of self-regulation and self-denial”. During data collection, Participant F 
informed the researcher that he was undergoing his longest period of being 
compliant with medication since he received his diagnosis.
When relaying information from his personalised booklet to him, Participant F 
did not argue with the researcher, but instead questioned some of the 
information and showed interest in the responses. It seemed that he was 
keen to take on an alternative perspective to his previously held beliefs 
regarding his mental state.
In the case of Participant F, prior to the start of the intervention, he reported 
that he considered that he might have had a mental illness. He was therefore 
prepared to engage in discussions regarding psychosis. He showed 
improvement in all areas of insight, in his Personal and Treatment Control of 
illness, but not in the Consequences and Illness Coherence representations.
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It may have been that the increase in insight in Participant F led to 
uncertainty in his beliefs about his illness and it’s consequences.
4.6.2.2 Participant D
Participant D is a White, single man in his mid-thirties. He has had a 
diagnosis of Paranoid Schizophrenia for the past 7 years. He had had four 
previous episodes prior to his present admission.
At the initial assessment, Participant D reported that he was at the base unit 
for "security purposes”. He stated that he had witnessed a drug operation 
and that he was under surveillance as a result. Participant D also informed 
the researcher, “All NHS workers are army trained” and that he felt unsafe in 
the base unit. The time of the assessment coincided with President Bush’s 
visit to the UK. Participant D attributed his surveillance and heightened 
security to this visit.
Prior to his admission, Participant D reported that he had been working 
throughout the night and had been getting little sleep. Furthermore, he stated 
that he smoked six or seven “joints” of cannabis per week.
When asked about his diagnosis, Participant D stated that he was not unwell. 
He said that his Psychiatrist had told him that he had Paranoid 
Schizophrenia, but that a private Psychiatrist had disagreed.
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Whilst delivering the psychoeducation package, Participant D was highly 
critical of all suggestions made regarding psychosis. He felt sure that he 
knew why he was at the base unit, the consequences of his admission and 
his goals for the future. Participant D’s views did not shift over the course of 
the three-session intervention.
Participant D denied the existence of any illness for the duration of the 
intervention. His delusional system was complex and he used any evidence 
available to him (e.g. President Bush’s visit to the UK) to erroneously confirm 
his beliefs. He was therefore not amenable to suggestions proffered during 
the psychoeducation package.
In terms of his results, of note is that Participant D significantly improved on 
both Consequences and Illness Coherence in the IPQ-R. However, he 
showed no improvement on any area of insight over the three time points. 
This suggests that Participant D’s engagement was minimal and that he was 
not socialised to the process of psychoeducation.
In conclusion, it is suggested that the intervention was offered at the optimal 
time for Participant F and not for Participant D. Participant F was able to 
engage, develop a relationship with the researcher and both were working 
towards shared goals. It is accepted that the assessment of the most 
appropriate time for intervening with acutely psychotic patients is beyond the 
scope of this study.
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5.0 DISCUSSION
This study aimed to assess the utility of a novel personalised 
psychoeducation approach for a group of inpatients in the acute stages of 
psychosis. This study recognises that the conditions that lead to therapeutic 
change in psychosis are not fully understood. The goal of the 
psychoeducation package was to socialise acutely ill patients to the therapy 
environment and allow them to make small gains in areas including insight, 
symptom reduction and compliance. Furthermore, this psychoeducation 
package may be seen as a precursor to future, in-depth therapies for this 
population. This study accepts that the design utilised does not have the 
methodological rigours to control for threats to internal validity, including 
regression to the mean, endogenous change and interfering events (Cook & 
Campbell, 1979). It was considered that a simple design was appropriate for 
assessing the utility of a new intervention. More sophisticated designs will be 
required in the future to illuminate key variables.
The results below are discussed in a style that describes the preliminary 
signs of clinical utility of the psychoeducation package, whilst acknowledging 
the limitations of the design. The results of the study are mixed. However, 
signs of positive change did occur in approximately one third of participants 
in at least one sub-scale of the five main outcome areas: psychiatric 
symptomatology, insight, compliance, illness representations and 
satisfaction. The approach was only successful in augmenting change on all 
outcome measures for one participant. In terms of insight, approximately a 
half of the participants available for data collection increased in at least one
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dimension of insight. However, the results suggest that only one participant 
could be considered to be compliant with treatment. Furthermore, over a 
quarter of participants showed significant changes in at least one of their 
illness representations of psychosis. Finally, satisfaction with overall 
treatment on the base unit was found in three quarters of participants. The 
results must be reviewed in the context of the impact of this psychoeducation 
package together with routine clinical care, as it is not possible to separate 
the effects of each.
This Discussion is divided into four sections. The first will consider the above 
results in more detail and comment on their relationship to previous literature. 
The second section will outline some methodological considerations and 
limitations of the present study. The third section will detail both preliminary 
scientific and clinical implications of the present research. The final section 
will outline the main conclusions of the study.
5.1 Overview of Results
A review of the five main outcome areas will be detailed below.
5.1.1 Psychiatric Symptomatology
Approximately one third of participants’ scores were found to significantly 
decrease on the following positive symptoms: Conceptual Disorganisation, 
Unusual Thought Content and Paranoid Ideation.
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The common aspect of these three symptoms is disordered thought 
processing. They are all contained within the category of “positive symptoms” 
(Andreasen, 1984) and form part of the psychotic experience.
In reference to the literature on psychoeducation, only two studies have 
reported changes in psychiatric symptomatology. These were Goldman and 
Quinn (1988) and Kelly and Scott (1990). The changes found in this study 
were similar to those found by Kelly and Scott, in terms of the decrease in 
positive symptoms.
Kelly and Scott (1990) provided an individualised psychoeducation package, 
personalised to each participant, all of whom were outpatients. This differed 
from Goldman and Quinn (1988) who administered group sessions of 
psychoeducation to inpatients. It may be that the provision of personalised 
information regarding specific symptoms allows the participant to reappraise, 
review and reconceptualise them, thereby decreasing their intensity.
However, the mechanisms by which symptom reduction may occur remain 
unclear.
Whether these results are due to the psychoeducation package or the effects 
of medication remains unanswered. Lewis (2002) stated that negative 
symptoms are rarely modified by anti-psychotic medication and that positive 
symptom change is often observed early when anti-psychotic medication is 
administered. All of the participants in the present study were compliant with 
taking anti-psychotic medication (as monitored in a hospital setting).
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In a study investigating early symptom change following the initiation of anti­
psychotic medication, Correll, Malholtra, Kaushik, McMeniman and Kane 
(2003) found that the first factor of the BPRS to show change was “thought 
disturbance”. This factor includes both Conceptual Disorganisation and 
Unusual Thought Content. When comparing the findings of Lewis (2002) and 
Correll et al. (2003) to this research, it may be argued that the symptom 
changes found in this study might be due to anti-psychotic medication alone. 
Thus, it is not possible to state whether the psychoeducation package 
contributed to the reduction in positive symptoms in up to approximately one 
third of participants.
In summary, although the findings of this study support those of Kelly and 
Scott (1990), research into the effects of anti-psychotic medication on people 
with psychosis suggested that the reduction found in positive symptoms 
might be due to medication alone. As the sample size is small, it is not 
possible to deliver firm conclusions in this area.
5.1.2 Insight
The findings of this study indicated that approximately a half of participants 
improved on at least one area of insight. These results are similar to those of 
Macpherson et al. (1996), who found improvement in insight following a 
three-session intervention. The approach utilised by these authors was an 
individualised psychoeducation package. Conversely, Merinder et al. (1999) 
did not find an increase in insight following an 8-session group format. It may 
again be suggested that the individualised approach offered in this study and
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in that by Macpherson et al. (1996) contributed to the increase of insight in 
some of the participants.
The psychoeducation package delivered in this study focused strongly on 
reviewing participants’ views of their illness before offering alternatives (see 
Kingdon, 1998; Tarrier and Barrowclough, 1986; Yalom, 1975). It could be 
argued that the package fulfilled this principle successfully and allowed 
participants’ insight into psychosis to increase over time. However, as the 
sample is small, it is stressed that these results may also be due to the 
effects of medication or of the hospital environment.
In summary, the finding of this study that insight significantly improved for 
approximately 50% of participants in at least one area is similar to a previous 
finding by Macpherson et al. (1996). The increases found in insight may have 
evolved from the personalised approach proffered to participants.
5.1.3 Illness Representations
The results of this study indicated that approximately one third of participants 
altered their illness representations in at least one area. These included the 
long-term consequences of having psychosis; the extent to which the 
individual could use personal control to cope with the illness; the degree to 
which the individual believed that treatment (medication or otherwise) could 
be helpful in controlling the illness; and the participant’s perceived ability to 
comprehend the illness.
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A possible explanation for the lack of change in illness representations over 
time is that many participants denied that they had an illness. This resulted in 
participants answering items on the Illness Perception Questionnaire -  
Revised (Moss-Morris et al., 2002) as if they did not have an illness. Pre- 
Intervention scores were therefore low for several participants.
An interesting finding of this study is that those who significantly decreased 
from Pre-Intervention to Post-Intervention on Illness Coherence and 
Consequences were those who scored better on insight measures than those 
who increased from Pre-Intervention to Post-Intervention on these illness 
representations. A suggested reason for these changes is that those who 
have more insight over time become less certain of the course of their illness. 
This argument is strengthened when considering one of the participants 
whose scores on Illness Coherence increased from Pre-Intervention to Post- 
Intervention (Participant D). He had a firm delusional system and responded 
to items on the Illness Coherence subscale at Post-Intervention with 
certainty.
Similar to the above scenario, in reference to the Consequences subscale, 
those who increased in scores from Pre-Intervention to Post-Intervention had 
less insight than those who decreased from Pre-Intervention to Post- 
Intervention. It is suggested that the psychoeducation package may have had 
the effect of allowing those with more insight to feel empowered about their 
futures than those with less insight. This may have led to them feeling less 
certain about the negative consequences of psychosis.
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In summary, the results of this study have found that equal numbers of 
participants significantly improved and significantly deteriorated in their 
illness representations over time. A possible explanation of this may be that 
changes in the Illness Coherence and Consequences variables may be 
related to both deterioration and improvement in insight, dependent on 
whether or not participants accepted the existence of an illness.
5.1.4 Compliance
This study found that only one participant fulfilled all of the criteria of 
compliance (as operationalised for this study). It could be argued that the 
follow-up period of this study was too short to find distinct changes in 
cognitive representations of illness for the majority of participants. 
Furthermore, all the participants resided in hospital throughout the 
administration of the psychoeducation package and were all under a section 
of the Mental Health Act (1983). It was therefore difficult to accurately 
measure compliance whilst medication was not being independently 
controlled, but rather was given by nursing staff. In addition, if participants 
had refused medication, it would have been forced on them due to their legal 
status. The measurement of compliance by attitudinal changes was therefore 
deemed most appropriate for the sample and the clinical setting. It is difficult 
to compare the findings regarding compliance from this study to previous 
studies due to differing means of operationalising the construct.
In summary, it is argued that the follow-up period for this study was too short 
to measure changes in compliance accurately. Furthermore, in retrospect, it
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was unrealistic to assume that participants would change their attitudes 
towards compliance in a short period of time and whilst in hospital. A longer 
follow-up period may have found different results.
5.1.5 Satisfaction
This study found that approximately three quarters of participants were 
satisfied with the overall care that they received at the base unit. 
Furthermore, this study quoted participants’ views of the psychoeducation 
package. These comments were broadly categorised into positive and 
negative feedback. Within the positive feedback, themes emerged regarding 
the accessibility of the package, the utility of information about local 
resources and the valued experience of being listened to by a member of 
staff. The negative feedback category included themes of not feeling 
understood and problems in retaining information from the booklet.
It is important to note that in some cases, the total score on the UKU-ConSat 
did not correlate with the comments made by the participant. An example of 
this was Case P. He scored -A at Post-Intervention and Follow-Up on the 
UKU-ConSat. This is suggestive of a degree of dissatisfaction. However, 
when asked specifically about his views of the psychoeducation package, he 
said,
“They actually tell you what is wrong with you. [Name of researcher] 
explains the reasons why you feel like you do. She tells you stuff the 
doctors don’t tell you”.
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This highlights that some participants viewed their overall care at the base 
unit as separate and different from participating in this study.
In reference to previous literature, the comments by Case P and others that 
they valued the personal contact from a member of staff and the chance to 
disclose their beliefs about their experience are similar to those found by 
Kemp and David (1996b). It is suggested that this was created through the 
use of a collaborative therapist-patient relationship, as was advocated by 
Kuipers (1996) and Kingdon (1998).
It is not possible to compare the results of this study to previous research 
considering psychoeducation and satisfaction. The construct was measured 
differently to the present study, making comparisons impossible (see 
Merinder et al.,1999; Kelly & Scott, 1990).
The development of the psychoeducation package relied heavily on the 
findings of satisfaction studies involving medical outpatients. Although this 
study is unable to determine whether or not satisfaction increased from Pre- 
Intervention to Post-Intervention, it is able to conclude that the majority of 
participants described a degree of satisfaction with their care at Post- 
Intervention. It is suggested that the attempt of this psychoeducation package 
to empower each participant, show empathy and involve him in designing the 
final manual led to a degree of satisfaction in most cases (see Ley, 1988).
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In summary, this study did not compare ratings of satisfaction from Pre- 
Intervention to Post-Intervention, but found that approximately three quarters 
of participants showed a degree of satisfaction with their care at Post- 
Intervention. The use of research on physical health patients’ satisfaction 
with healthcare has been imperative in the design and delivery of this 
psychoeducation package.
5.2 Methodological Considerations I Limitations
This section of the Discussion will evaluate the design of this study; highlight 
considerations regarding some of the measures; and review the statistical 
analysis used.
5.2.1 Design
This study employed an open trial without a control group, with each 
participant serving as his own control. It is considered efficient to use a 
simple design, such as the one used in this study, when testing a new 
intervention prior to investing in a large-scale study. Furthermore, Barlow and 
Hersen (1984) noted a range of advantages in using a simple design, 
including avoiding the ethical issue of withholding the intervention from a 
control group. They further argued this by stating that in many clinical 
settings, professionals use any treatment, no matter how inadequate, for 
patients who are visibly struggling with their illness. It is therefore more 
appropriate to assess the utility of the treatment package on a small group 
than to administer the intervention without any examination of its validity.
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However, the limitations of undertaking a simple design must be considered. 
One problematic area is the inability of this type of design to generalise 
findings, i.e. across participants, therapists and settings (Barlow & Hersen, 
1984). This indicates weak external validity. It is noted that it is not possible 
to identify the usefulness of the intervention if conducted by therapists other 
than the main researcher of this study or if administered in different settings. 
The results must be considered within these restrictions.
Furthermore, this design does not allow for consideration of the effects of the 
intervention separate from routine care, as there was no control group. All 
patients on the base unit were administered with anti-psychotic medication, 
received support from nursing staff and therapeutic interventions from 
Occupational, Art and Drama Therapists. The results must therefore be 
considered in the context of the effects of the psychoeducation package 
together with routine care and not in isolation.
A further limitation is that this study cannot make firm conclusions about the 
suitability of the psychoeducation package for certain individuals in terms of 
their age, gender, diagnosis, duration of illness or number of previous 
episodes of illness. However, it is possible to hypothesise and suggest the 
direction of future studies on the basis of the findings (Kiesler, 1971).
As a result of the difficulties of recruiting and engaging participants with acute 
psychosis, a number of compromises of the design and methodology of the 
study were undertaken. It would have been preferable to recruit both
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intervention and control groups, but soon after data collection began, it 
became clear that this would not be possible. An alternative design would 
have been a multiple single case study, assessing multiple baselines 
following each intervention session and comparing this with Post-Intervention 
and Follow-Up scores. However, it was felt that it would be both impractical 
and unethical to take more intrusive measures with acutely ill participants. It 
was therefore decided that an open trial without a control group, with each 
participant serving as his own control was the most appropriate means of 
assessing the effects of this intervention, together with routine care, on this 
sample.
In summary, it is argued that the use of an open trial without a control group 
was appropriate in this study as it creates research questions for future larger 
scale studies. However, limitations of this design must be taken into 
consideration when interpreting results, including lack of generalisability; the 
combination of the intervention and routine care; and the inability to conclude 
the suitability of the personalised psychoeducation package to specific 
individuals.
5.2.2 Sample
The sample was a group of consecutively referred patients to a Psychiatric 
Intensive Care Unit. Although only one participant did not have a diagnosis of 
Schizophrenia and another was the only female member of the sample, 
these participants were included as the sample was deemed to be clinically 
relevant and represented the reality of the setting. The drop-out rate at
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Follow-Up was high. This was partly a function of the majority of participants 
being discharged or transferred from the base unit. However, every effort 
was made to contact all participants for the Follow-Up. In the two cases when 
participants dropped out after Pre-Intervention, letters were sent to offer them 
the opportunity to debrief about their experiences. These participants chose 
not to meet again with the researcher.
A number of limitations of the sample must also be highlighted. Firstly, the 
sample was somewhat heterogeneous, in terms of age, number of previous 
episodes of psychosis and duration of illness. Due to the small sample size, it 
has not been possible to consider which of these variables best predicts 
good outcome following the psychoeducation package.
Secondly, those who refused to participate in the study may have responded 
differently to the intervention to those who agreed. This is described as a 
type of sampling bias that may have affected the results. It is speculated that 
those who were willing to participate may have had higher levels of insight 
and satisfaction prior to the intervention than those who declined to be 
recruited to the study. These limitations have contributed to the lack of 
external validity of this study. Results must only be considered in the context 
of those who participated and cannot be generalised to the entire target 
population (i.e. all people with acute psychosis in psychiatric intensive care 
units).
128
5.2.3 Measures
Some strengths of this study are that a range of different measures and a 
variety of methods of assessment were used, including observer-rated, self- 
report and semi-structured interviews. Barker et al. (2002) stated that it is 
important to use different methods of assessment as the same methods have 
a tendency to correlate together, even when they are assessing different 
constructs. This sub-section will review each of the measures in turn and 
comment on their utility in this study.
5.2.3.3 Brief Psychiatric Rating Scale (Overall & Gorham, 1962) and Brief 
Symptom Inventory (Derogatis, 1993)
Both of the above measures are well known and widely utilised in 
Psychological and Psychiatric literature. They have been used in a number of 
studies on psychoeducation for people with psychosis (e.g. Kelly & Scott, 
1990; Atkinson et al., 1996). The use of both observer-rated and self-report 
measures of psychiatric symptomatology was a strength of this study.
A limitation of this study is that two members of staff rated the BPRS (a 
Psychiatrist and a Consultant Clinical Psychologist) and inter-rater reliability 
scores were not obtained. There is therefore a risk that some participants 
were rated as being less acute than others when this may not have been the 
case. However, the Psychiatrist rated the majority of participants (12 
participants were rated by the Psychiatrist and 4 were rated by the 
Consultant Clinical Psychologist). This allowed for a degree of consistency 
amongst most participants.
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In summary, this study utilised two highly reported measures, using different 
methods, to assess psychiatric symptomatology. It is limited in the lack of 
inter-rater reliability between assessors of the BPRS.
5.2.3.2 Scale to Assess Unawareness in Mental Disorder (Amador et
al., 1993)
The SUMD assesses insight as a multidimensional phenomenon. It is 
suggested that this multidimensional perspective of insight has been useful in 
this study. In particular, this study was able to use scores of awareness of the 
achieved effects of medication as part of the operationalisation of the 
construct ‘Compliance’.
A possible limitation of the SUMD is that it is reliant on the view of one rater 
and scores are calculated on the basis of a brief interview. Perhaps it would 
have been useful to incorporate corroborative reports from nursing staff, who 
have the most regular contact with participants in comparison with all other 
members of the Multi-disciplinary Team. This would have acted as inter-rater 
reliability of the results.
In summary, the SUMD has been a valuable tool in the assessment of both 
insight and compliance in this study. However, it is scored on the basis of the 
subjective experience of the rater following a brief interview.
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5.2.3.3 The Insight Scale (Markova & Berrios, 1992)
The Insight Scale was included in this study as it is one of the few self-report 
measures of insight available. The findings from the Insight Scale have 
added little to the results from the SUMD. This section will consider the 
Insight Scale in further detail and possible reasons for the lack of participants 
showing improvements on this measure.
Constable, Lopez-lbor, Kemp and David (1998), when comparing a number 
of insight measures, found that the Insight Scale by Markova and Berrios 
(1992) did not correlate with any other scale. It seems therefore that this 
scale measures a different construct to the SUMD by Amador et al. (1993).
The Insight Scale scores insight as either positive or negative. Positive 
insight items included, “My condition can be treated by medicines” and “I 
understand why other people think I should be in hospital”. Negative items 
included, “Mental illness does not exist” and “Someone is controlling my 
mind”. It could be argued that the positive items indicate some degree of 
insight, whereas the negative category highlights lack of insight. This 
therefore suggests that the Insight Scale is failing to measure insight as a 
multidimensional phenomenon, but considers it as a unitary concept, based 
on the number of items in the positive category answered appropriately. It is 
suggested that Positive insight may be a similar construct to “awareness of 
having a mental disorder” in the SUMD. This study found that two 
participants improved on positive insight. These participants also improved 
on “awareness of having a mental disorder” in the SUMD.
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The disadvantages of measuring insight as a categorical, or unitary concept 
are that it is not possible to assess whether participants can attribute their 
unusual experiences to a mental illness, despite accepting anti-psychotic 
medication. In this study, participants who showed significant increases on 
Positive insight on the Insight Scale may therefore have only partial 
awareness into their difficulties. However, in using the Insight Scale, it is not 
possible to identify the specific aspects of insight of which the participants are 
aware. This is a limitation of using the Insight Scale with this sample.
Since developing this study, a revised version of the Insight Scale has been 
published (Markova et al., 2003). The present study had been finalised by the 
time of publication of the revised scale and it was too late to include it in this 
study. Markova et al. (2003) found that the revised scale correlated with the 
insight scale incorporated in the Present State Examination (Wing, Cooper & 
Sartorius, 1974, cited in Markova et al., 2003). The revised version of the 
Insight Scale appears to be a more robust measure than the original scale. It 
would have been interesting to determine whether or not different results 
would have been found from this study with the use of the new version.
In summary, although Markova and Berrios (1992) stated that the Insight 
Scale considers a multidimensional concept of insight, it has been argued 
above that this scale does not cover the concept adequately.
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5.2.3.4 Illness Perception Questionnaire -  Revised (Moss-Morris et al., 
2002)
The IPQ-R is a tool to assess the Self-Regulatory Model (Leventhal et al., 
1984). Although it has not previously been used on a sample of people with 
psychosis, Lobban et al. (2003) suggested that the Self-Regulatory Model 
could appropriately be attributed to psychosis. Furthermore, a modified 
version of the IPQ (Weinman, Petrie, Moss-Morris & Horne, 1996) was used 
in a study to assess illness perceptions of carers of people with 
Schizophrenia (Barrowclough, Lobban, Hatton & Quinn, 2001).
Intuitively, the IPQ-R seemed to be a useful tool to use with a group of 
inpatients with psychosis. In retrospect, the follow-up period of this study (six 
weeks) was possibly too short to find change in any of the illness 
representations. It is suggested that a longer follow-up period in which 
participants move from the acute stages of illness to more stability may have 
found alternative results.
5.2.3.5 UKU-ConSat (Ahlfors et al., 2001)
The UKU-ConSat was used in this study as it was validated on a large group 
of psychiatric patients who had been discharged from hospital in the previous 
three days to completing the measure. Although not the same, this sample 
was similar to that of the present study as they had all recently been 
inpatients and a proportion of them had a diagnosis of a psychosis (22.20%). 
It also provided the participants with the opportunity to express their views
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regarding the psychoeducation package, as the tool is administered as a 
semi-structured interview and not as a questionnaire.
Limitations of the scale should be considered when interpreting results. One 
main concern is that Ahlfors et al. (2001) have not provided clear information 
regarding the means and standard deviations of scores. It is therefore not 
possible to compare results from the present study to those of Ahlfors et al. 
(2001). Malm and Lewander (2001) stated that the UKU-ConSat has a range 
from -24  (low satisfaction) to +24 (high satisfaction). Furthermore, these 
authors stated that any score above 0 should be considered as a degree of 
satisfaction. This scoring cut-off was used to assess satisfaction in this study, 
although it is clearly broad and inclusive.
In summary, the results must be considered within the context of the 
restraints imposed by the methodological concerns of the measure, 
mentioned above. However, the use of a semi-structured interview to obtain 
participants’ views of the psychoeducation package added meaning to raw 
scores.
5.2.4 Statistical Analysis: Reliable Change Index
This study employed the Reliable Change Index (Jacobson & Truax, 1991) to 
assess change in individual cases. This analysis tests whether differences in 
scores between two time points for individual cases are significantly greater 
than the error expected from the outcome measure. As it considers each 
participant’s scores separately, it does not rely on the sample size. It was
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decided to use the Reliable Change Index to analyse the data, as the sample 
of this study was small and there was no control group.
In a review of this statistical approach, Hafkenscheid (2000) compared seven 
different methods of Reliable Change indices. The method employed was the 
assessment of a sample of psychiatric inpatients on the BPRS over two time 
points. The approach by Jacobson and Truax (1991), originally developed by 
Jacobson et al. (1984), was termed as a “classic approach” because it uses 
raw scores to assess Reliable Change. Hafkenscheid stated that the 
approach by Jacobson et al. (1984) was one of the most sensitive methods 
as it utilised the most stringent significance level (p<.05) of all the Reliable 
Change indices.
Hafkenscheid (2000) concluded that the classic approach is a safe procedure 
to use as it produces the lowest estimates of treatment efficacy, due to the 
use of stringent statistical levels. This allows the researcher to be confident 
that significant results were not derived by chance. Furthermore, 
Hafkenscheid stated that the classic approach has fewer statistical 
assumptions than other Reliable Change indices, as it does not require 
information from the whole sample to calculate population parameters, as do 
some other methods. Instead, the approach by Jacobson et al. (1984) relies 
solely on the standard error of the outcome measure which is calculated by 
using the test-retest reliability and standard deviation of the population on 
which the tool was developed.
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The Reliable Change Index has some limitations. Primarily, the analysis is 
dependent on the accessibility of good quality validation studies in order to 
obtain test-retest reliability scores and standard deviations. This information 
is not always practically accessible and must be taken into account when 
designing a small sample study (Jacobson & Truax, 1991). In terms of the 
present study, effort was made to obtain the best quality validation studies.
In summary, the Reliable Change Index, as cited in Jacobson and Truax 
(1991) was the most appropriate method of analysis for this study. It provided 
stringent and therefore realistic results of treatment efficacy as it is a “classic 
approach”. However, there are some limitations of obtaining appropriate 
validation studies that must be taken into consideration.
5.3 Implications
This section will firstly discuss the scientific implications of the study, with 
regards to the research questions, followed by a reflection on administering 
the intervention. It will then consider the clinical implications of the study.
5.3.1 Scientific Implications
Due to the small sample size, the lack of a control group and the lack of 
power, it is not possible to reach any firm conclusions about the utility of this 
psychoeducation package. Alternatively, this study has been able to generate 
some hypotheses on the basis of the results. These include that a 
personalised psychoeducation package may be able to improve some 
positive psychiatric symptoms over time (within a framework of traditional
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treatment delivery systems). It is also hypothesised that the psychoeducation 
programme may be able to increase insight in specific areas, including that of 
having a mental disorder, of the achieved effects of medication and of the 
social consequences of having a mental disorder. Finally, it is hypothesised 
that a personalised psychoeducation programme may be able to increase 
patients’ satisfaction of treatment care. The results of this study do not allow 
for hypotheses regarding the connection between receiving psychoeducation 
and compliance with medication, nor with altered illness representations.
The scientific implications of this study point to the need for a control group 
and an open trial design. This would allow the researcher to ascertain 
whether or not improvements made in the areas of positive symptomatology, 
insight and satisfaction are due to the effects of the psychoeducation 
package or the routine care received on a Psychiatric Intensive Care Unit. 
Following the implementation of an open trial (with a control group), results 
may support a further randomised controlled trial (see Barker et al., 2002).
Despite advocating a larger scale study, the clinical utility of the present 
study must not be overlooked. In order to complete an open trial (i.e. 
implementing control and intervention groups) and to assess results using 
multivariate analyses, it is suggested that a total of 64 participants per group 
would be required to find a medium effect size at p<.05 (see Cohen, 1992). 
As the groups would be similar in nature, residing in the same environment 
and in receipt of the same routine care, a suitable sample to find a small 
effect size would be desirable. This would require 393 participants per group
137
at p<.05 (according to Cohen, 1992). Clearly, to find even a medium effect 
size, the study would have to run for several years if recruitment rates were 
similar to those of the present study. It is suggested that a multi-centre trial 
would be required to recruit appropriate numbers of participants. However, 
this design would have the ethical dilemma of restricting many patients from 
an intervention that may be clinically useful whilst a large study is completed. 
It is argued that the design that was employed in this study was appropriate 
in assessing the utility of this intervention for this sample and in delivering the 
package to as many participants as possible over a short period of time.
A longer follow-up period is suggested for future studies to further assess the 
areas that were not shown to improve following the psychoeducation 
package (i.e. medication compliance and illness representations). These 
attitudinal changes are likely to emerge beyond a six-week follow-up period. 
This is indicated in previous studies of medication compliance. Boczkowski et 
al. (1985), who found an effect of psychoeducation on medication 
compliance, had a 3-month follow-up period, that is, double the duration of 
the follow-up period of this study. Furthermore, many of the studies of 
medication compliance used outpatients who had control of their medication. 
In this study, all participants were inpatients and were given their medication 
by nursing staff. This study therefore provided a new operationalisation of 
medication compliance. It is suggested that future studies may consider 
assessing the utility of this way of measuring compliance.
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In summary, future studies incorporating more robust designs than this study 
are indicated to assess the effect of this personalised psychoeducation 
package on psychiatric symptoms, different dimensions of insight and 
satisfaction. Furthermore, the findings of this study imply that future studies 
with a longer follow-up period of at least 3 months are needed in order to 
assess the effects of this psychoeducation package on medication 
compliance and illness representations. Specifically, a randomised controlled 
trial could be implemented in which intervention and control groups (receiving 
routine care) would be compared. The data could be analysed using 
multivariate analyses to compare between groups. In addition, multiple 
regression analyses may be utilised to predict the outcome variables most 
likely to be related to participants’ improvement (e.g. as measured by time 
between admission and discharge) following the receipt of the 
psychoeducation package.
5.3.2 Reflections of the Personalised Psvchoeducation Manual 
Although this psychoeducation package had a strong basis in literature, on 
reflection, future studies may consider revising some aspects. Firstly, the 
manual is fairly lengthy. At times, it was difficult to read through with 
participants who were easily distracted. As low concentration is a common 
feature of people who have psychosis (Lindsay & Powell, 1994), this is not a 
surprising occurrence. Any revised version of the current psychoeducation 
package should consider shortening the length of the manual.
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Secondly, any revision should consider the way in which information 
regarding symptoms is delivered. The package attempted to provide a 
collaborative therapeutic experience through the use of the initial assessment 
procedure and the opportunity for participants to amend the first version of 
the manual. However, it is suggested that although the manual clearly stated 
the beliefs of the participants, it presented opposing views and labelled each 
individual’s experience as being part of psychosis. Examples of this are 
presented in Appendix 21, page 2. After having reiterated the experiences of 
the participant in his own words, the manual then states that his experiences 
are “common for people who have a psychosis”. In the following paragraph, 
the experiences are re-labelled as symptoms of psychosis. It could be 
suggested that the method of delivery of this information moved away from a 
collaborative therapist-patient relationship of compromise to an authoritarian 
position by the therapist. Alternative means of modifying beliefs are 
suggested below.
Chadwick and Lowe (1990), in a study considering modification of delusional 
beliefs, found that delusions arise out of personalised thinking processes in 
reaction to specific experiences. They found that modification of delusions 
was more likely if this process was explained to the participants than if they 
were told that their beliefs were a result of a mental illness. This study did not 
incorporate the findings of Chadwick and Lowe. Some of the quotes from the 
UKU-ConSat indicated participants’ dissatisfaction with this part of the 
psychoeducation package. This included,
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“It was frustrating at first, trying to get my message across”.
This quote suggests that the participant was definite in his beliefs regarding 
his delusions and that he assumed that the way in which his symptoms were 
conveyed in the manual were evidence of the researcher’s lack of 
understanding. This may have arisen as a result of direct challenging of 
symptoms and labelling of them as part of a mental illness, rather than by 
modifying them in the way suggested by Chadwick and Lowe above. This 
may be considered in a revised version of the psychoeducation package.
A further consideration is that the development of participants’ beliefs may 
have been more closely examined through the use of the Causal Belief 
Questionnaire (Whittle, 1996b). Whittle suggested that causal beliefs 
regarding the emergence of psychiatric disorder evolve from “Psychosocial”, 
“Biological”, “Structural” and “Stress” beliefs and that these help patients to 
obtain some control through their understanding of their illnesses. Whittle 
(1996a) suggested that the lay beliefs that clients (and their relatives) hold 
with regards to mental disorder will have a bearing on their expectations for 
treatment and therapy. The use of the Causal Belief Questionnaire in the 
present study may have been useful in further understanding the lay beliefs 
of each participant and in enhancing the personalisation of the 
psychoeducation package.
Finally, this study utilised the definition of insight from Amador et al. (1993) 
as a multidimensional phenomenon. These authors suggested that the
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assessment of insight as a number of different facets could be used to target 
interventions. This function has not been utilised in this study, but may be 
considered in future work.
In summary, the length of the package, the way in which beliefs were 
challenged and the lack of targeting the intervention to tackle particular areas 
of insight were reflected above. These may be considered in a revised 
version of the psychoeducation package.
5.3.3 Clinical Implications
A number of clinical implications have evolved. Firstly, this study has 
supported the idea of personalising psychoeducation programmes as 
opposed to running them in groups. This approach relates to previous 
literature (e.g. Macpherson et al., 1996) and appears to lead to an 
improvement in some areas of insight.
Secondly, similar to the findings of Kemp and David (1996b), participants 
positively reported that they appreciated the chance to express their views to 
a member of staff. This implies that initially, rapport may be built between 
staff and patients if staff members do not offer alternative explanations of 
patients’ beliefs. Later, when a strong therapy relationship has been built, 
patients may be challenged about their psychotic ideas.
Thirdly, several participants mentioned that they valued being given 
information regarding local resources. It is suggested that this approach, in
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line with NICE guidelines, was empowering for participants and allowed them 
to begin to positively contemplate their futures. This was an example of the 
aim of the psychoeducation package to move away from the medical model 
towards a biopsychosocial perspective. It is argued that this aim was 
achieved and proved successful for many participants.
Finally, the personalised psychoeducation package designed for this study 
can be viewed as a possible precursor stepped care approach to CBT. It is 
short in duration and could be administered by any member of the Multi- 
Disciplinary Team. It could therefore be widely accessible to patients with 
acute psychosis. However, a larger sample and a robust design are needed 
prior to determining the exact effects of this intervention. Furthermore, 
additional research is indicated to investigate whether this psychoeducation 
package is able to increase collaboration with the therapist and positively 
impact on a future course of CBT.
In summary, a range of clinical implications has been highlighted above. 
These included the individualisation of psychoeducation; providing patients 
with the opportunity to discuss their experiences; the useful provision of 
information regarding local resources; and using psychoeducation as a 
stepped care approach prior to CBT.
5.4 Conclusions
In reference to the quote at the beginning of this thesis (Maslow, 1963), this 
study has found that the provision of the appropriate information allows
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patients with psychosis to fulfil “the need to understand”. By utilising a 
collaborative approach and a biopsychosocial perspective, participants of this 
study were provided with the opportunity to feel empowered in being able to 
control their psychosis. Furthermore, the delivery of information regarding 
local resources and services offered participants some hope for their futures.
This study has contributed to the literature on psychoeducation for people 
with psychosis, but gaps remain. These include information regarding the 
mechanisms by which psychiatric symptomatology change, other than by 
taking medication. In addition, the ways in which people who have psychosis 
conceptualise their illness representations is unclear. The construct of 
compliance to treatment (medication and otherwise) also remains ill defined. 
Future studies are needed to determine if these results can be generalised 
beyond this sample and setting.
In conclusion, on the basis of these preliminary findings of a new 
psychoeducation package, a larger scale study is indicated. This would 
compare the effectiveness of this approach with treatment as usual. It would 
also assess whether or not this type of package can be usefully implemented 
during the acute stages of psychosis, prior to the delivery of more in-depth 
therapies. This study has contributed to the field of psychosocial 
interventions for people with acute psychosis, but further work must now be 
conducted.
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Appendix 1: Brief Psychiatric Rating Scale
BPRS Score Sheet
0 1 2 3 4 5 6
Absent Very
Mild
Mild Moderate Moderate/
Severe
Severe Extremely
Severe
ITEM SEVERITY SCORE
Somatic Complaint
Anxiety
Emotional Withdrawal
Conceptual Disorganisation
Guilt Feeling
Tension
Mannerism and Posturing
Grandiosity
Depressive Mood
Hostility
Suspiciousness
Hallucinations
Motor Retardation
Unco-operativeness
Unusual Thought Content
Blunted or Inappropriate A ffect
Elation Euphoria
Disorientation
Appendix 2: Scale to Assess Unawareness in Mental 
Disorder
162
Assessment of Insight in Psychosis
Amador. Strauss, Yale, et al
The scale requires that the subject have a mental disorder with one of the symptoms listed 
below. For each' symptom item on the scale, it must first be ascertained that the subject has 
exhibited the particular symptom during the period under investigation. The severity of the 
symptom is not relevant, only that it is clearly present. The symptom checklist must be 
completed prior to filling out the scale, in order to determine which symptom items are relevant. 
The three nonsymtoms "summary items" are usually relavant and should be completed if this is 
the case.
In the "Current" column, rate the highest level of awareness obtained at the-time of the 
interview for current-psychopathology.
In the "Past" column, rate the present level of awareness for each item occurring during the 
period of time preceding the current period of investigation. In other words, when questioned 
about a particular episode in the past, would the subject currently say s/he was delusional, 
thought disordered, asocial, mentally ill etc at that time?
Longer or shorter time periods may be used to assess the current and retrospective awareness ■ 
and attributions, depending on the goals of the investigation.
Following each symptom item (numbers 4-20), you are asked to rate the subject's 
understanding of the cause of the symptom (i.e. attribution). NOTE for any symptom attribution 
.items are rated only if the subject received a score between 1 and 3 on the awareness item.
General items
1. Awareness of m ental disorder
In the most general terms, does the subject believe that he I she has a mental disorder, 
psychiatric problem, emotional difficulty etc.?
c P
0 0 Cannot be assessed
1 1 Aware: subject clearly 
believes that he/ she has a 
mental disorder
2-.. 2 ..........................—
3 3 Somewhat: is unsure whether 
he / she has a mental 
disorder but can entertain the 
idea that he / she might
4 4
5 5 Unaware: believes that he / 
she does not have a mental 
disorder
2. Awareness of achieved effects of medication
What is the subject's belief regarding the effects of medication? Does the subject 
believe that medications have lessened the intensity or frequency of his /  her symptoms 
(i.e. if applicable)?
C P
0 0 Cannot be assessed or item 
not relevant
1 1 AWare: subject clearly 
believes medications have 
lessened the intensity or 
frequency of his / her 
symptoms
2 2
3 3 Somewhat: is unsure whether 
medications have lessened 
the intensity or frequency og 
his /  her symptoms but can 
entertain the idea
4 4
5 5 Unaware: believes that 
medications have not ■ 
lessened the intensity or 
frequency of his / her 
symptoms
3. Awareness o f the social consequences o f mental disorder
What is the subject's belief regarding the reas.on he / she has been admitted to the 
hospital, involuntarily hospitalised, arrested, evicted, fired, injured, etc.?
c P
0 0 Cannot be assessed or item 
not relevant
1 1 Aware: subject clearly 
believes that the relevant 
social consequences are 
related to having a mental 
disorder
2 2
3 3 Somewhat: is unsure whether 
the relevant social 
consequences are related to 
having a mental disorder
4 4
5 5 Unaware: believes that the 
relevant social consequences 
have nothing to do with 
having a mental disorder
Appendix 3: The Insight Scale
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m i l
1. I have come into hospital for a rest yes no Don’t know
2. I have never been so ill in my life yes no Don’t know
3. Mental illness does not exist yes no Don’t know
4. I am here because I was asked to come yes no Don’t know
5. My condition can be treated with medicines yes no Don’t know
6. Why have you come to hospital (you can ring more than 
one)
a)My doctor asked me to
b)l am ill and need treatment
c)My wife/husband might leave me if I didn’t
d)l feel nervous but not ill
e)l was forced
7. Should anyone be here instead of you? yes no Don’t know
8. To feel well I only need some advice and talking to. yes no Don’t know
9. I have been having some silly thoughts. yes no Don’t know
10. Nothing is the matter with me. yes no Don’t know
11. The mind cannot become ill, only the body. yes no Don’t know
1 2 .1 shall sue the hospital if I am not allowed out. yes no Don’t know
13. No one believes I am ill. yes no Don’t know
14. Something very strange is happening to me. yes no Don’t know
15. My neighbours are after me. yes no Don’t know
1 6 .1 feel my mind is going. yes no Don’t know
1 7 .1 know that my thoughts are silly but I cannot help it. yes no Don’t know
1 8 .1 cannot stop worrying about things yes no Don’t know
19. The voices I hear are not in my mind. yes no Don’t know
20. Someone is controlling my mind. yes no Don’t know
21. All I need is to pull myself together. yes no Don’t know
2 2 .1 feel different from my normal self. yes no Don’t know
2 3 .1 am losing contact with my environment. yes no Don’t know
2 4 .1 am losing contact with myself. yes no Don’t know
2 5 .1 understand why I am in hospital. yes no Don’t know
26. I understand why other people think I should be in hospital. yes no Don’t know
2 7 .1 feel in control of my thoughts. yes no Don’t know
2 8 .1 feel in control of my feelings. yes no Don’t know
2 9 .1 could have prevented this situation. yes no Don’t know
3 0 .1 find it difficult to explain how I feel. yes no Don’t know
3 1 .1 want to know what is happening to me. yes no Don’t know
3 2 .1 want to know why I am feeling like this. yes no Don’t know
Appendix 4: Illness Perception Questionnaire - Revised
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IL L N E S S  P E R C E P T IO N  Q U E S T IO N N A IR E  (IP Q -R )
Name...............................................  Date....................................................
YOUR VIEWS ABOUT YOUR ILLNESS
Listed below are a number of symptoms that you may or may not have experienced since your 
illness. Please indicate by circling Yes or No, whether you have experienced any of these symptoms 
since your illness, and whether you believe that these symptoms are related to your illness.
I have experienced this This symptom is related to
symptom since my illness my illness
Pain Yes No Yes No
Sore Throat Yes No Yes No
Nausea Yes No Yes No
Breathlessness Yes No Yes No
Weight Loss Yes No Yes No
Fatigue Yes No Yes No
Stiff Joints Yes No Yes No
Sore Eyes Yes No Yes No
Wheeziness Yes No Yes No
Headaches Yes No Yes No
Upset Stomach Yes No Yes No
Sleep Difficulties Yes No Yes No
Dizziness Yes No Yes No
Loss of Strength Yes No Yes No
We are interested in your own personal views of how you now see your current illness.
Please indicate how much you agree or disagree with the following statements about your illness by 
ticking the appropriate box.
VIEWS ABOUT YOUR ILLNESS STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISAGREE
AGREE STRONGLY
AGREE
IP l* My illness will last a short time
IP2 My illness is likely to be permanent rather 
than temporary
IP3 My illness will last for a long time
11*4* This illness will pass quickly
1P5 I expect to have this illness for the rest of my 
life
IP6 "" My illness is a serious condition
1P7 My illness has major consequences on my life
IPS* My illness does not have much effect on my 
life
1P*> My illness strongly affects the way others see 
meim i' My illness has serious financial consequences
iph My illness causes difficulties for those who are 
close to meIP li There is a lot which I can do to control my 
symptoms
npn' What I do can determine whether my illness 
gets better or worseIP 14 The course of my illness depends on me
“TPT5*- Nothing I do will affect my illness
"1PTC I have the power to influence my illness
lP i7 * My actions will have no affect on the outcome 
of my illness1PT8* My illness will improve in time
1P10* There is very little that can be done to 
improve my illness1P2U My treatment will be effective in curing my 
illness
IP21 The negative effects of my illness can be 
prevented (avoided) by my treatment
1P22 My treatment can control my illness
1P23* There is nothing which can help my condition
1P24 The symptoms of my condition are puzzling to 
me1P25 My illness is a mystery to me
nrPTfi I don’t understand my illness
TPT7 " My illness doesn’t make any sense to me
1F28* I have a clear picture or understanding of my 
condition
1P29 The symptoms of my illness change a great 
deal from day to day
IP3& My symptoms come and go in cycles
'7P3T My illness is very unpredictable
' 1P32 I go through cycles in which my illness gets 
better and worse.IP3J I get depressed when I think about my illness
1FJ4 When I think about my illness I get upset
!P35 My illness makes me feel angry
1P36* My illness does not worry me
1P37 Having this illness makes me feel anxious
1P3S My illness makes me feel afraid
CAUSES OF MY ILLNESS
We are interested in what you consider may have been the cause of your illness. As people are very 
different, there is no correct answer for this question. We are most interested in your own views about the 
factors that caused your illness rather than what others including doctors or family may have suggested to 
you. Below is a list of possible causes for your illness. Please indicate how much you agree or disagree that 
they were causes for you by ticking the appropriate box.
POSSIBLE CAUSES STRONGLYDISAGREE DISAGREE NEITHER AGREE NOR 
DISAGREE
AGREE STRONGLY
AGREE
Cl Stress or worry
C2 Hereditary - it runs in my family
C'3 A Germ or virus
C4 Diet or eating habits
C5 Chance or bad luck
C6 Poor medical care in my past
C'7 Pollution in the environment
CH My own behaviour
C!» My mental attitude e.g. thinking about life 
negatively
C1U Family problems or worries caused my 
illness
T i l  1 Overwork
T 1 2 My emotional state e.g. feeling down, lonely, 
anxious, empty
CIS Ageing
T i l ' Alcohol
CIS Smoking
T H Accident or injury
C17 My personality
CIS Altered immunity
In the table below, please list in rank-order the three most important factors that you now believe caused 
YOUR illness. You may use any of the items from the box above, or you may have additional ideas of your 
own.
The roost important causes for me:-
1.  
2.
3.
Appendix 5: UKU-ConSat
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U KU-C onS
UKU-ConSat (Consumer Satisfaction Rating Scale)
Patient name/initials: Interviewer
Date of birth: Date of interview:
Gender Male □  Female □
Evaluation period:  - .....................
date date
Interviewer involved in the treatment/caire of the patient: Yes □  No □
Assessment of Inpatient care □  Daycare □  Outpatient care □
Compulsory care □  Voluntary care □
A. Structure and process
1. Availability of treatment/care _____
Possibility to get caro when needed. Note positive/negative factors, that has affected 
hospitalisation or outpatient consultation, time on waiting list, etc.
Subtract 1 point for disapproval of compulsory tzeatmcnt/carc or pressure to seek care.
Add 2 points far approval o f cocrcivo measures taken.
However, the entered rating should not exceed-3 o r+3.
2. Environment and services _____
The atmosphere of the ward or office, respectively; arrangements, level o f service, -l  n. L'  a'-7rK' ..
attitude apdinteraction with personnel. •itou-a*...,
3. Availability of various'treatment modalities  2.
Opportunity for psychotherapy and other treatment modalities.
Availability and continuity o f personnel.
4. Information _____
Availability of spontaneous or requested information regarding planning of 
treatment/care, its nature and contents, c-g. decisions diagnostic methods, 
participation in decisions.
5. Drug treatment _____
Subjective opinion regarding the properties of the drugs, mode of administration, 
effects, aide effects. NBI If  no drugs given, enter dash (-) *.
6. Psychosocial Interventions _____
Social skills training, help with femily problems, offered and effectuated social 
measures that might affect e.g. the private economy, employment or living conditions.
NBI If  no psychosocial measures needed, enter dash (-)* .:
Subtotal, items 1 - 6 _____
A. Outcome
7. Usefulness of the treatment/care
Achieved or no subjective usefulness of the treatment/care, respectively.
8. General well being
Satisfaction with life as a result of fee treatment/care provided; at ease or 
sick at heart; optimistic or pessimistic. .
Subtotal, items 7 -8  
Total score:
*) For scoring - see the Manual
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UKU-ConSat (Consumer Satisfaction Rating Scale)
MANUAL
The assessment shall be based upon the subjective opinion of the patient, but be performed in 
thie form of an interview. The interviewer, who preferably should not be directly involved in 
thte treatment/care of the patient, scares according to the contents of the patient’s answers. The 
interview should be structured according to toe standard farm:
"How satisfied arc you with ...7".
Ccnnplementba^-qu^sdonsimay be asked especially when there arc problems with 
understanding. The evaluation shouldbe done independently from psychopathological factors 
according to the following:
-3 = Completely negative attitude to the contents of the treatment/care, the outcome,
environment or other factors, e.g. worthless treatment or mainly adverse effects of 
drugs. Not even details arc looked upon positively. Subjectively the condition has 
deteriorated to a considerable degree dim'ng die treatment period.
-2 = Negative attitude to the contents and outcome of the treatment/care. Only isolated and 
unimportant details are reported positively, e.g. regarding the environment or 
opportunities for interaction,with the personnel. Drugs are without effect, or harmful 
in some respect Subjectively, the condition has deteriorated during treatment
-1 =  Somewhat negative attitude to the contents, outcome of the treatment/care, die
environment or other factors. The main attitude is negative, even though the patient 
acknowledges positive details. Too small an effect of the medication or adverse 
effects that are not markedly troublesome. Subjectively, the condition has not 
improved during the treatment/care.
0 = No specific subjective assessment or vague answers that are difficult to rate.
+1 = Somewhat positive attitude to tho contents and outcome of the treatment/care, or
other factors. The main attitude should not bo negative. Negative points of view may 
be expressed regarding details, e.g. aspects of tho medication or tho ward atmosphere, 
but the mildly positive attitude predominates. Subjectively, the condition has 
improved somewhat
+2 = Positivo attitude to the contents and outcome of tho treatment/care, or other factors. 
Minor, less important negative points of view may be expressed, but the attitude is 
mainly positive. Subjectively, the condition has improved to a considerable degree.
+3 = Extraordinary positive attitude to the contents of the treatment/care, environment,
personnel, etc. Marked satisfaction or gratitude. Subjectively, the patient has 
recovered as a result of the treatment/care.
NBI If Drugs have not been given (Item 5), or Psychosocial interventions have not 
been undertaken (Item 6), the mean scores of the remaining endorsed ratings 
shall be used.
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APPENDIX 6
PATIENT INFORMATION SHEET 
Study Title
Patient as Partner: Therapeutic Information Provision for People Suffering 
with Severe Mental Health Problems
You are being invited to take part in a research study. Before you decide, it is 
important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully and 
discuss it with others if you wish. Ask us if there is anything that is not clear 
or if you would like more information. Take time to decide whether or not you 
wish to take part.
Thank you for reading this.
What is the purpose of the study?
The Clinical Psychology Team at the <name of base unit> feel that it is 
important to share as much information as possible about your illness while 
you are a patient on the ward. We have therefore put together an information 
and skills pack that we hope will help you to understand your difficulties in 
more detail. We believe that this will help you to get better quicker and stay 
better for longer.
Many people often feel that they are not being listened to when they first 
come into hospital. Three essential parts of our approach are:
1. To help us understand how you see your difficulties
2. To work together on the beliefs about your illness that may keep 
you stuck
3. To work together on a shared understanding of unusual or 
upsetting things that you have experienced while you were unwell.
The study will be looking at how effective this pack is in helping you to 
understand your symptoms.
Why have I been chosen?
You have been chosen for this study because you are a new patient of the 
<name of base unit>. We will be asking a total of 16 people, who are also 
new patients, to join in with this study.
Do I have to take part?
It is up to you to decide whether or not to take part. If you do decide to take 
part you will be given this information sheet to keep and be asked to sign a 
consent form. If you decide to take part, you are still free to withdraw at any 
time and without giving a reason. A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you receive at 
the <name of base unit>.
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What do I have to do?
The study will involve you meeting with a member of the Clinical Psychology 
team on three separate occasions. Each meeting will last approximately 30 
minutes. The meetings will be arranged at 2-week intervals after your 
admission to the <name of the base unit>.
What are the possible disadvantages and risks of taking part?
We do not expect there to be any risks from taking part in this study.
However, if you feel distressed during the study, you are free to withdraw. In 
this case, you will be offered access to the most appropriate support for you, 
through either the nurses, the Clinical Psychologist or your Psychiatrist.
What are the possible benefits of taking part?
We hope that this treatment will help you to gain a better understanding of 
your symptoms. However, this cannot be guaranteed. The information we get 
from this study may help us to treat future patients with mental health 
difficulties better.
Will taking part in this study be kept confidential?
All information which is collected about you during the course of the research 
will be kept strictly confidential. Any information about you which leaves the 
<name of base unit> will have your name and address removed so that you 
cannot be recognised from it.
What will happen to the results of the research study?
The results of the study will be published as the doctoral thesis of Judith 
Friedman for the qualification of Doctorate in Clinical Psychology at 
University College London. This will be published in June 2004. We also 
intend to submit the results in a suitable academic publication. If you would 
like a copy of the results, this can be obtained from Judith Friedman in June 
2004. You will not be identifiable in any publication.
Who is organising and funding the research?
The research is being organised by Gary Kupshik and Judith Friedman. No 
funding has been requested for this research. No professional involved in this 
study is being paid specifically to carry out this research.
Who has reviewed the study?
This study has been reviewed by the <name of the local Ethics Committee>.
It has also been peer reviewed by the Research Sub-Committee at the Sub­
department of Clinical-Heath Psychology.
Contact for Further Information
We are happy to discuss the study further with you if you have any questions. 
Please contact either Judith Friedman or Gary Kupshik at the addresses 
below:
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Mrs Judith Friedman
Trainee Clinical Psychologist
Sub-Department of Clinical-Health Psychology
University College London
Gower Street
London WC1E6BT
Telephone: 0207 679 5699
Dr Gary Kupshik 
Consultant Clinical Psychologist 
Department of Clinical Psychology 
<address>
You will be given a copy of the information sheet and a signed consent form 
to keep.
Thank you for taking the time to read this information sheet.
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APPENDIX 6
CONSENT FORM
Name
■ I give my consent to participate in the study
■ I understand the information given in the handout explaining the purpose 
of the research.
■ I understand that the results of the study may be shared with other clinical 
staff, including nurses, doctors, Occupational Therapists and any other 
professional involved in my care.
■ I understand that the results of the study may be published but that I will 
not be identifiable in any way.
■ I understand that I can withdraw from the study at any time should I wish 
to, without giving an explanation.
■ This form will not influence the treatment that I would ordinarily receive 
from the <name of base unit>.
Signature_____________________________  Date_
Witnessed by (signature)______________  Date_
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Appendix 7: Ethical Approval and Chairman’s Action
Details of the base unit have been erased to 
protect confidentiality
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H I The Luton and Dunstable Hospital i~yTTT3
E,.d bT ,h. nhs T^st \ k I i  r J
H“ "hQuS O b tH  B E D F O R D S H IR E  LO C A L R ESEA R C H  ETHICS C O M M ITTEE
Lewsey Road
Chairman: Mr. R. Driver  LUTON
Administrator: Mrs. D. Chapman  LU4 ODZ
Facsimile: 01582 564543 Sw itchboard: 01582 491122
E-mail: Debbie. Chapman(a)ldh-tr. analox. nhs. uk
To: Dr. G. A. Kupshik, Consultant Clinical Psychologist, Department of
Psychology
Copy to:
Date of Approval: 29.08.03 
Members of the LREC:
Mr. R. Driver, Chairman: Dr. J. Dove, Vice Chairman: Mrs M. Turton (Community Health Council): 
Dr. J. Ana (General Practitioner): J. Ang (Community Health Care Trust): Mr. D. Fairclough (Lay 
Member): Dr. W. Matta (General Practitioner): Dr. S. Stein (Consultant Child Psychiatrist): B. 
Thatcher (Pharmacist): P. Davies (Senior Nurse): Elizabeth Bradley (Lay Member): Dr. C. Travill 
(Director of Research and Development -  as an observer)
Title of study: Patient as Partner: Therapeutic Information Provision for People
Suffering with Severe Mental Health Problems
SBLRECK<;/: 
pkase quote this reference
Study considered for first time by the Committee
Study reviewed by the Committee
XX
Study examined by Chairman (preliminary)
Chairman's action, following examination by the 
full committee, and subsequent modifications
Chairman's action only; examination by committee 
not necessary
XX
OUTCOME: Study APPROVED (WITH COMMENT)
ftoji
w w w .idh .nhs.uk  
Chairman: Dr Soraya Dhillon Chief Executive: Mr Stephen Ramsden
A,__
■tab in
H I)
The South Bedfordshire Local Research Ethics Committee conforms to the ICH  
Guidelines on Good Clinical Practice.____________________________________________
A DD ITIO N A L C O M M EN T:
1. Page 4: ... The decision regarding the capacity to give consent would be the
responsibility of the RMO, Dr. , who is independent of this study ... Members would 
like a letter from Dr. to say that he would be happy to do this.
This study is approved subject to the above condition.
DOCUMENTS CONSIDERED:
Protocol No/Date:
Version No.:
Patient Information:
Consent Form:
Questionnaire:
ONE OF THE CONDITIO NS OF THIS APPROVAL IS THAT YOU SUBM IT TO  
TH E C O M M ITT E E  ANNUAL REPORTS ON TH E PROGRESS OF TH E  STUDY.
A REM INDER LETTER  W IL L  BE SENT TO YOU A M O N TH  BEFORE TH E FIRST 
REPORT IS DUE.
FAILURE TO PROVIDE REPORTS MAY RESULT IN APPROVAL BEING
WITHDRAWN
Signed (Chairman/Vk^-Chairman)
Date ^ f \  / /Q~Z
Correspondence to: 
Mrs D. Chapman 
L.R.E.C. Administrator
S outh  B edfordsh ire  L ocal R esearch  E th ics  C om m ittee
Luton and Dunstable Hospital NHS Trust
Lewsey Road 
Luton 
Bedfordshire 
LU4 0DZ
Tel: 01582 497420 
Fax: 01582 564543
 ( p l e a s e  q u o t e  t h i s  r e f e r e n c e  o n  a l l  c o r r e s p o n d e n c e )  
07 November 2003
Mrs Judith Friedman 
Trainee Clinir.al Psychologist
Dear Mrs Friedman
Re: Patient as Partner: Therapeutic information provision for people suffering with severe
mental health problems
Thank you for your letter dated 29 October 2003. The amendment you wish to make, involving contacting 
about 16 participants 6 weeks after completing the last intervention session, has been approved by 
Chairman’s Action on behalf of the Committee.
The South Bedfordshire Local Research Ethics Committee conforms to the ICH Guidelines on 
Good Clinical Practice.
One of the conditions of this approval is that you submit to the Committee Annual Reports on the 
progress of the study. A reminder letter will be sent to you a month before the first report is due.
F a i l u r e  t o  p r o v i d e  r e p o r t s  m a y  r e s u l t  i n  a p p r o v a l  b e i n g  w i t h d r a w n .
Yours sincerely
j/p Mr. Ron Driver
Chairman - South Bedfordshire Local Research Ethics Committee
An advisory comm ittee to  Bedfordshire and Hertfordshire Strategic Health Authority
Appendix 8
First Session Interview
Thank you for agreeing to participate in this research. My name is Judith 
Friedman and I am a Trainee Clinical Psychologist As you are aware, I will be 
using the information that I obtain today as part of a research project The 
purpose of today’s session is to find out a little about why you think you’re at 
the <name of base unit>t and what difficulties you feel you have.
I would like to start the session by asking you a few questions. Before I begin, 
do you have any questions you’d like to ask me?
1. Can you tell me the reasons why you are in the <name of base 
unit>?
2. What do you think is wrong with you at the moment?
3. What do you think will help you to get better?
4. What do you think will stop you from getting better?
5. What do you think could make you get worse?
6. What have you been told is wrong with you (by doctors, nurses, 
family, friends etc)?
7. What are the most difficult / troublesome symptoms that you 
experience?
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8. What do you think has made you feel this way?
9. What do you think is wrong with you?
10. Have you ever seen or heard anything that other people can’t see 
or hear?
11. Please take a moment to think back to life before you came to the 
<name of base unit>. Can you describe a typical day to me?
If participant doesn’t respond, prompt by asking what time s/he would 
normally awaken; what s/he would do in the morning etc.
11. How much alcohol did you used to drink?
12. Did you take drugs? If so, what drugs? How often did you take 
drugs?
13. Is there anyone in your life who would notice if you weren’t feeling 
well? If so, who are they? What do they think is wrong with you just 
now
14. When did you first notice that you weren’t feeling like your usual 
self?
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15. Thinking back, when you have felt unwell in the past, what have you 
been able to do to make yourself feel better? Has this worked?
16. Do any of your relatives suffer from the difficulties that you have?
17. Do you know of any problems your mother had when she was 
pregnant with you?
Were there any problems during your birth?
Did you have any problems at school?
18. What would you like to achieve whilst you’re at the <name of the 
base unit>?
19. What do you hope to do in the future? Where do you hope to live? 
Do you intend to work? If so, what would you like to do?
20. In the future, if you feel unwell again, what do you think you would 
do? Who would you go to for help?
Thank you for answering these questions. I will meet with you again in 2 
weeks. At that time, I will be able to give you a shared description of what you 
think your problems are and of what I think your problems are. We will then 
have a chance to discuss this further.
Do you have any further questions?
If you realise there is something else that you would like to ask, feel free to 
ask me or Gary Kupshik, Consultant Clinical Psychologist. We will be happy 
to answer any queries.
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Appendix 9
Template for Manual
1. What the participant thinks is wrong
Insert paragraph about what the patient generally thinks is wrong with them, 
e.g. they are being watched by others; they are being spoken to by the devil 
etc.
Include the participant’s account of the incidents that led to admission. 
Include information regarding what the patient has been diagnosed with in 
the past and whether or not he agrees.
2. General information about Psychosis
The experiences that you are having, like <include symptoms mentioned by 
participant are common for people who have a psychosis. A psychosis is a 
condition in which the person’s contact with reality is lost or highly distorted. 
<ln cases where participant has been diagnosed with Schizophrenia, state, 
“One illness in which people suffer from psychosis is Schizophrenia>. Many 
people who have a psychosis don’t believe that they are suffering from an 
illness in the early stages.
Hallucinations
In our discussion, you mentioned that you <insert hallucination, e.g. 
sometimes hear people talking to you; see things that others can’t .  These 
symptoms are called hallucinations and often seem to occur out of 
nowhere. Hearing voices that other people can’t hear is the most common 
type of hallucination. In your case, the vo\ces<describe your activities; carry 
on a conversation; give you orders; warn of dangers>.
In cases of auditory, tactile or olfactory hallucinations, include details of 
symptom and state that they are part of psychosis.
Delusions
You mentioned that you believe <insert delusion e.g. you believe that 
someone is following you; that you are an important person; that your 
neighbour is spying on you; that people on television are sending you special 
messages; that your thoughts are being broadcast out loud to others>. These 
beliefs seem to be true to you and can make you feel very frightened. They 
can make you feel alone because other people don’t believe you. This is a 
symptom of psychosis and is called a delusion. Delusions are a common 
symptom of psychosis.
Thought disorder
You mentioned that you are having difficulty in <insert person’s description, 
e.g. thinking straight; making sense of your thoughts etc>. This can make it 
difficult for you to have a conversation and can make you feel isolated and 
lonely. This symptom is called “thought disorder” and is common for people 
who have psychosis.
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Blunted affect
In our discussion, you said that it is difficult to <insert, e.g. get out of bed; 
motivate yourself etc>. You’re no longer interested in the things you used to 
enjoy. Sometimes you can spend days doing nothing at all. You find it difficult 
sometimes to wash or dress yourself. This is another symptom common to 
people who have psychosis and is called “blunted or flat affect”.
3. Summary of symptoms
Insert table summarising partcipant's belief and alternative explanation (for 
delusions). Change to “Your Experience” and “Alternative Explanations” for 
other symptoms.
Your Belief Alternative Explanations
4. What causes psychosis?
Brain factors
It is likely, but not certain, that you and other people who have psychosis 
have imbalances in your brain. These imbalances are in the chemicals that 
send messages around your brain. The main chemical involved in psychosis 
is called dopamine.
Vulnerabilities 
Genetic factors
You mentioned that your <insert relative who had psychotic episodes> also 
had symptoms like the ones you’re experiencing now. Psychosis is known to 
run in families.
Developmental factors
You mentioned that <insert complication, e.g. your mother's pregnancy with 
you was difficult; your mother had a virus when she was pregnant; your birth 
was complicated and difficult. It may be that this difficulty was one of the 
causes that led you to develop psychosis.
Stressors
Behavioural factors
You mentioned that for a while <insert stressor, e.g. you have not been 
getting enough sleep; you have been particularly stressed; you have been 
taking <insert illicit drug». Researchers called Dr Zubin and Dr Spring wrote 
in 1977 and said that people, like you, who have a tendency to develop 
psychosis, and who do things that puts stress on their bodies, like <insert 
stressor> are more likely to develop symptoms of psychosis than if they 
didn’t do those things.
Insert diagram below:
STRESS --------- ► Individual with tendency to develop psychosis ► PSYCHOSIS
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Drugs
You mentioned that you sometimes take <insert name participant used to 
describe drug>. Your use of drugs is not unusual. <lf participant uses 
cannabis, then state, “Cannabis is one of the three substances most 
frequently misused by people with mental health difficulties like you”>. We 
feel that your use of <name ofdrug(s)> needs to be moderated significantly, 
if not stopped altogether. Researchers think that cannabis should be seen as 
something which can precipitate further episodes of illness. Other Doctors, 
like <name of lead Psychiatrist at base unit> feel that cannabis increases the 
risk of hospital readmission.
Drugs cause worsening of your symptoms and can trigger a further episode 
of psychosis. We know that the medication that you have been prescribed 
will block an important neurochemical called dopamine. We think that drugs 
have the effect of unblocking or enhancing dopamine pathways that cause 
<name of symptom that participant experiences>.
5. How do we understand your symptoms?
Delusions
You talked about feeling <insert delusion>. This seems to be real to you. We 
understand this in a different way.
Dr. Garety and her colleagues think that your symptoms are caused by your 
wish to make sense of these strange things happening to you, so you grasp 
the first conclusion you come to, even though this may not be the right one. 
So, in your case, you believe <insert delusion> when, in fact, there may be 
many other explanations, like there is a chemical imbalance in your brain that 
causes you to think this way.
Dr Bentall in Manchester has also written about what delusions are. He 
thinks that if you think someone is trying to get you <only insert if there is 
persecutory delusion> then you won’t feel depressed about all the things that 
you haven’t done in your life, because you’ll be able to blame it on someone 
else.
Dr Frith in London has another different idea about delusions. He thinks that 
it is difficult for you to understand that other people may be thinking 
something different from you. This leads you to become confused about 
whether a bad thought is coming from your own mind or is coming from 
someone else <insert delusion, e.g. like the devil>.
Hallucinations
In our discussion, you mentioned that you sometimes hear voices that other 
people can’t hear. There have been many Psychologists who have thought 
about why someone like you hears these voices. Dr Baddeley thinks that you 
have a fault in the way that you hear information. This means that you are not 
always sure if a thought has come from inside your head or from someone 
else. This is called a disturbance of inner speech.
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Dr Bentall and Dr Slade also think that sometimes you become confused with 
noises that you hear and think that those noises are voices when they are 
not. This is called an input theory.
Dr Frith thinks that you have some difficulties in realising that you had 
intended to think something. The result of this is that you think that the 
thought has come from somebody else, but it has actually come from inside 
your head. This is called a disturbance of self-monitoring.
6. Metaphor
A useful way to think about your symptoms is to use the following metaphor. 
It’s about a tug of war:
“The situation you are in is like being in a tug-of-war with a monster. In 
between you and the monster is a pit, and so far as you can tell, it is 
bottomless. If you lose this tug-of-war, you will fall into this pit and will be 
destroyed. So you pull and pull, but the harder you pull, the harder the 
monster pulls, and you edge closer to the pit.
The hardest thing to see is that our job here is not to win the tug-of- 
war Our job is to drop the rope”.
In this metaphor, think about the rope as the problems in your life. It says that 
if you keep using the same strategies to manage your difficulties, then drop 
the rope because they’re making things worse. How might this apply to you?
7. What can be done to improve vour symptoms 
Medication
You have been asked by your doctor to take anti-psychotic medication, 
<insert name of medication>. This is one of the most helpful ways of getting 
rid of psychosis. The medication acts on the dopamine in your brain. It 
cannot “cure” your psychosis, but it take away many of your symptoms or 
make them milder. In some cases, they can shorten the course of an episode 
of psychosis as well.
Other wavs to control Psychosis
Taking your medication regularly is an important way of controlling psychosis, 
but not the only way. You can also look after yourself better by taking regular 
exercise, eating healthily and avoiding stressful situations.
The other important way of controlling your psychosis is not to take street 
drugs. You mentioned that you take <insertname ofdrug>. You are much 
more likely to have a bad reaction to street drugs than someone who doesn’t 
have psychosis.
Psychosocial environment
In our discussion you told me that the people who you mix with also like to 
take drugs and don’t have jobs. You mentioned that you find it difficult to say
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“no” when they offer you drugs. Sometimes being with these people can 
make you feel worse. You mentioned that you began to notice that your 
symptoms came out again when you were with these people. You may think 
about changing your friends in the future if you want to stay well.
Previous daily routine
You told us that when you started having your symptoms, you didn’t have 
much to do during the day. You didn’t have a job and you didn’t have much 
money. You were bored. We think that this lifestyle made it easy for your 
symptoms to come out. In the future, you may plan to do other things with 
your life. You may even try to get a job. These things will help you to control 
your difficult psychotic symptoms.
8. Relapse Prevention
In our meeting, you said that before you became ill you used to <insert daily 
activities, including job, hobbies, people they used to see etc>. We hope that 
you are able to return to doing those things again.
The most important way of making sure that you become well is to keep 
taking your medication. When medication is stopped, people who have 
psychosis often relapse and suffer from their hallucinations and delusions 
again.
Another way of making sure that you don’t relapse is to get enough sleep. 
When you notice that you haven’t been getting much sleep, speak to your 
<insert keyworker, doctor, social worker etc>.
Keep away from street drugs to make sure you don’t relapse. <insert name of 
drug patient takes> affects the dopamine in your brain. This is the chemical 
involved in psychosis.
Another way of staying healthy is to try to keep stress at bay. If you become 
stressed, your psychotic symptoms may emerge. Ways of keeping stress at 
bay are to exercise, to socialise and to eat healthily <insert specific activities 
that person used to engage in>.
9. What should I do if mv symptoms start again?
When you know that your symptoms are starting again, the most important 
thing for you to do is tell someone. One person you could tell is <insert name 
of Social Worker and phone number> or you may choose to tell a family 
member.
It is likely that your doctor will prescribe you some anti-psychotic medication.
It is really important that you take this to reduce the uncomfortable feelings.
Remember, your psychosis is an illness. It can be treated. You can make it 
better by taking your medication, staying stress-free and by not taking street 
drugs. There are lots of people around to help you. You’re not alone.
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10. Plans for the future
It’s great that you want to <insert participant’s words, e.g. get a job, go to 
college, do some volunteer work etc.>.
It may be helpful for you to contact <insert names and telephone number of 
relevant organisations, e.g. Citizens’ Advice Bureau; local college; supported 
working schemes; volunteer projectsW
If participant admitted to misusing drugs, insert:
If you find you are again having problems with drugs, you may either want to 
contact your doctor (GP or Psychiatrist). You may also find it helpful to 
contact Drugline to talk to someone about your difficulties. Their phone 
number is <insert phone number>.
Useful phone numbers
Insert all names and phone numbers mentioned above again.
I hope you have found this helpful,
Yours sincerely,
Judith Friedman 
Trainee Clinical Psychologist
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Appendix 10: Intervention as a Letter
Headed paper with Trust Logo
Psychology Department 
Address of Base Unit
Date
CONFIDENTIAL
Joe Bloggs 
Ward Name
It was good to meet you on the <insert dates of first and second sessions>.
In the first session, we were discussing the reasons why you are in the 
Orchard Unit and what you feel your difficulties are at the moment. In the 
second session, I gave you a letter with a shared idea of your understanding 
of what is happening to you right now and my understanding. In that session, 
you had the chance to change any aspects that you did not agree with. This 
letter is the amended version of the last letter.
In our meeting, you told me that you are in the <name of base unit> because 
you stopped taking your medication. You were also feeling stressed and 
upset because you were having difficulties with your relationship and 
because a good friend of yours committed suicide. You began to re­
experience symptoms, including hearing voices and having “telepathic 
communications” from your friend who died. These messages were telling 
you to throw yourself in front of a train. When I met you the second time, you 
said that you were hardly getting any of these symptoms. You told me this 
was because the medication had started to work.
I asked you about what the doctors feel is wrong with you at the moment.
You told me that they have told you that you have Paranoid Schizophrenia. 
You told me that you have had this in the past, but that you do not believe 
that you have it now.
Over the course of our session, you mentioned several times that you had 
been treated unfairly because of your Schizophrenia. You seemed to feel that 
other people are against you because of your illness.
The experiences that you are having, like receiving telepathic messages and 
hearing voices are common for people who have a psychosis. A psychosis is 
a condition in which the person’s contact with reality is lost or highly distorted. 
One illness in which people suffer from psychosis is Schizophrenia. Many 
people who have a psychosis don’t believe that they are suffering from an 
illness in the early stages. In your case, you told me that you are not sure at
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the moment whether or not you are ill, but feel that in a few weeks, you will 
look back on this experience and realise that you are ill.
You mentioned that you have telepathic communications from the dead 
telling you to kill yourself. You also hear voices. These symptoms are called 
hallucinations and often seem to occur out of nowhere. Hearing voices that 
other people can’t hear is the most common type of hallucination. In your 
case, the voices give you orders to kill yourself.
You mentioned that you feel that everyone knows that you have 
Schizophrenia and think badly of you because of this. This belief seems to be 
true to you and can make you feel very frightened. It can make you feel alone 
because other people don’t believe you. This symptom is a delusion and is a 
common symptom of psychosis.
What Causes this Illness?
It is likely, but not certain, that you like other people who have a psychosis, 
have imbalances in your brain. These imbalances are in the chemicals that 
send messages around your brain. The main chemical involved in psychosis 
is called dopamine.
You mentioned that before your admission to <name of base unit>, you felt 
stressed because of the death of your friend and because you had been 
having relationship difficulties. In addition, you had stopped taking your 
medication.
Dr Zubin and Dr Spring wrote in 1977 and said that people, like you, who 
have a tendency to develop a psychosis and who experience extreme stress 
are more likely to develop a psychosis than if they had not had this stress.
You mentioned that you used to abuse many street drugs, including cocaine, 
heroin, crack, cannabis and speed. Your use of drugs is not unusual. 
Cannabis is one of the three substances most frequently misused by people 
with mental health difficulties like you. We feel that your use of cannabis and 
other drugs needs to be moderated significantly, if not stopped altogether. 
Researchers consider that cannabis should be seen as something which can 
precipitate further episodes of illness. Other Doctors like <name of 
Psychiatrist at base unit> feel that cannabis increases the risk of hospital 
readmission.
Drugs cause worsening of your symptoms and can trigger a further episode 
of psychosis. We know that the medication that you have been prescribed 
will block an important neurochemical called dopamine. We think that drugs 
have the effect of unblocking or enhancing dopamine pathways, which cause 
paranoid thinking, delusions and hallucinations.
How do we understand vour symptoms?
In our discussion, you mentioned that sometimes you hear voices that other 
people can’t hear and believe that people are against you because you have
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Schizophrenia. There have been many Psychologists who have thought 
about this.
Dr Baddeley suggested that your symptoms are caused by a fault in the way 
that you hear information. This means that you are not always sure if a 
thought has come from inside your head or from someone else. This is called 
a disturbance of inner speech.
This means that the difficult voices that you hear about killing yourself are 
generated from your own anxieties about the world (for example, about 
people around you dying or leaving you). They are your own thoughts that 
are interpreted as coming from outside of your head.
Dr Frith at University College London said that people like you may have 
some difficulties in realising that you had intended to think something. The 
result of this is that you think that the thought (or voice) has come from 
somebody else, but it has actually come from inside your head. This is called 
a disturbance of self-monitoring.
This means that the thoughts of wanting to throw yourself in front of a train 
originate from inside your head, but because of a disturbance of self- 
monitoring, you do not realise that you had intended to think them, so you 
perceive them as voices coming from outside of your head.
Dr Bentall in Manchester said that if people think that others are conspiring 
against them, then they won’t feel depressed about all the things that they 
haven’t done in their lives, because they’ll be able to blame it on someone 
else.
For you, this means that your experiences of feeling that others are 
persecuting you for having Schizophrenia may be a symptom of 
Schizophrenia. The theory suggests that you can blame others for you 
having Schizophrenia as you have found this difficult to accept yourself. This 
stops you from feeling depressed about the Schizophrenia, but instead ends 
up with you being angry with others.
A useful way to think about your symptoms is to use the following metaphor. 
It’s about a tug of war:
‘The situation you are in is like being in a tug-of-war 
with a monster. In between you and the monster is a pit, 
and so far as you can tell it is bottomless. If you lose this 
tug-of-war, you will fall into this pit and will be 
destroyed. So you pull and pull, but the harder you pull, 
the harder the monster pulls, and you edge closer to the 
pit.
The hardest thing to see is that our job here is not 
to win the tug-of-war Our job is to drop the rope.’
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In this metaphor, think about the rope as the problems in your life. It says that 
if you keep using the same strategies to manage your difficulties, then drop 
the rope because its making things worse. How might this apply to you?
What can be done to improve vour symptoms?
You have been asked by your doctor to take anti-psychotic medication, called 
Clozaril. This is one of the most helpful ways of getting rid of psychosis. The 
medication acts on the dopamine in your brain. It cannot cure your psychosis, 
but it can take away many of the symptoms and make them milder. In some 
cases, they shorten the course of an episode of psychosis as well.
The other important way of controlling your psychosis is not to take street 
drugs. You mentioned that you take many different drugs and you know that 
these help to get rid of your symptoms in the short-term, but make them 
worse in the long term. This is because they interfere with the dopamine in 
your brain, that we talked about before.
One way of controlling your symptoms is to look after yourself by taking 
regular exercise (like going to the gym and kick-boxing, that you enjoy), 
eating healthily and avoiding stressful situations.
In our discussion, you told me that some of the people that you mix with also 
like to take drugs and don’t have jobs. Sometimes being with these people 
can make you feel worse. You also told me that you have two circles of 
friends: those who take drugs and those who do not. You said that you are 
going to try to avoid the friends who take drugs to help you to stay off them. 
We also encourage you to do this.
Relapse Prevention
In our meeting, you told me that, in the future, you are keen to get a job that 
you enjoy, e.g. engineering or mechanical work. We very much hope that you 
will be able to take up this lifestyle.
The most important way of making sure that you become well is to keep 
taking your medication. When medication is stopped, people who have a 
psychosis often relapse and suffer from their delusions and hallucinations.
What should I do if my symptoms start again?
When you know that your symptoms are starting again, the most important 
thing for you to do is to tell someone. You could tell your Social Worker 
<name>, your GP <name>, your Psychiatrist <name> or your CPN <name>.
It is likely that your doctor will prescribe you some medication. It is really 
important that you take this to reduce the uncomfortable feelings.
Remember, your psychosis is an illness. It can be treated. You can make it 
better by taking your medication and by staying stress-free. There are lots of 
people around to help you. You’re not alone.
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Another way of making sure that you don’t relapse is to get enough sleep. 
When you notice that you haven’t been getting enough sleep, speak to your 
Social Worker <name> or GP <name> or CPN <name>.
When we talked about how you were feeling before you came to hospital, 
you said:
■ Feeling lethargic
■ Having no motivation 
8 Feeling depressed
■ Hearing voices
■ Receiving telepathic messages
These symptoms were probably the signs that your psychosis was coming 
back. This is called “Relapse”. When you start to experience these 
symptoms, it is important that you contact your Social Worker, CPN or doctor 
immediately.
Finally, a key way of staying healthy is to keep stress at bay. If you become 
stressed, your symptoms, including delusions and hallucinations, may
emerge. Ways of keeping stress at bay are to exercise (including kick boxing
and going to the gym), to socialise and to eat healthily.
Plans for the Future
It’s great that you want get a job, e.g. engineering or mechanics.
You may want to get some advice about your future career by calling the 
Citizens Advice Bureau. Their phone number is <local branch>. Also, there is 
a Personal Advisor Service that you may find useful in thinking about your 
career. The phone number is free and is telephone number>.
You may want to go to college to train in engineering or mechanics. The local 
college that has this sort of course is <name> and you can contact them on 
<number>
If you find that you are again having problems with drugs, you may either 
want to contact a doctor (your GP or Psychiatrist) of you may also find it 
helpful to contact Drugline to talk to someone about your difficulties. Their 
phone number is <insert telephone number>.
I hope you have found this helpful.
Yours sincerely,
Judith Friedman
Trainee Clinical Psychologist
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Appendix 11
QUESTIONNAIRE
We are currently undertaking a research study in an inpatient ward and would 
appreciate your feedback. We are investigating the usefulness of a psychological 
therapy for patients suffering from psychosis, in which the patients are provided 
with information regarding their illness. We have developed two possible formats 
in which to present the information to the patient and are interested as to which 
you believe would be more useful. We would appreciate it if you would take a few 
minutes to look at the two manuals and then answer the questions listed below, 
using the rating scale provided. Thank you!
Judith Friedman -  Trainee Clinical Psychologist 
Anna Hames -  Assistant Psychologist
Very much so Reasonably so Satisfactory 
Rating Scale: 1 2 3
Poor
4
Not at all 
5
. Is the manual easy to read?
Manual 1 1 2 3 4 5
Manual 2 1 2 3 4 5
. Is the manual appealing to look at?
Manual 1 1 2 3 4 5
Manual 2 1 2 3 4 5
. Is the information in the manual easy to understand?
Manual 1 1 2 3 4 5
Manual 2 1 2 3 4 5
. Is the information in the manual accessible?
Manual 1 1 2 3 4 5
Manual 2 1 2 3 4 5
5. What improvements would you make to the layout of the manual? 
Manual 1...................................................................................
Manual 2
6. Overall, which manual do you prefer?
Manual 1 □
Manual 2 □
Please could you explain your reasons
THANK YOU VERY MUCH FOR YOUR TIME
Appendix 12 Reliable Change Index Information
SE is the standard error of measurement
Sdiffis the standard error of difference between the two test scores. It 
describes the spread of distribution of change that would be expected if no 
actual change had occurred (Jacobson & Truax, 1991).
The SE and Sdiff scores for each sub-scale of the measures amenable to the 
Reliable Change Index are highlighted below.
BPRS
SE Sdiff
Anxiety 1.14 1.61
Depression 0.98 1.39
Hostility 0.99 1.40
Suspiciousness 0.80 1.13
Unusual Thought 0.59 0.83
Content
BSI
SE Sdiff
Anxiety 0.52 0.74
Depression 0.48 0.68
Hostility 0.40 0.57
Paranoid Ideation 0.45 0.64
Psychoticism 0.45 0.64
The Insight Scale
S E Sdiff
Positive 1.89 2.67
Negative 1.21 1.71
IPQ-R
S E Sdiff
Consequences 1.98 2.80
Personal Control 2.93 4.14
Treatment Control 2.04 2.88
Illness Coherence 3.01 4.26
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Appendix 13 Case Summary of Recruitment
The table below illustrates a case summary of those who dropped out of 
treatment and where missing values were used.
Case Summary of Intent to Treat Analysis__________________________
Case Completer Drop-Out___________________________________
A _ Missing values for Psychology data at Follow-Up.
Participant had deteriorated in mental state.
B _ Missing values for Psychiatry data at Follow-Up.
C
D
E
F
G _ Participant dropped out after Post-Intervention. Missing
values for Psychiatry and Psychology data at Follow- 
Up.
H _  Participant dropped out after Post-Intervention. Missing
values for Psychiatry and Psychology data at Follow- 
Up.
I
J _ Missing values for Psychiatry data at Follow-Up.
Participant’s mental state had deteriorated and he 
refused to engage in Psychiatric interview.
K _ Participant dropped out after Pre-Intervention. Missing
values for Psychiatry and Psychology data at Post- 
Intervention and Follow-Up.
L
M _ Participant dropped out after Post-Intervention. Missing
values for Psychiatry and Psychology data at Follow- 
Up.
N _ Participant dropped out after Pre-Intervention. Took
illicit substances whilst on leave and mental state 
deteriorated. Missing values for Psychiatry and 
Psychology data at Post-Intervention and Follow-Up.
O
P _ Participant accepted Psychiatry and Psychology data at
Pre-Intervention and Psychology data only at Post- 
Intervention. Missing values for Psychiatry data at Post- 
Intervention and Follow-Up and for Psychology data at
__________________ Follow-Up._______________________
* denotes that participant completed data at all three time points.
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Appendix 14: Raw Data
Detailed below is the raw data for each participant on all of the variables 
analysed for this study.
Participant A
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 1 2 0
Depression 1 1 0
Conceptual
Disorganisation
3 1 0
Unusual Thought 
Content
6 0 0
Hostility 0 0 0
Suspiciousness 5 0 1
BSI
Anxiety 0.50 1.17 -
Depression 1.33 0.83 -
Paranoid Ideation 2.25 0.80 -
Psychoticism 1.33 0.33 -
Hostility 0.25 0.40 -
SUMD
Mental Disorder 5 1 1
Medication 5 2 1
Social
Consequences
5 1 3
Insight Scale
Positive Insight 19 7 -
Negative Insight 5 26 -
IPQ-R
Consequences 27 19 -
Personal Control 24 20 -
Treatment
Control
16 19 -
Illness
Coherence
14 19 -
UKU-ConSat 5 -
- missing data
188
Participant B
Pre-Intervention Post-
Intervention
Follow-Up
BPRS 0 -
Anxiety 3 0 -
Depression 2 0 -
Conceptual
Disorganisation
0 0 -
Unusual Thought 
Content
0 0 -
Hostility 1 0 -
Suspiciousness 0 0 -
BSI
Anxiety 2.67 0 0 .83
Depression 0.67 0 0 .50
Paranoid Ideation 1.00 0 0
Psychoticism 1.33 0 0 .40
Hostility 1.75 0 0
SUMD
M ental Disorder 5 1 -
Medication 5 1 -
Social
Consequences
1 5 -
Insight Scale
Positive Insight 19 22 20
Negative Insight 8 11 8
IPQ-R
Consequences 23 16 20
Personal Control 23 22 22
Treatm ent Control 25 20 20
Illness Coherence 5 10 16
UKU-ConSat 13 13
- missing data
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Participant C
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 3 1 0
Depression 0 0 0
Conceptual
Disorganisation
0 0 0
Unusual Thought 
Content
4 0 0
Hostility 2 0 0
Suspiciousness 4 1 0
BSI
Anxiety 0.17 0 0
Depression 0 0.17 0
Paranoid Ideation 2.25 0 0 .60
Psychoticism 1.33 0.33 0 .40
Hostility 0 .75 0 0 .20
SUMD
M ental Disorder 5 1 3
Medication 5 1 1
Social
Consequences
5 1 5
Insight Scale
Positive Insight 9 23 17
Negative Insight 7 10 5
IPQ-R
Consequences 17 20 21
Personal Control 23 21 21
Treatm ent Control 13 18 18
Illness Coherence 14 20 19
UKU-ConSat 4 0
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Participant D
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 2 0
Depression 0 0 0
Conceptual
Disorganisation
2 3 2
Unusual Thought 
Content
2 0 r\z
Hostility 0 3 0
Suspiciousness 3 4 3
BSI
Anxiety 0.17 0.50 0 .17
Depression 0.17 1.17 0 .67
Paranoid Ideation 1.50 2 .60 1.00
Psychoticism 0.33 0.33 0
Hostility 0.25 0.20 0 .20
SUMD
M ental Disorder 5 5 5
M edication 5 5 5
Social
Consequences
5 5 5
Insight Scale
Positive Insight 18 15 19
N egative Insight 8 8 7
IPQ-R
Consequences 12 19 7
Personal Control 26 24 20
Treatm ent Control 10 10 12
Illness Coherence 5 15 11
UKU-ConSat -10 -10
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Participant E
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 0 0
Depression 0 0 0
Conceptual
Disorganisation
0 0 0
Unusual Thought 
Content
3 3 3
Hostility 3 2 2
Suspiciousness 3 3 3
BSI
Anxiety 1.00 0 0
Depression 0.50 0.50 0 .17
Paranoid Ideation 2.00 0.60 0 .60
Psychoticism 1.33 0.67 0 .20
Hostility 1.25 0.20 0 .20
SUMD
M ental Disorder 5 5 5
Medication 5 5 5
Social
Consequences
5 5 5
Insight Scale
Positive Insight 15 15 15
Negative Insight 12 8 8
IPQ-R
Consequences 10 10 8
Personal Control 14 16 14
Treatm ent Control 13 15 13
Illness Coherence 5 15 9
UKU-ConSat 4 4
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Participant F
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 2 0 0
Depression 3 0 0
Conceptual
Disorganisation
0 1 0
Unusual Thought 
Content
0 0 0
Hostility 0 0 0
Suspiciousness 0 0 0
BSI
Anxiety 2 .17 0 0
Depression 1.33 0 0
Paranoid Ideation 2.75 0 0 .40
Psychoticism 2.33 0.33 0 .60
Hostility 0 0 0
SUMD
M ental Disorder 3 5 1
Medication 5 3 1
Social
Conseouences
3 1 1
Insight Scale
Positive Insight 12 17 20
Negative Insight 6 6 7
IPQ-R
Consequences 25 23 29
Personal Control 20 30 30
Treatm ent Control 17 25 24
Illness Coherence 20 10 15
UKU-ConSat 12 12
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Participant G
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 0 -
Depression 0 0 -
Conceptual
Disorganisation
3 0 -
Unusual Thought 
Content
3 0 -
Hostility 1 0 -
Suspiciousness 1 0 -
BSI
Anxiety 0 0.67 -
Depression 0 0.67 -
Paranoid Ideation 0.67 2.60 -
Psychoticism 0 1.00 -
Hostility 0 0.60 -
SUMD
M ental Disorder 5 5 -
Medication 5 5 -
Social
Consequences
5 5 -
Insight Scale
Positive Insight 13 14 -
Negative Insight 3 9 -
IPQ-R
Consequences - - -
Personal Control - - -
Treatm ent Control - - -
Illness Coherence - - -
UKU-ConSat -12 -
- missing data
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Participant H
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 0 -
Depression 2 3 -
Conceptual
Disorganisation
2 0 -
Unusual Thought 
Content
3 1 -
Hostility 0 0 -
Suspiciousness 2 0 -
BSI
Anxiety 1.67 1.00 -
Depression 3.00 1.67 -
Paranoid Ideation 2.50 1.80 -
Psychoticism 0.67 0.33 -
Hostility 2.25 2 .20 -
SUMD
M ental Disorder 5 1 -
Medication 5 1 -
Social
Consequences
3 1 -
Insight Scale
Positive Insight 22 20 -
Negative Insight 8 8 -
IPQ-R
Consequences 24 20 -
Personal Control 11 20 -
Treatm ent Control 14 15 -
Illness Coherence 20 12 -
UKU-ConSat - ^  ' • ■ - ■ '  ’ 3 -
- missing data
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Participant I
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 3 3 0
Depression 2 2 3
Conceptual
Disorganisation
0 0 0
Unusual Thought 
Content
1 0 1
Hostility 1 1i 0
Suspiciousness 0 0 0
BSI
Anxiety 1.83 1.33 1.33
Depression 0.33 0.33 0
Paranoid Ideation 0.25 0 0
Psychoticism 0 0.33 0.60
Hostility 0 .25 0.40 0
SUMD
M ental Disorder 4 3 1
Medication 3 3 1
Social
Consequences
5 3 1
Insight Scale
Positive Insight 18 22 22
Negative Insight 7 8 5
IPQ-R
Consequences 23 21 20
Personal Control 22 19 19
Treatm ent Control 17 16 17
Illness Coherence 20 21 19
UKU-ConSat 5 7
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Participant J
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 1 1 -
Depression 2 1 -
Conceptual
Disorganisation
4 1 -
Unusual Thought 
Content
3 0 -
Hostility 3 0 -
Suspiciousness 2 0 -
BSI
Anxiety 2 .17 1.67 1.17
Depression 2.00 1.17 1.33
Paranoid Ideation 1.25 0.80 2 .20
Psychoticism 3.33 2.33 0 .60
Hostility 0 .50 1.40 0 .40
SUMD
M ental Disorder 5 1 -
Medication 5 1 -
Social
Consequences
5 3 -
Insight Scale
Positive Insight 16 21 11
Negative Insight 8 6 4
IPQ-R
Consequences - 20 21
Personal Control - 25 23
Treatm ent Control - 16 18
Illness Coherence - 15 23
UKU-ConSat 1 3 -2
- missing data
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Participant K
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 4 - -
Depression 1 - -
Conceptual
Disorganisation
4 - -
Unusual Thought 
Content
5 - -
Hostility 6 - -
Suspiciousness 6 - -
BSI
Anxiety 4 .0 0 - -
Depression 2.83 - -
Paranoid Ideation 3.75 - -
Psychoticism 2.33 - -
Hostility 1.75 - -
SUMD
M ental Disorder 5 - -
Medication 5 - -
Social
Consequences
5 - -
Insight Scale
Positive Insight 20 - -
Negative Insight 6 - -
IPQ-R
Consequences 16 - -
Personal Control 23 - -
Treatm ent Control 22 .50 - -
Illness Coherence 10 - -
UKU-ConSat
..................................... ..........  ................... - -
- missing data
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Participant L
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 2 2 2
Depression 0 0 0
Conceptual
Disorganisation
3 3 0
Unusual Thought 
Content
2 2 0
Hostility 0 0 0
Suspiciousness 2 3 0
BSI
Anxiety 2 .17 3.33 2 .67
Depression 2.17 2.17 2 .00
Paranoid Ideation 1.75 3.20 2 .40
Psychoticism 2.33 1.67 2 .20
Hostility 0 .25 1.40 0 .20
SUMD
M ental Disorder 3 1 5
Medication 2 5 1
Social
Consequences
5 5 5
Insight Scale
Positive Insight 19 20 20
Negative Insight 9 10 8
IPQ-R
Consequences 26 20 23
Personal Control 22 22 27
Treatm ent Control 20 19 20
Illness Coherence 13 20 12
UKU-ConSat ............ ................... 4 7
199
Participant M
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 2 0 -
Depression 1 0 -
Conceptual
Disorganisation
2 2 -
Unusual Thought 
Content
2 1 -
Hostility 0 0 -
Suspiciousness 3 0 -
BSI
Anxiety 2.00 0.67 -
Depression 2.67 1.33 -
Paranoid Ideation 3.50 3.00 -
Psychoticism 0.67 1.33 -
Hostility 0 .25 0 -
SUMD
M ental Disorder 5 5 -
Medication 5 5 -
Social
Consequences
3 4 -
Insight Scale
Positive Insight 26 26 -
Negative Insight 11 10 -
IPQ-R
Consequences 25 22 -
Personal Control 12 14 -
Treatm ent Control 15 17 -
Illness Coherence 18 21 -
UKU-ConSat 4 -
- missing data
2 0 0
Participant N
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 - -
Depression 0 - -
Conceptual
Disorganisation
0 - -
Unusual Thought 
Content
1 - -
Hostility 0 - -
Suspiciousness 2 - -
BSI
Anxiety 0 .83 - -
Depression 1.67 - -
Paranoid Ideation 0 - -
Psychoticism 1.33 - -
Hostility 1.25 - -
SUMD
M ental Disorder 3 - -
Medication 1 - -
Social
Consequences
1 - -
Insight Scale
Positive Insight 13 - -
Negative Insight 8 - -
IPQ-R
Consequences 19 - -
Personal Control 19 - -
Treatm ent Control 6 - -
Illness Coherence 9 - -
UKU-ConSat - -
- missing data
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Participant O
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 2 2
Depression 0 0 0
Conceptual
Disorganisation
3 0 0
Unusual Thought 
Content
3 0 0
Hostility 0 0 0
Suspiciousness 3 2 0
BSI
Anxiety 0.67 0.83 0
Depression 2.00 1.00 0.33
Paranoid Ideation 2.25 1.20 0
Psychoticism 1.67 0.33 0
Hostility 3.25 0.80 0
SUMD
M ental Disorder 5 1 1
Medication 1 1 1
Social
Consequences
5 3 1
Insight Scale
Positive Insight 21 23 19
Negative Insight 9 8 6
IPQ-R
Consequences 28 14 17
Personal Control 23 19 20
Treatm ent Control 25 15 22
Illness Coherence 15 16 10
UKU-ConSat 1 1
2 0 2
Participant P
Pre-Intervention Post-
Intervention
Follow-Up
BPRS
Anxiety 0 - -
Depression 0 - -
Conceptual
Disorganisation
1 - -
Unusual Thought 
Content
0 - -
Hostility 3 - -
Suspiciousness 2 - -
BSI
Anxiety 1.50 1.33 -
Depression 3.00 1.17 -
Paranoid Ideation 2 .00 0.60 -
Psychoticism 2.67 1.33 -
Hostility 1.25 0.40 -
SUMD
M ental Disorder 5 - -
Medication 5 - -
Social
Consequences
5 - -
Insight Scale
Positive Insight 21 - -
Negative Insight 10 - -
IPQ-R
Consequences 21 17 -
Personal Control 21 23 -
Treatm ent Control 15 15 -
Illness Coherence 13 20 -
UKU-ConSat -4 -
- missing data
2 0 3
Appendix 15 BPRS -  Reliable Change Indices
The tables below indicate the Reliable Change Index values for each 
individual when comparing results from Pre-Intervention to Post-Intervention 
and Pre-Intervention to Follow-Up on the BPRS.
Pre-Intervention to Post-Intervention
Anxiety Depression Conceptual
Disorganisation
Unusual
Thought
Content
Hostility Suspiciousness
A -0.62 0 3.08* 10.17* 0 4.42*
B 1.86 1.44 0 0 0.71 0
C 1.24 0 0 6.78* 1.43 2.65*
D -1.24 0 -1.54 -1.69 0 -0.88
E 0 0 0 0 0.71 0
F 1.24 2.16* -1.54 0 0 0
G 0 0 4.62* 5.08* 0.71 0.88
H 0 -0.72 3.08* 3.39* 0 1.77
I 0 0 0 1.69 0 0
J 0 0.72 4.62* 5.08* 2.14* 1.77
K - - - - - -
L 0 0 0 0 0 -0.88
M 1.24 0.72 0 1.69 0 2.65*
N - - - - - -
0  -1.24 0 4.62* 5.08* 0 0.88
P - - - - - -
* significant finding (i.e. RCI >1.96)
- missing data
Pre-Intervention to Follow-Up
Anxiety Depression Conceptual Unusual Hostility Suspiciousness
Disorganisation Thought
Content
A 0.62
p
0.72 4.62* 10.17* 0 3.54 *-
C 1.86 0 0 6.78* 1.43 3.54*
D 0 0 0 0 0 0
E 0 0 0 0 0.71 0
F 1.24 2.16* 0 0 0 0
G - - - - - -
H - - - - - -
I 1.24
i
1.44 0 1.69 0.71 0
j
K - _ _
L 0 0 4.62* 3.39* 0 1.77
M - - - - - -
N - - - - - -
0  -1.24 0 4.62* 5.08* 0 2.65*
P - - - - - -
* significant finding (i.e. RCI >1.96) 
- missing data
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Appendix 16 BSI -  Reliable Change Indices
The tables below indicate the Reliable Change Index values for each 
individual when comparing results from Pre-Intervention to Post-Intervention 
and Pre-Intervention to Follow-Up on the BSI.
Pre-Intervention to Post-Intervention
Anxiety Depression Paranoid
Ideation
Psychoticism Hostility
A -0.90 0.74 2.27* 1.56 -0.26
B 3.60* 0.98 1.56 2.08* 3.07*
C 0.23 -0.25 3.52* 1.56 1.32
D -0.45 -1.47 -1.72 0 0.09
E 1.35 0 2.19* 1.04 1.84
F 2.93* 1.96* 4.30* 3.13* 0
G -0.90 -0.98 -3.02 A -1.56 -1.05
H 0.90 1.96* 1.09 0.52 0.09
I 0.68 0 0.39 -0.52 -0.26
J 0.68 1.23 0.70 1.56 -1.58
K - - - - -
L -1.58 0 -2.27 A 1.04 -2.02 A
M 1.80 1.96* 0.78 -1.04 0.44
N - - - - -
0 -0.23 1.47 1.64 2.08* 4.30*
P 0.23 2.70* 2.19* 2.08* 1.49
* significant finding (i.e. RCI >1.96)
A significant deterioration (i.e. RCI <-1.96) 
- missing data
Pre-Intervention to Follow-Up
Anxiety Depression Paranoid
Ideation
Psychoticism Hostility
A - - - - -
B 2.48* 0.25 1.56 1.46 3.07*
C 0.23 0 2.58* 1.46 0.96
D 0 -0.74 0.78 0.52 0.09
E 1.35 0.49 2.19* 1.77 1.84
F 2.93* 1.96* 3.67* 2.71 * 0
G - - - - -
H - - - - -
I 0.68 0.49 0.39 -0.94 0.44
J 1.35 0.98 -1.48 4.27* 0.18
K - - - - -
L -0.68 0.25 -1.02 0.21 0.09
M - - - - -
N - - - - -
O 0.90 2.45* 3.52* 2.60* 5.70*
P - - - - -
* significant finding (i.e. RCI >1.96)
A significant deterioration (i.e. RCI <-1.96) 
- missing data
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Appendix 17 SUMD -  Changes in Scores Over Time
The tables below indicate the change in scores for each individual when 
comparing Pre-Intervention to Post-Intervention and Pre-Intervention to 
Follow-Up.
Pre-Intervention to Post-Intervention
Awareness of Awareness of the Awareness of the Social
having a Mental Achieved Effects of Consequences of having a
Disorder Medication Mental Disorder
A 4 * 3 * 4 *
B 4 * 4 * -4
C 4 * 4 * 4 *
D 0 0 0
E 0 0 0
F -2 2 * 2 *
G 0 0 0
H 4 * 4 * 2 *
I 1 * 0 2 *
J 4 * 4 * 2 *
K - - -
L -2 -3 0
M 0 0 -1
N - - -
0  4 * 0 2 *
P - - -
* denotes improvement in insight 
- missing data
Pre-Intervention to Follow-Up
Awareness of Awareness of the Awareness of the Social
having a Mental Achieved Effects of Consequences of having a
Disorder Medication Mental Disorder
A 4 * 4 * 2 *
B - - -
C 2 * 4 * 0
D 0 0 0
E 0 0 0
F 2 * 4 * 2 *
G - - -
H - - -
I 3 * 2 * 4 *
J - - -
K - - -
L -2 1 * 0
M - - -
N - - -
0  4 * 0 4 *
P - - -
* denotes improvement in insight 
- missing data
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Appendix 18 The Insight Scale -  Reliable Change Indices
The tables below indicate the Reliable Change Index values for each 
individual when comparing results from Pre-Intervention to Post-Intervention 
and Pre-Intervention to Follow-Up on the Insight Scale.
Pre-Intervention to Post-Intervention
Positive Insight Negative Insight
A 2.62* 1.17
B 1.12 1.75
C 5.24* 1.75
D -1.12 0
E 0 0
F 1.87 0
G 0.37 3.51 *
H -0.75 0
I 1.50 0.58
J 1.87 -1.17
K - -
L 0.37 0.58
M 0 -0.58
N - -
0 0.75 -0.58
P - -
* significant finding (i.e. RCI > 1.96)
- missing data
Pre-Intervention to Follow-Up
Positive Insight Negative Insight
A - -
B 0.37 0
C 3.00* -1.17
D 0.37 -0.58
E 0 0
F 3.00* 0.58
G - -
H - -
I 1.50 -1.17
J -1.87 -2.34 A
K - -
L 0.37 -0.58
M - -
N - -
0 -0.75 -1.75
P - -
* significant finding (i.e. RCI >1.96)
A significant deterioration (i.e. RCI <-1.96) 
- missing data
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Appendix 19 IPQ-R -  Reliable Change Indices
The tables below indicate the Reliable Change Index values for each 
individual when comparing results from Pre-Intervention to Post-Intervention 
and Pre-Intervention to Follow-Up on the IPQ-R.
Pre-Intervention to Post-Intervention
Consequences Personal
Control
Treatment
Control
Illness
Coherence
A -2.73 A -0.97 1.04 1.17
B -2.39 A -0.24 -1.74 1.17
C 1.02 -0.48 1.74 1.41
D 2.39* -0.48 0 2.35*
E 0 0.48 0.69 2.35*
F -0.68 2.42* 2.78* -2.35 A
G - - - -
H -1.37 2.17* 0.35 -1.88
I -0.68 -0.72 -0.35 0.23
J - - - -
K - - - -
L -2.05 A 0 -0.35 1.64
M -1.02 0.48 0.69 0.70
N - - - -
O -4.78 A -0.97 -3.47 A 0.23
P -1.37 0.48 0 1.64
* significant finding (i.e. RCI >1.96)
A significant deterioration (i.e. RCI <-1.96) 
- missing data
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Pre-Intervention to Follow-Up
Consequences Personal
Control
Treatment
Control
Illness
Coherence
A - - - -
B -1.07 -0.24 -1.74 2.58*
C 1.43 -0.48 1.74 1.17
D -1.79 -1.45 0.69 1.41
E -0.71 0 0 0.94
F 1.43 2.42* 2.43* -1.17
G - - - -
H - - - -
I -1.07 -0.72 0 -0.23
J - - - -
K - - - -
L -1.07 1.21 0 -0.23
M - - - -
N - - - -
0 -3.93 A -0.72 -1.04 -1.17
P - - - -
* significant finding (i.e. >1.96)
A significant deterioration (i.e. <-1.96) 
- missing data
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Appendix 20 UKU-ConSat (total scores)
The table below indicates the total score for each individual on the UKU- 
ConSat at Post-Intervention and Follow-Up.
Post-Intervention Follow-Up
A 5 -
B 13 13
C 4 0
D -10 -10
E 4 4
F 12 12
G -12 -
H 3 -
I 5 7
J 3 -2
K - -
L 4 7
M 4 -
N - -
O 1 1
P -4 -
- missing data
210
Appendix 21: Personalised Psychoeducation Manual
This is a sample manual. Details have been 
changed to protect confidentiality.
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TRUST LOGO
CONFIDENTIAL
PERSONALISED INFORMATION BOOKLET
Joe Bloggs 
* Final Session
Date
PSYCHOLOGY DEPARTMENT
ADDRESS
Date
Dear Joe,
It was good to meet you on the <insert dates of first and second 
sessions>. In the first session, we were discussing the reasons 
why you are in the <name ofunit> and what you feel your 
difficulties are at the moment. In the second session, I gave you 
a letter with a shared idea of your understanding of what is 
happening to you right now and my understanding. In that 
session, you had the chance to change any aspects that you did 
not agree with. This letter is the amended version of the last 
letter.
In our meeting, you told me that you are in the <name of base 
unit> because you stopped taking your medication. You were 
also feeling stressed and upset because you were having 
difficulties with your relationship and because a good friend of 
yours committed suicide. You began to re-experience symptoms, 
including hearing voices and having “telepathic communications” 
from your friend who died. These messages were telling you to 
throw yourself in front of a train. When I met you the second 
time, you said that you were hardly getting any of these 
symptoms. You told me this was because the medication had 
started to work.
I asked you about what the doctors feel is wrong with you at the 
moment. You told me that they have told you that you have 
Paranoid Schizophrenia. You told me that you have had this in 
the past, but that you do not believe that you have it now.
Over the course of our session, you mentioned several times 
that you had been treated unfairly because of your 
Schizophrenia. You seemed to feel that other people are against 
you because of your illness.
1
The experiences that you are having, like receiving telepathic 
messages and hearing voices are common for people who have a 
psychosis. A psychosis is a condition in which the person’s 
contact with reality is lost or highly distorted. One illness in which 
people suffer from psychosis is Schizophrenia. Many people who 
have a psychosis don’t believe that they are suffering from an 
illness in the early stages. In your case, you told me that you are 
j io t  sure at the moment whether or not you are ill, but feel that in a 
few weeks, you will look back on this experience and realise that 
you are ill.
You mentioned that you have telepathic communications from the 
dead telling you to kill yourself. You also hear voices. These 
symptoms are called hallucinations and often seem to occur out 
of nowhere. Hearing voices that other people can’t hear is the 
most common type of hallucination. In your case, the voices give 
you orders to kill yourself.
You mentioned that you feel that everyone knows that you have 
Schizophrenia and think badly of you because of this. This belief 
seems to be true to you and can make you feel very frightened. It 
can make you feel alone because other people don’t believe you. 
This symptom is a delusion and is a common symptom of 
psychosis.
Your Experience Alternative Explanations
• Receiving telepathic 
messages from your 
friend who died telling 
you to kill yourself.
• This belief seems true 
to you, but can make 
you feel alone 
because other people 
don’t believe you and 
don’t have the same 
communications
. We think these 
feelings are due to a 
symptom called a 
hallucination.
• Hallucinations are a 
common symptom of 
psychosis.
Your Belief Alternative Explanations
. You believe that 
everyone around you 
knows that you have 
Schizophrenia and 
thinks badly of you 
because of this.
. Although you believe 
this very strongly we 
think these feelings 
are due to a symptoms 
called a delusion 
• Delusions are a 
common symptom of 
psychosis.
WHAT CAUSES THIS ILLNESS?
It is likely, but not certain, that you like other people who have a 
psychosis, have imbalances in your brain. These imbalances are 
in the chemicals that send messages around your brain. The main 
chemical involved in psychosis is called dopamine.
You mentioned that before your admission to <name of base 
' *+unit>, you felt stressed because of the death of your friend and 
' ^because you had been having relationship difficulties. In addition, 
you had stopped taking your medication.
Theory: Dr Zubin & Dr Spring, 1977
People, like you, who have a tendency to develop a psychosis and 
who experience extreme stress are more likely to develop a 
psychosis than if they had not had this stress.
STRESS
Individual with 
tendency to 
develop mental 
illness
PSYCHOSIS
You mentioned that you used to abuse many street drugs, 
including cocaine, heroin, crack, cannabis and speed. Your use of 
drugs is not unusual. Cannabis is one of the three substances 
most frequently misused by people with mental health difficulties 
like you. We feel that your use of cannabis and other drugs needs 
1 |^o be moderated significantly, if not stopped altogether.
■Researchers consider that cannabis should be seen as something 
which can precipitate further episodes of illness. Other Doctors 
like <name of Psychiatrist at base unit> feel that cannabis 
increases the risk of hospital readmission.
Drugs cause worsening of your symptoms and can trigger a 
further episode of psychosis. We know that the medication that 
you have been prescribed will block an important neurochemical 
called dopamine. We think that drugs have the effect of unblocking 
or enhancing dopamine pathways, which cause paranoid thinking, 
delusions and hallucinations.
HOW DO WE UNDERSTAND YOUR SYMPTONS?
In our discussion, you mentioned that sometimes you hear 
voices that other people can’t hear and believe that people are 
against you because you have Schizophrenia. There have 
been many Psychologists who have thought about this.
Theory: Dr Baddeley
Your symptoms are caused by a fault in the way that you hear 
information. This means that you are not always sure if a 
thought has come from inside your head or from someone 
else. This is called a disturbance of inner speech.
HOW THIS MAY RELATE TO YOU: The difficult voices that 
you hear about killing yourself are generated from your own 
anxieties about the world (for example, about people around 
you dying or leaving you). They are your own thoughts that are 
interpreted as coming from outside of your head.
Theory: Dr Frith, University College London 
You have some difficulties in realising that you had intended to 
think something. The result of this is that you think that the 
thought (or voice) has come from somebody else, but it has 
actually come from inside your head. This is called a 
disturbance of self-monitoring.
HOW THIS MAY RELATE TO YOU: The thoughts of wanting 
to throw yourself in front of a train originate from inside your 
head, but because of a disturbance of self-monitoring, you do 
not realise that you had intended to think them, so you 
perceive them as voices coming from outside of your head. 
Theory: Dr Bentall, Manchester
If people think that others are conspiring against them, then 
they won’t feel depressed about all the things that they haven’t 
done in their lives, because they’ll be able to blame it on 
someone else.
HOW THIS MAY RELATE TO YOU: Your experiences of 
feeling that others are persecuting you for having 
Schizophrenia may be a symptom of Schizophrenia. The 
theory suggests that you can blame others for you having 
Schizophrenia as you have found this difficult to accept 
yourself. This stops you from feeling depressed about the 
Schizophrenia, but instead ends up with you being angry with 
others.
A useful way to think about your symptoms is to use the following 
metaphor. It’s about a tug of war:
‘The situation you are in is like being in a tug-of-war 
with a monster. In between you and the monster is a pit,
1 and so far as you can tell it is bottomless. If you lose this
1 ^  tug-of-war, you will fall into this pit and will be
destroyed. So you pull and pull, but the harder you pull, 
the harder the monster pulls, and you edge closer to the 
pit.
The hardest thing to see is that our job here is not 
to win the tug-of-war Our job is to drop the rope.’
In this metaphor, think about the rope as the problems in your life. It 
says that if you keep using the same strategies to manage your 
difficulties, then drop the rope because its making things worse. 
How might this apply to you?
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WHAT CAN BE DONE TO IMPROVE YOU SYMPTONS?
You have been asked by your doctor to take anti-psychotic 
medication, called Clozaril. This is one of the most helpful 
ways of getting rid of psychosis. The medication acts on the 
dopamine in your brain. It cannot cure your psychosis, but it 
can take away many of the symptoms and make them milder. 
In some cases, they shorten the course of an episode of 
psychosis as well.
The other important way of controlling your psychosis is not to 
take street drugs. You mentioned that you take many different 
drugs and you know that these help to get rid of your 
symptoms in the short-term, but make them worse in the long 
term. This is because they interfere with the dopamine in your 
brain, that we talked about before.
One way of controlling your symptoms is to look after yourself 
by taking regular exercise (like going to the gym and kick­
boxing, that you enjoy), eating healthily and avoiding stressful 
situations.
In our discussion, you told me that some of the people that you 
mix with also like to take drugs and don’t have jobs.
Sometimes being with these people can make you feel worse. 
You also told me that you have two circles of friends: those 
who take drugs and those who do not. You said that you are 
going to try to avoid the friends who take drugs to help you to 
stay off them. We also encourage you to do this.
RELAPSE PREVENTION
In our meeting, you told me that, in the future, you are keen to get 
a job that you enjoy, e.g. engineering or mechanical work. We 
very much hope that you will be able to take up this lifestyle.
The most important way of making sure that you become well is to 
keep taking your medication. When medication is stopped, people 
'l Who have a psychosis often relapse and suffer from their 
delusions and hallucinations.
Another way of making sure that you don’t relapse is to get 
enough sleep. When you notice that you haven’t been getting 
enough sleep, speak to your Social Worker <name> or GP 
<name> or CPN <name>.
When we talked about how you were feeling before you came to 
hospital, you said:
■ Feeling lethargic
■ Having no motivation
■ Feeling depressed
■ Hearing voices
■ Receiving telepathic messages
These symptoms were probably the signs that your psychosis was 
coming back. This is called “Relapse”. When you start to 
§£perience these symptoms, it is important that you contact your 
1 Spcial Worker, CPN or doctor immediately.
Finally, a key way of staying healthy is to keep stress at bay. If you 
become stressed, your symptoms, including delusions and 
hallucinations, may emerge. Ways of keeping stress at bay are to 
exercise (including kick boxing and going to the gym), to socialise 
and to eat healthily.
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WHAT SHOULD I DO IF MY SYMPTONS START AGAIN?
When you know that your symptoms are starting again, the 
most important thing for you to do is to tell someone. You could 
tell your Social Worker <name>, your GP <name>, your 
Psychiatrist <name> or your CPN <name>.
It is likely that your doctor will prescribe you some medication.
It is really important that you take this to reduce the 
uncomfortable feelings.
Remember, your psychosis is an illness. It can be treated. You 
can make it better by taking your medication and by staying 
stress-free. There are lots of people around to help you. You’re 
not alone.
PLANS FOR THE FUTURE
It’s great that you want get a job, e.g. engineering or mechanics.
You may want to get some advice about your future career by 
calling the Citizens Advice Bureau. Their phone number is <local 
branch>. Also, there is a Personal Advisor Service that you may find 
■ ireful in thinking about your career. The phone number is free and 
i%<telephone number>.
You may want to go to college to train in engineering or mechanics. 
The local college that has this sort of course is <name> and you can 
contact them on <number>
If you find that you are again having problems with drugs, you may 
either want to contact a doctor (your GP or Psychiatrist) of you may 
also find it helpful to contact Drugline to talk to someone about your 
difficulties. Their phone number is <insert telephone number>.
Useful phone numbers
Citizens Advice Bureau: insert phone number
Personal Advisor Service: insert phone number
Name of local college: insert phone number
Qfugline: insert phone number
-
I hope you have found this helpful.
Yours sincerely,
Judith Friedman
Trainee Clinical Psychologist
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